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ABSTRACT
The object of this thesis was to develop and
characterise monoclonal antibodies which would
recognise damaged and or regenerating endothelial cells
and which might therefore be useful in the diagnosis
and treatment of vascular disease.
The work described was carried out with cultured
vascular endothelial cells of human, bovine, or porcine
origin. In vitro models of endothelial damage were
devised in which cells were damaged by various methods.
Mouse monoclonal antibodies were raised by inoculation
with cultured endothelial cells and tested against
damaged endothelium in vitro. A number of antibody
producing clones were identified, isolated and grown on
for characterisation of the antibody produced.
Using an immunohistochemical system for localising
the sites of binding of these antibodies to cultured
endothelial cells, a number of different patterns of
antibody binding were identified. Attention was
concentrated on antibodies which appeared to
selectively bind to damaged endothelial cells.
In an attempt to identify the antigens recognised
by the monoclonal antibodies the protein constituents
of endothelial cell lysates were separated by sodium
dodecyl sulphate polyacrylamide gel electrophoresis.
The protein bands were transferred to nitrocellulose
membranes so that specific bands which reacted with
individual protein bands could be identified. A number
of protein bands were identified which reacted with
specific monoclonals. An interaction between damaged
endothelial cells and the Fc component of IgG has been
previously described in the literature. The non¬
specific interaction of IgG with endothelial cells was
confirmed in this study and the binding component
identified. Reasons for believing that the monoclonal
antibodies raised in this project predominantly
interacted with damaged endothelial components by
specific rather than non-specific binding are
discussed.
Attempts were made to label some of the monoclonal
antibodies with radionuclides so that they could be
used in an in vivo model system. Only limited success
was achieved in labelling with radioactive iodine. but
it did prove feasible to produce internal labelling
with tritium by growing the antibody producing cells in
medium containing tritiated lysine.
The possibility of using a monoclonal antibody to
target a drug to areas of endothelial damage was
investigated by covalently linking urokinase to one of
the monoclonal antibodies. The ability of the conjugate
to produce fibrinolysis strictly limited to areas of
endothelial damage was demonstrated in an in vitro
model. This agent may have possible uses as a strictly
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The endothelium consists of a single layer of
tightly apposed cells which lines the luminal surface
of the entire cardiovascular and lymphatic systems
(Altschul 1954). It constitutes a continuous and
dynamic interface between the blood and the rest of the
body tissues, with many complex biochemical
interactions occurring within the cell and at the cell
surface. (Cryer 1983, Fishman 1982).
Endothelial integrity is critical for normal
vascular function, particularly in its role of blood
compatibility and maintenance of blood fluidity (Jaffe
1984, Gimbrone 1986).
This chapter reviews the structural and functional
properties of the endothelium and the consequences of
endothelial injury and dysfunction.
1.1. GENERAL MORPHOLOGY AND STRUCTURE.
The ultrastructure of endothelial cells has been
studied in some detail. Each cell has a single nucleus
surrounded by scant cytoplasm. Cell thickness on cross-
sectioning is approximately 0.2microns through the
cytoplasm and 3microns through the nucleus (Simionescu
et al 1978). This 'bulging' nucleus gives the
endothelium a 'cobblestone' appearance in scanning
electron micrographs of en face preparations.
In the cytoplasm, mitochondria, rough endoplasmic
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reticulum, Golgi complexes, pinocytic vesicles and
multivesicular bodies are present. The Golgi complexes
tend to be perinuclear and numerous microtubules and
microfilaments of various sizes criss-cross the
cytoplasm (HaudenschiId et al 1975). These
microfilaments and microtubules are thought to have a
crucial role in cell motility and replication (Selden &
Schwartz 1979, Gotlieb et al 1983, Wong & Gotlieb
1984).
Weibel-Palade bodies (WP bodies) are electron
dense, rod-shaped organelles, which consist of unit
membrane bound bundles of tubules of approximately 150
Angstroms in width (Weibel & Palade 1964, Haudenschild
et al 1975). These organelles are often clustered near
the periphery of the cell cytoplasm. Their function is
not entirely clear but they have been associated with
von Willebrand factor (vWF) and may be storage sites
for this substance (Jaffe et al 1973, Wayne et al 1982,
Wagner et al 1982, Wagner & Marder 1984).
WP bodies appear to be exclusive to endothelial
cells and are particularly abundant in human umbilical
cord vein endothelium. However they have proven to be
unreliable markers for endothelial cell identification
since they are present in only 30 to 70% of cells
otherwise identified as endothelium. They are rarely
seen in capillary endothelium (Jaffe et al 1973). Large
3
numbers of WP bodies have been reported in injured
endothelial cells but these findings are inconsistent
(Trillo & Pritchard 1979, Reidy & Schwartz 1983).
Scanning electron microscopy studies of the
endothelium in vivo, show a single layer of very
closely apposed cells with extensive overlapping of
'cytoplasmic flaps' of neighbouring cells (Reidy &
Schwartz 1981a, Reidy & Schwartz 1981b, Woolf 1983). In
large vessels the endothelium consists of flattened,
elongated cells (and nuclei) with the longitudinal axis
aligned with the direction of blood flow. Cell shape
tends to vary from vessel to vessel and within the same
large vessel, with elongation being more prominent near
vessel branch points. Cell shape may indicate an
adaptation of the cells to blood flow and shear stress
and may also reflect the elastic properties of the
vessel wall (Woolf 1983). In static culture endothelial
cells have a rounded polygonal shape, giving the cells
a morphologically typical cobblestone appearance (Jaffe
et al 1973).
In the capillaries and the post-capillary venules
of the lymph nodes the endothelium has become
specialised in structure. This 'high endothelium' has a
columnar structure with deep troughs between individual
cells, therefore effectively increasing the surface
area to aid the passage of lymphocytes to and from the
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circulation through the capillary walls (Cho & De Bruyn
1979, Ager 1987).
1.2. CONTACT INHIBITION AND GROWTH CONTROL.
1.2.1. Contact inhibition and the role of cell shape
in growth control.
Endothelial cells differ from most other cells in
culture in that they show a final growth saturation
density that is independant of serum concentrations,
nutrients or other growth factors (HaudenschiId et al
1979, Schwartz et al 1979). This suggests that
endothelial cell growth is controlled intrinsically by
the cells. This has been substantiated by studies that
have shown that membrane extracts from confluent cells
could arrest the growth of subconfluent cultures of the
same cell type (Whittenberger & Glaser 1977, Natraj &
Datta 1978). Vlodavsky and co-workers (1979)
demonstrated the presence of a cell surface protein of
60,000 Dalton molecular weight (CSP-60) on confluent
vascular endothelial cells that was not present on the
same cells at subconfluent densities. However there is
no evidence that CSP-60 has an active role in growth
contro1.
In anchorage dependant cells, cell to cell contact
inhibits or reverses cell movement (Albrecht-Buehler
1977). However it seems unlikely that cell contact
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alone is sufficient to inhibit growth. Work by Folkman
& Moscona (1978) has shown that DNA synthesis is
associated with cell shape in anchorage dependant cell
growth. At sparse plating densities cells adhere and
spread out along the growth substrate in a flattened
and often elongated manner. These cells are active in
DNA synthesis. By changing the growth substrate so that
sparsely plated cells retain a more rounded spheriodal
shape, DNA synthesis was shown to be inhibited. As cell
density increases, as in a confluent cell monolayer,
individual cells become rounded, spheroidal and 'less
flattened'. In confluent monolayers DNA synthesis and
hence cell replication ceases. It is therefore
postulated that cell shape influences DNA synthesis and
therefore has a role in controlling replication and
growth.
This hypothesis may explain the pattern of cell
replication in a regenerating wounded monolayer, shown
by Schwartz et al (1978), where DNA synthesis was not
confined to the cells at the immediate wound edge but
also present in cells away from the wound edge. The
cells at the wound edge, spread out to cover the
denuded area, taking 'the pressure off' the cells
further back, which spread out to maintain monolayer
integrity. The resulting shape change initiates DNA
synthesis.
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1.2.2. Gap junctions and growth control.
Communication between cells in the vascular wall
occurs via intercellular gap junctions, tight junctions
and desmosomes. Thus maintaining cell homeostasis by
transport of nutrients, growth factors / inhibitors and
electrolytes, between cells and the surrounding medium
(Larson & Sheridan 1985, Huttner et al 1973, Lowenstein
et al 1981). Regenerating and proliferating cells do
not have gap junctional structures, which only appear
when regrowth is complete and the monolayer intact
(Schwartz et al 1975, Lowenstein 1979, Bruzzoni & Meda
1988). For this reason gap junctions and the passage of
growth controlling molecules may have a role in contact
inhibition.
Cultured endothelium shows fewer gap junctions
than in vivo preparations. Gap junctions also exist
between endothelium and the intimal smooth muscle
cells, supporting other evidence of the role of
endothelium in the control of smooth muscle
proliferation . In vitro, numbers of gap junctions in
the endothelium decreases with increasing number of
subcultures (Davies et al 1985, Joris & Majno 1977). If
this is also true of aging endothelium in vivo it may
support the role of gap junctional communication in the
control of intimal smooth muscle cell proliferation by
the endothelium and the development of atherosclerosis
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as part of the ageing process.
Gap junctional communication and intercellular
passage of molecules between endothelial cells and
adhering leukocytes has also been reported (Guinan
et al 1988).
1.2.3. Growth factors.
There is considerable evidence that endothelial
cell growth is controlled by extrinsic polypeptide
growth factors. These growth factors may play important
roles in the body's response to injury, by promoting
wound healing such as the action of epidermal growth
factor (EGF) (Brown et al 1986) and also in
angiogenesis and neovascularisation (Folkman &
Klagsbrun 1987).
Many peptide growth factors have been identified
and characterised and would appear to be
multifunctional and interactive with each other (Sporn
& Roberts 1988). Among the first angiogenic growth
factors to be identified, and the most important to
endothelial growth are a group of heparin binding
polypeptides. Fibroblast growth factor (FGF) was first
isolated from brain (Gospodarowizc et al 1978a). It
exists in two forms, acidic and basic FGF. Endothelial
cell growth factor (ECGF) was first isolated from
hypothalamus (Maciag et al 1979). Two forms of ECGF, a
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and b, have been isolated and are thought to be members
of the acidic FGF family (Burgess et al 1985). The
basic FGF family share many biochemical features with
the ECGF/acidic FGF family and it is likely that the
various FGF molecules are multiple forms of acidic or
basic FGF. Whether this is physiologically significant
or just an artifact of purification is not clear.
Heparin - binding growth factors mediate
biological activity through a high affinity polypeptide
receptor on the endothelial cell surface. It would
appear that distinct receptors for acidic and for basic
FGF forms exist (Friesal et al 1986, Huang & Huang
1986). The FGF/ECGF molecule is rapidly translocated to
the nucleus where it stimulates the transcription of
ribosomal genes (Bouche et al 1987).
The role of heparin in the mechanism of ECGF/FGF
receptor binding is unclear, although it is known to
increase the binding of ECGF to endothelial cells and
it also protects FGF from inactivation (Schreiber et al
1985, Gospodarowicz & Cheng 1986).
Both types of FGF/ECGF stimulate endothelial cell
proliferation in vitro and in vivo. In vitro, FGF is
reported to be necessary for the clonal growth of
endothelial cells and for prolonging the replicative
life span of bovine aortic endothelial cells
(Gospodarowicz et al 1976). However, bovine cells can
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be grown from clonal densities and for a large number
of replications without addition of FGF (Levine &
Mueller 1979, Chapter 2 ). Human endothelial cells in
vitro do seem to have a greater requirement for
ECGF/FGF at sparse densities (Johnson et al 1979,
Gospodarowicz et al 1978b). It has been observed in
vivo, that regrowth of endothelial cells after
widespread loss stops even though reendothe1ia1isation
is not complete. Cell senescence and inhibition of
endothelial replication by underlying smooth muscle
cells did not seem to be responsible (Reidy et al 1983,
Reidy 1988). Growth of these quiescent cells could be
stimulated by bFGF (Lindner et al 1990).
Almost all normal tissues produce heparin- binding
growth factors, however, endothelial turnover in vitro
is extremely low. This raises questions as to the role
of these growth factors in vitro. Does contact
inhibition and the influence of cell shape at
confluence have a role in 'switching off' growth factor
receptor mediated action ? Or, are growth factors
sequestered within the cells of origin and do not have
access to endothelial cells under normal conditions ?
After damage to the cells or tissues FGF/ECGF may be
released to play a major role in tissue repair.
However, much is still to be learned about the exact
mechanisms of growth factor action.
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A number of other angiogenic growth factors have
been identified in recent years which may have more
relevance to the vascularisation process in tumours
than in vascular repair. Angiogenin was first isolated
from the conditioned medium of a human adenocarcinoma
cell line and is a potent stimulator of angiogenesis
(Fett et al 1975). Its cell specificity is unknown but
it is not a mitogen for vascular endothelial cells.
Transforming growth factors (TGF) were originally
isolated from viral - transformed rodent cells and are
known to alter phenotypes of some normal cells to
transformed cells (De Larco & Todaro 1980). TGF-a also
stimulates microvascular endothelial cell
proliferation. TGF-b on the other hand inhibits
proliferation of vascular endothelial cells in vitro
but seems to have some sort of stimulatory effect on
neovascularisation in vivo, either directly or through
mediation by another growth factor (Schreiber et al
1986) .
Endothelial cells have the ability to condition
their own medium, which can support the growth of other
endothelial cells and fibroblasts at sparse densities
in the absence of other growth factors (Greenburg et al
1980, Gajdusek et al 1980). This endothelial derived
growth factor (EDGF) has not been fully characterised.
It has also been reported to stimulate the growth of
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monoclonal antibody producing hybridoma cells at clonal
density. The existence of such a growth promoting agent
supports the importance of intrinsic factors in the
control of growth.
A growth factor derived from platelets (PDGF) has
produced some conflicting results. PDGF levels in
plasma are low, but should be increased locally at
sites of endothelial injury due to platelet activation
(Goldberg et al 1980). D'Amore and Shepro (1977) found
that bovine aortic endothelium showed a higher rate of
proliferation in the presence of PDGF and whole
platelets. However, other studies have shown that both
human and bovine endothelium grow readily in the
absence of PDGF and other platelet factors (Schwartz et
al 1979, Davies & Ross 1978, Gadjusek & Schwartz 1983,
Jarrell et al 1984). This is also true for cells at the
wound edge.
The role of growth factors in general cell growth
control is unclear. Studies on the role of these agents
have all been done in vitro, which may reflect the
behaviour of cells under culture conditions rather than
true responses in vivo.
1.3. LIFE SPAN AND CELL SENESCENCE.
In culture, endothelial cells have been shown to
have a finite life span with cellular senescence
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occurring after repeated subculture (Jaffe et al 1973,
Schwartz 1978, Gajdusek & Schwartz 1983, Jarrell et al
1984, Gimbrone et al 1974). This finite life span
appears to be a pre-programmed event that is dependant
on the number of cell divisions rather than chronologic
time. Studies by Levine et al (1984) have shown that
the exact point in terms of population doublings , at
which senescence occurred, in cloned bovine endothelial
cells, varied from clone to clone but was reproducible
for each clone.
The loss of proliferative capacity of serially
cultivated endothelium is accompanied by other cellular
changes. Giant multinuclear cells are a common feature
of senescing cultures. These cells have a protein
content three to four times greater than that of normal
cells, with an increased number of vacuoles,
multivesicular bodies, lipid droplets and Golgi
complexes (Rosen et al 1981). Senescent cells show no
Weibel-Palade bodies (HaudenschiId et al 1975).
Chromosomal abnormalities are also observed with the
loss of proliferative capacity in models of cellular
senescence (Miller et al 1975). Synthetic and metabolic
capabilities are also affected. The decrease and
eventual loss of production of angiotensin converting
enzyme in cells of increasing number of subcultures is
well documented (Levine et al 1983, Auerbach 1984). The
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loss of Weibel-Palade bodies in giant senescing cells
may reflect a change in distribution and storage of vWF
rather than loss of synthetic capabilities by these
aging celis.
The finite life span of cultured endothelial cells
is due to their low frequency of spontaneous
transformation . Some bovine endothelial cell cultures
with indefinite or greatly expanded life spans in the
absence of growth factors have been reported but are
thought to be the result of cell transformation
(Schwartz et al 1980, Gaynor 1971, Caplan & Schwartz
1973, Schwartz & Benditt 1976). These studies have also
shown focal areas of increased cell turnover which are
frequently found near vessel branch points and may be
due to hypertension (Schwartz & Benditt 1977), the
effects of flow and shear stress (Caplan & Schwartz
1973) or hyper1ipidemia (Bondjers et al 1977). The
daily cell turnover rate of these areas has been
reported to be as high as 10%. Such constant high cell
turnover may exhaust the cells' life span, leaving
areas of senescent cells and eventual denudation.
Altered subendothe1ium affecting the replacement of
such areas by adjacent 'normal' cells must be
considered. The implications of this phenomenon in age-
related disease process is discussed below.
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1.4. ENDOTHELIAL REGENERATION.
The initial phase of re-endothe1ia1isat ion after a
denuding injury is by movement of the adjacent cells
into the wound, followed by cell replication. This
movement is unidirectional and highly coordinated,
requiring the presence of nucleotides (Haudenschi1d &
Harris-Hooker 1984, Gotlieb et al 1981, Gotlieb &
Spector 1981). Static non-migrating cells have
microtubules radiating from a perinuclear organising
centre, in a random fashion. Migrating cells show
alignment of microtubules parallel to the direction of
movement with the microtubule organising centre in
front of the nucleus facing the direction of movement
(Gotlieb et al 1979, Gotlieb et al 1983). Small single
cell wounds are closed very rapidly (within 30 to 40
minutes) by movement of cytoplasmic lamellopodia from
surrounding cells into the denuded area (Wong & Gotlieb
1984). This does not seem to be followed by cell
replication.
In larger denuding injuries, cell movement is
followed by cell replication but the latter is not
initiated for up to 20 hours after the initial wounding
event (Schwartz et al 1978). Thymidine index values
remain elevated for approximately 96 hours after
wounding. In extensive denuding injuries, cell
replication may stop before reendothe1ia1isation is
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complete. This is not due to contact inhibition, cell
senescence or inhibition by smooth muscle cells (Reidy
et al 1983, Reidy 1988). Regrowth could be stimulated
by the addition of bFGF (Lindner et al 1990).
Wound regeneration in vivo has two major
differences from that in vitro. First, cells in vivo
regenerate faster in a direction parallel to blood
flow. Second, unlike wounding in vitro where response
is confined to cells proximal to the wound edge, a zone
of regeneration extending approximately 100 cells back
from the line of injury occurs in vivo. In this zone
cells show an increased proliferation, in excess of
that required for simple cell replacement. Such areas
of wounding in vivo can be recognised by endothelium of
increased cell density which seems to persist for some
time after injury (Schwartz et al 1978, Reidy &
Schwartz 1981b). In non-denuding cell injuries such as
that caused by bacterial endotoxin where cell death
occurs slowly over a period of time, cell regeneration
occurs before cell loss. Healthy cells migrate
underneath the injured cells, possibly stimulated by
breakdown in intercellular communication, pushing dead
cells off the vessel wall once the re-




NORMAL ENDOTHELIAL SURFACE WITH A NET NEGATIVE CHARGE
ELECTROSTATICALLY REPELS PLATELETS, ALSO WITH
A NET NEGATIVE CHARGE.
'Q©G+ + + + + + V—-f + + +
(
"ALTERED" ENDOTHELIAL SURFACE LOSES NEGATIVE CHARGE
CAUSING IT TOBECOME "STICKY" TO PLATELETS.
DIAG. 1.1 Non-thrombogenicity of endothelium in terms of
electrostatic repulsion.
1.5. NON-THROMBOGENIC AND FIBRINOLYTIC ACTIVITIES OF
ENDOTHELIUM.
1.5.1. Physical properties of intact endothelium.
The non—thrombogenic properties of endothelium was
first recognised by Virchow (1856) and until fairly
recently this function was attributed to
physico-chemical properties of the luminal cell surface
and the glycocalyx (Pelikan et al 1979, Skutelsky et al
1975). Both the endothelial and platelet surface
membranes have a high sialoglycoprotein content, which
gives the cells a net negative charge. It has been
suggested that the forces of electrical repulsion
prevent platelet aggregation on the endothelial surface
(Born & Palinski 1984)(Diag.1.1). However, this process
alone seems highly unlikely in preventing the
initiating stages of haemostasis which is a highly
complex and coordinated process.
1.5.2. Prostacyclin production by endothelial cells.
A more active role of the endothelium in
controlling haemostatic / thrombotic balance was
considered with the discovery that endothelial cells
synthesize prostacyclin (PGI2)(Weks1er et al 1977,
Moncada et al 1977, Maclntyre et al 1978). PGI2 is a
potent inhibitor of platelet aggregation as well as
being a powerful vasodilator .
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PGI2 works by stimulation of adenylate cyclase
which raises intracellular levels of cAMP which in turn
limits the active transport of calcium ions into the
the cell cytoplasm. This inhibits calcium - dependant
phospho1ipase activity (Gorman et al 1977, Moncada
1983). Physiologically it inactivates platelet
aggregation by inhibiting shape change, platelet factor
3 activity and blocking the formation of membrane
receptors for fibrinogen and vWF (Moncada et al 1976,
Ehrman & Jaffe 1980, Fujimoto et al 1982).
High concentrations of PGI2 also inhibit platelet
adherence to subendothe1ia1 matrix (fibrinogen and vWF
being major components of this matrix)(Weiss & Turitto
1979) .
PGI2 does not inhibit its own synthesis since
endothelial cells possess a very active cAMP
phosphodiesterase which maintains a low cAMP level
during PGI2 synthesis and in the presence of exogenous
PGI2. It has also been found that high cAMP does not
depress endothelial synthesis of PGI2 (Hopkins & Gorman
1981, Brotherton & Hoak 1982).
Age and sex hormones both affect the production of
PGI2 by the endothelium. Male rats produce more PGI2
than females (Pomerantz et al 1980). When female
rabbits were given ethynyl estradiol, PGI2 production
dropped and conversely cultured female porcine
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endothelial cells increased PGI2 synthesis when given
testosterone (Elam et al 1980, Seillan et al 1983).
The state of growth of endothelial cells in
culture also affects synthesis. Human umbilical vein
endothelium produce more when pre-confluent than when
fully confluent. Bovine cells produce more the longer
they are maintained at confluence and can be
subcultured numerous times before PGI2 synthesis is
diminished. In contrast, adult human and porcine
endothelial cells in culture lose their capacity to
produce PGI2 during routine subculture (Eldor et al
1983, Weksler et al 1977). These effects may reflect
the consequences of tissue culture conditions rather
than the intrinsic differences in PGI2 synthesis.
Extrapolation of these results from in vitro studies to
in vivo behaviour in terms of PGI2 production must be
dealt with carefully.
Numerous substances such as ATP, bradykinin and
histamine stimulate the production of PGI2 (Pearson et
al 1983, Hong 1980, Baezinger et al 1981). Thrombin
causes a rapid but transient increase in human and
porcine cells but not in bovine cells (Czervionke et al
1979). Cell injury such as that caused by hypoxia and
hypotonicity induces a rapid release of PGI2 followed
by a marked decrease in capacity to synthesize it






















DIAG.1.2. Activation of protein C and initiation of fibrinolysis
by binding of thrombin to thrombomodulin.
The physiological role of PGI2 remains uncertain
since there is very little in the normal 'resting'
circulation and inhibition does not cause catastrophic
thrombosis. It seems more likely that PGI2 functions as
a part of the defence mechanisms of the endothelium
against local injury.
1.5.3. Thrombomodulin and activated protein C.
Studies with cells sub-lethally damaged by
irradiation, which causes a decrease in PGI2
production, show that although no PGI2 is produced the
cells still maintain non-thrombogenic properties (Eldor
et al 1983b). This is due to a number of other
properties of the endothelium in maintaining the
balance between anti-coagulation and pro-coagulation.
Endothelial cells have a unique membrane protein,
thrombomodulin, which binds thrombin reversibly and
with high affinity. This inactivates the enzyme's pro-
coagulant activity and at the same time thrombin
acquires the capacity to activate protein C (Esmon et
al 1982a, Bauer et al 1983, Esmon & Owen 1981, Esmon et
al 1982b). Activated protein C in turn inactivates
factor Villa and factor Va and may also mediate the




Fibrin formation is a central feature of
haeraostasis and tissue repair with the endothelium
playing a major role in the control of fibrin formation
and dissolution. Injury to the vessel wall and
disruption of the endothelial continuity results in the
formation of a fibrin / platelet plug. This process is
the result of a series of complex cascade events
initiated by exposure of the basement membrane. Fibrin
deposition on intact endothelial monolayers results in
cell contraction, disorganisation of the monolayer and
exposure of basement membrane thereby promoting further
fibrin formation (Schleef & Birdwell 1984, Weimar &
Delvos 1986). The mechanisms of fibrin induced
monolayer disruption are however poorly understood. The
fibrinolytic activity of normal endothelium may
therefore represent a self protecting mechanism by
preventing fibrin formation beyond the area of injury.
The primary fibrinolytic enzyme is plasmin, which
is formed by cleavage of its inactive circulating
precursor plasminogen by the action of plasminogen
activators (PA's). Two immunologically distinct
molecules with similar modes of action have been
characterised. These activators cleave the plasminogen




DIAG.1.3 Fibrinolytic pathway of u-PA
Urokinase or urinary type plasminogen activator
(u-PA) was originally found in the urine (Stump et al
1986a, Husain et al 1983). It exists in two
enzymatica1ly active forms, single chain u-PA (scu-PA)
or pro-urokinase (PRO-UK) and two chain u-PA (tcu-PA)
or high molecular weight urokinase (HMW-UK). Scu-PA is
produced by various cells in culture including
endothelium (Stump et al 1986b, Loskutoff 1986). Human
plasma concentrations have not been clearly determined.
Scu-PA has fibrin specific plasminogen activator
activity but does not actually bind to the fibrin
molecule (Gurewich & Pannell 1987). Without fibrin,scu-
PA has no plasminogen activator activity. This would
suggest a conformational change in plasminogen when
bound to fibrin that makes it receptive to scu-PA
activation.
In the presence of plasmin and kallikrein scu-PA
is converted to tcu-PA . Cleavage of the scu-PA
molecule occurs at the Phe-Lys bond at position 158,
resulting in a two chain molecule held together by
disulphide bonds (Ichinose et al 1986). Tcu-PA activity
does not require the presence of fibrin which suggests
a role in the activation of free circulating
plasminogen (Diag.1.3). This is substantiated by
studies which have shown scu-PA to have 3 to 4 times
greater thrombolytic activity than tcu-PA, and that
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ENDOTHELIAL CELLS
DIAG.1.4. Fibrinolytic pathway of t-PA
tcu-PA causes systemic fibrinogen depletion (Zamarron
et al 1984, Stump et al 1987).
Plasminogen activator inhibitors, also produced by
the endothelium, bind to circulating u-PA. PAI-1 and
PAI-2 react with tcu-PA but not with scu-PA (Verheijen
et al 1984, Kruithof et al 1986). Thrombin can cleave
the scu-PA molecule resulting in inactivation (Ichinose
1986).
Tissue type plasminogen activator (t-PA) is
predominantly produced by endothelial cells (Shepro et
al 1980, Levin & Loskutoff 1979, Laug 1981, Levin &
Loskutoff 1982b). Like u-PA, t-PA cleaves plasminogen
at the same arginine - valine bond. However, t-PA
activity requires binding of the molecule to fibrin
(Hoylaerts et al 1982), whereas u-PA acts on fibrin
bound plasminogen without binding to fibrin itself.
(Diag.1.4).
T-PA exists in two variants, single chain t-PA
(sct-PA) and a proteolytica1ly degraded two-chain form
(tct-PA). These molecules differ in molecular weight
and carbohydrate content (Rijken et al 1985). In the
presence of small amounts of plasmin and tissue
kallikrein, sct-PA is converted to tct-PA. Some
functional differences exist between sct-PA and tct-PA
but the physiological significance of these two
variants is unclear (Tate et al 1987, Rijken et al
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1985, Ranby & Wallen 1985). In the absence of fibrin
both forms of t-PA are poor activators of plasminogen,
sct-PA more so than tct-PA. Turnover rates of
plasminogen activation at physiological concentration
increase 200 to 400 times in the presence of fibrin
(Nieuwenhuizen et al 1983). Sct-PA has a greater
affinity for fibrin, but when bound to fibrin both
forms activate plasminogen equally well. The conversion
of the sct-PA form to the two chain form occurs on the
fibrin surface which would suggest that physiological
fibrinolysis induced by sct-PA occurs mainly via the
two chain derivative but this conversion does not
appear to play a significant role in the regulation of
fibrinolysis (Rijken et al 1982). Although local
concentrations of t—PA can be high, the circulating
levels in human plasma are very low with most of it
being complexed with PAI-1. This process appears to
occurs at the endothelial cell surface, with t-PA
covalently binding to membrane associated PAI-1. In
vitro, the resulting complex dissociates from the cell
surface (Barnathan et al 1988, Russell et al 1990).
Both sct-PA and tct-PA are inactivated equally well by
PAI-1, but PAI-2 inactivates tct-PA 100 times more
efficiently than sct-PA (Astedt et al 1985, Verheijen
et al 1984).
In cultured endothelial cells the synthesis and
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secretion of plasminogen activators is influenced by
the cell source, growth rate, state of nutrition and a
variety of external stimuli (Levin & Loskutoff 1982a,
Levin & Loskutoff 1980). Bovine endothelial cells
produce both u-PA and t-PA in culture (Levin &
Loskutoff 1982b). In log phase growth these cells show
a low rate of synthesis and release of t-PAs. On
reaching confluence and being maintained at confluence,
u-PA production is increased 20 to 30 times. Cultured
human endothelial cells synthesise more t-PA than
bovine cells (Levin & Loskutoff 1979).
Recent work has shown that cultured human
endothelial cells exhibit discrete binding sites for
both t-PA and u-PA (Hajjar & Hamel 1990, Barnathan et
al 1990). These binding sites are surface membrane
associated proteins of 40,000 and 48,000 KDa molecular
weights respectively (Hajjar & Hamel 1990). The
presence of these membrane binding sites may play a
role in the localisation of plasmin formation at the
vessel wall surface and maintain the non-thrombogenic
properties of the intact vessel.
1.5.5. Interaction of the endothelium with leukocytes.
Endothelial cell-leukocyte interactions play a
major role in the inflammatory and immune responses.
Vascular cell adhesion molecules are known to be
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important modulators of endothelial cell-leukocyte
interactions. A number of endothelial cell adhesion
molecules have been identified and characterised.
Cytokines such as interleukin-1 (IL-1) and tumour
necrosis factor-alpha (TNF-a) rapidly induce adhesion
molecule expression (Cotran et al 1988). In situ
adhesion molecule expression can be demonstrated,
immunohistochemically at sites of endothelial
activation (Cotran et al 1986). ELAM-1 (endothe1ia1-
leukocyte adhesion molecule-1) appears to be absent in
normal endothelium, but can be detected in post¬
capillary venule endothelial cells (high endothelium)
in delayed hypersensitivity reactions and after
immunotherapy with IL-1. ELAM-1 may have a role in the
initial phase of transendothe1ia1 neutrophil and
lymphocyte migration (Bevilacqua et al 1989).
ICAM-1 (intercellular adhesion molecule-1) is found
on a number of cells including lymphocytes and
endothelial cells (Simmons et al 1988). ICAM-1 is
present on normal endothelium and expression is
upregulated following cytokine treatment (Munro et al
1988) .
PECAM-1 (platelet -endothelial cell adhesion
molecule ) is an integral membrane protein that is
widely distributed in human endothelial cells and is
also cytokine inducible. This protein is predominant at
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intercellular junctions (Muller et al 1989).
GMP-140 is a member of the same family of adhesion
molecules as ELAM-1. It mediates the adhesion of
neutrophils and monocytes, and is stored in the alpha-
granules of platelets and the Weibel-Palade bodies of
endothelial cells. It is mobilised to the cell surface
after stimulation by thrombin and other products of the
coagulation cascade (Johnston et al 1989, Larsen et al
1989).
1.6. ENDOTHELIAL INJURY AND THE RESPONSE OF THE BLOOD /
VESSEL WALL.
1.6.1. Injury.
The endothelium, because of its unique position at
the interface between the blood and the tissues, is
subjected to a variety of foreign and endogenous
substances that may prove injurious. U1trastructura1ly,
cell injury appears to have two phases, the early and
possibly reversible phase is characterised by breakdown
of intercellular junctions and loss of cell to cell
communication, and dilatation of cytoplasmic vacuoles
and vesicles. The late and probably irreversible phase,
shows breakdown of mitochondria, destruction of plasma
and intracellular membranes, accumulation of calcium
(Trump & Arstila 1975, Farber et al 1981). Dead
cellular material is removed from the system by
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macrophages (Wyllie et al 1980). Whether Ca influx is
a result of loss of mitochondrial function and plasma
membrane channels and has an active part in cell death,
or whether it accumulates, coincidentally as a result
of increased permeability of the plasma membrane, is
debatable (Jennings et al 1975, Farber et al 1981,
Smith et al 1981, Hansson & Schwartz 1988).
1.6.2. Assays of cell injury.
A number of methods for assaying cell death both in
vitro and in vivo have been developed. The most
commonly used methods involve the principle of anionic
dye exclusion by intact plasma membrane. On cell death
or damage to the plasma membrane dyes such as trypan
blue, Evans blue and lissamine green gain access to
intracellular proteins to which they bind (Holmberg
1961). In effect these dyes are indicators of plasma
membrane injury.
Deposition of intracellular calcium is a
characteristic of cell death. The antibiotic
chlorotetracyc1ine binds to intracellular calcium
deposits and can be detected by fluorescence (Hansson &
Schwartz 1983). Similarly the accumulation of IgG has
been shown to occur in damaged cells. Damaged plasma
membranes allow the entry of IgG molecules into the
cell where they bind to the vimentin component of
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intermediate filaments. This occurs via the Fc
component of the Ig molecule (Hansson et al 1979,
Hansson et al 1984).
An alternative approach to detecting cell damage
is to look for cytoplasmic materials which leak into
the extracellular surroundings. A commonly used cell
damage marker is the cytoplasmic enzyme lactate
dehydrogenase (Morgan et al 1978). Such a method may be
useful in looking at large scale endothelial damage,
but cannot be used for localisation of small focal
areas of injury.
Various metabolic labels can be used to localise
damage with varying degrees of sensitivity. Fluoroscein
diacetate and acridine orange / ethidium bromide are
compounds that are metabolised by viable cells to give
a green fluorescence (Rotman & Papermeister 1966).
Adenine uptake gives an indication of nucleotide
production and hence the state of metabolism and
viability (de Bono et al 1977). Similarly ®^Rb efflux
can be employed as a fairly sensitive measure of
potassium efflux, an indicator of cell viability (Ager
et al 1984).
1.6.3. Types of endothelial injury.
Injury can be classified at two levels. That which
results in the loss of endothelial integrity, exposing
29
the underlying subendothe1ium, and that which causes
endothelial dysfunction but without cell loss. Most
studies of denuding endothelial injury come from in
vivo and in vitro models of deliberate physical damage
(Schwartz et al 1975, Clowes & Karnovsky 1977). This
type of damage may have some relevance to the sort of
pathological damage that occurs to the endothelium
after accidental trauma, during routine surgery and
also during some routine invasive diagnostic and
therapeutic techniques such as cardiac catheterisation
and balloon angioplasty.
Increased endothelial cell turnover has been
postulated as having a role in the initiation of
denuding injuries. Continuous high endothelial cell
turnover depletes the cells replicative life-span
leading to senescence and cell death . The reason for
observed focal areas of increased endothelial cell
turnover is unclear, but disturbances in flow,
hypertension, high shear stress and homocystinuria
have all been implicated (Davies 1988, Caplan &
Schwartz 1973, Starkebaum & Harlan 1986). There is no
evidence of spontaneous denudation although it is known
that endothelial cells undergo spontaneous loss and
replacement (Coutard et al 1986).
Cell injury, death and increased endothelial cell
turnover does not necessarily imply denudation. Studies
30
by Reidy and Schwartz (1983) have shown that
endothelial regeneration can be rapid and in cases
where cell death occurs over a prolonged period of
injury, as with endotoxin damage, dead cells are
replaced before denudation occurs.
Agents injurious to the endothelium are numerous.
Some such as bacterial endotoxins, viruses and
cytotoxic sera are foreign to the body, while others
are endogenous components which are 'activated' or
produced as a result of pathological or disease
processes.
The effects of endotoxin on endothelium is well
documented. At sublethal doses it is known to induce
the production of tissue factor, a cofactor for the
initiation of coagulation by endothelial cells (Galdal
1984, Schorer et al 1985). It has been implicated in
the pathogenesis of disseminated intravascular
coagulation in man and animals (Bradley 1979), and it
promotes neutrophil adhesion (Schleiner & Rutledge
1986).
Viruses have been found in vascular cells
associated with atherosclerotic plaques in both humans
and animals (Minick et al 1979, Fabricant et al 1978,
Cunningham 1988). Whether they have an active role in
the initiation of atherosclerosis or are simply
opportunistic pathogens is not yet clear. Viral
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infections of endothelial cells have been reported to
elevate the biosynthetic levels of interferon (Einhorn
et al 1985). Interferon in turn enhances the
susceptibility of infected cells to cytotoxic T cells
(Bukowski & Welsh 1985, Yu et al 1985). Interferon and
tumour necrosis factor (TNF) increases endothelial
permeability by structural changes to the monolayer
(Stolpen et al 1986). TNF and inter1eukin-1 promote
pro-coagulation activity of endothelial cells (Pober et
al 1986, Bevilacqua et al 1986).
Cytotoxic antibodies which are induced after
transplantation are also reported to increase pro-
coagulant activity of endothelium and similarly in
immune - mediated thrombocytopenia (de Bono 1977, Cines
et al 1987). A similar effect of cigarette smoke
through the inhibition of PGI2 production has also been
observed (Reinders et al 1986). Nicotine has been
reported to increase endothelial cell turnover
(Zimmerman & McGeachie 1985).
Neutrophil activation during the inflammatory
response produces superoxide anions, hydroxyl radicals
and hydrogen peroxide which have all been implicated in
endothelial injury (Varami et al 1985, Stroncek et al
1986). The reaction of xanthine with xanthine oxidase
to produce hydrogen peroxide has been used as a model
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DIAG.1.5. Intrinsic and Extrinsic pathways of thrombin
formation. Bold characters indicate active
components.
et al 1984, Ager & Gordon 1984). Hydrogen peroxide is
also thought to be the injurious agent in
homocystinuria (Starkebaum & Harlan 1986). Oxygen
free radicals are thought to cause vascular damage by
causing increased cell permeability, cellular
contraction which leads to disrupted monolayer
morphology and eventual cell loss.
1.6.4. Thrombosis as a response to endothelial injury.
Injury to vascular endothelium or loss of
endothelial integrity initiates the haemostatic
process. The exposure of the subendothe1ia1 collagen,
vWF and fibrinectin initiates platelet adhesion and
activation which in turn initiates the production of
thrombin which activates fibrin polymerisation. The
formation of thrombin from its inactive precursor is
initiated by a complex cascade system. (Diag.1.5). Many
of the reactions of the intrinsic pathway occur at the
endothelial cell surface (factors XII, IX, X are
activated at the cell surface, and factor V is
synthesised by endothelial ce11s)(Anjanayate et al
1986). Tissue thromboplastin, the initiator in the
extrinsic pathway is an endothelial cell surface
protein (Maynard et al 1977).
The pro-coagulant and anti-coagulant capacities of
the endothelium are normally kept in haemeostatic
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balance by a number of other endothelial cell derived
modulators. Thrombin is rapidly inactivated by
antithrombin III which is catalysed by cell surface
glycosaminoglycans (Busch & Owen 1982). It can also be
inactivated by binding to thrombomodulin, an
endothelial membrane protein. This process activates
protein C which promotes fibrinolysis by plasmin
formation through factors Va and Villa (Diag.1.2).
Thrombin itself is reported to have a damaging effect
on endothelial cells by causing an increase in
permeability and cell contractility (Lough & Moore
1975, Killacky 1986, Galdal et al 1982).
Disturbance of the haemostatic balance between
these two processes under pathological conditions may
lead to thrombosis.
1.6.5. Atherosclerosis.
The normal artery wall consists of three distinct
layers, intima , media and adventitia. The intima which
is the lining of endothelial cells bound by a sheet of
elastic fibres (internal elastic lamina), with the
occasional smooth muscle cell (SMC) between the two.
The media consists of SMC surrounded by collagen,
proteoglycans and some small elastic fibres. The
adventitia is separated from the media by the external
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elastic lamina and is made up of a loose arrangement of
fibroblasts, SMC, collagen and proteoglycan .
Two types of lesion are characteristic of
atherosclerotic disease, the fatty streak and the
atherosclerotic plaque. The fatty streak is a focal
accumulation of lipid bearing cells (foam cells) in the
intima of the vessel wall. Microscopically and
immunologically these foam cells are thought to be of
monocyte / macrophage origin (Schaffner et al 1980,
Gerrity 1981). These lesions cause little or no
obstruction and appear to have no associated clinical
symptoms.
Atherosclerotic plaques are structurally more
complex lesions. Their principal characteristic is the
proliferation and accumulation of lipid laden SMC in
the subendothe1ia1 intimal zone. Advanced lesions have
a fibrous cap of SMC and dense connective tissue
consisting of elastin, collagen, proteoglycans and
basement membrane. The core is often a necrotic mixture
of cellular debris, extracellular matrix, foam cells,
cholesterol crystals and calcium deposits (Cotran &
Munro 1988). Atherosclerotic plaques protrude into the
vessel lumen causing decreased and disturbed blood flow
and sometimes total occlusion. They are complicated by
thrombosis, calcification and rupture. SMC accumulation
and proliferation is the central feature of
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atherosclerotic lesions and it is now generally
accepted that the initiating factor in this event is
endothelial cell injury (Ross & Glomset 1976)
Endothelial cells are in direct communication with SMC
and exert some control over their growth. It is thought
that endothelium produces SMC growth inhibitors
(Castellot 1980). In the event of endothelial cell loss
this inhibitory function is also lost and adhering
platelets release growth factors which stimulate SMC
migration and proliferation . Endothelial denudation
stimulated SMC proliferation is a self limiting
process, with cessation of SMC proliferation with
endothelial regeneration. It seems unlikely that this
sort of injury alone is responsible for the formation
of atherosclerotic lesions. Evidence exists to indicate
that endothelial denudation is actually a late event in
atherosclerosis (Davies et al 1988).
Non-denuding endothelial injury, dysfunction or
altered behaviour is initiated in a number of ways.
Hypertension, hypercholesterolemia / lipidemia,
lymphokine activation, viral transformation, disturbed
blood flow and inflammatory reaction products, all
promote increased endothelial adhesiveness to both
platelets and circulating macrophage / monocytes. This
probably leads to the migration of lipid filled
macrophages into the subendothe1ium leading to fatty
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streak formation. The relationship between fatty
streaks and the development of fibrous plaques is
unclear. Fatty streak development seems to precede
atherosclerotic plaque formation in the vessels and
their distribution in the vasculature is similar.
Therefore it has been suggested that they are
precursors of the advanced atherosclerotic lesion (Ross
& Glomset 1976). More recent evidence has supported
this theory by showing platelet adherence to
endothelium at sites of fatty streaks and the
subsequent SMC proliferation (Faggiotto et al 1984,
Schwartz et al 1986). THe intrusion of foam cells
underneath the endothelium does not disrupt endothelial
integrity but raises the area of cells above the level
of the surrounding normal endothelium. These raised
cells are prone to the effects of disturbed blood flow
and shear stress (Davies 1988). Therefore the initial
reaction to focal cell damage (fatty streak formation)
may in turn promote further cell damage leading to
progression of atherosclerotic lesions.
1.7. AIMS OF THE PROJECT.
Thrombosis and atherosclerosis are the pathological
manifestations of the breakdown in homeostatic
interaction between the vessel wall and blood elements.
Elucidation of the cellular and molecular events of
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vascular disease have provided a greater understanding
of the development of atheroma and have shown it to be
a complex multifactorial process. The role of
endothelial injury in acute thrombotic events is well
established and there is no lack of evidence in
experimental models to show that changes in the
endothelial cell are associated with atherogenesis. It
is however not entirely clear if atherosclerotic
lesions develop at sites of endothelial injury or if
endothelial changes occur as a later event in well
established atheroma.
Clinically the effects of thrombosis and
atherosclerosis are most notable in coronary artery
disease. Diagnostic and therapeutic procedures carried
out in the management of coronary artery disease are
not entirely free of drawbacks . Balloon angioplasty is
frequently used to re-establish blood flow in occluded
atheromatous coronary arteries. It is also used to
induce endothelial damage in experimental models. In
using the procedure therapeutically , the risk of local
thrombosis due to endothelial injury is increased. It
is common clinical practise to use systemic
anticoagulants and thrombolytic agents to control local
thrombosis. However the inability of these agents to
distinguish between thrombi and haemostatic plugs
increases the risk of systemic bleeding.
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Monoclonal antibodies have been used extensively in
endothelial cell research for identification
(Schlingeman 1985, Drenk 1987) and in the elucidation
of structure and function (Darnule et al 1983, Kaplan
et al 1983, Arvieux et al 1986, Ketis et al 1986, Sage
et al 1986, Favaloro et al 1990).
Monoclonal antibodies to structurally and
functionally "altered" or damaged endothelial cells and
to regenerating endothelium may prove useful in
detection and elucidation of the early phases of
vascular disease, to monitor endothelial regeneration
after invasive diagnostic or therapeutic techniques and
may provide a way of targetting coagulant or anti¬
coagulant agents to specific sites.
It was the aim of this project to 1. develop
monoclonal antibodies specific to damaged and/or
regenerating endothelial cells. 2. To characterise the
antigens recognised by these antibodies. 3. To assess
the suitability of these antibodies for diagnostic
purposes. 4. To conjugate these antibodies with
thrombolytic agents and target such activity





2.1 ENDOTHELIAL CELL CULTURE
2.1.1. Introduction
In 1963 Maruyama described a method of isolating
and culturing human endothelial cells from umbilical
cord vein. This was an easily obtainable and abundant
source of human material which could yield large
numbers of cells. However, Maruyama and other workers
at that time ( Pollak & Kasai, 1964 ; Pomerat & Slick,
1963 ; Fryer et al, 1966. ) were limited by a
difficulty in growing and maintaining a heterogenous
culture for more than a few weeks. The cells they were
culturing were never positively identified as being
endothe1ia1.
Jaffe et al (1973) and Gimbrone (1974) extended the
work of Maruyama and devised the method for isolating
and culturing human umbilical endothelial cells which
is widely used at present. They also established the
morphologic and immunological criteria on which
endothelial identification is based. However, it was
found that human umbilical vein endothelial cells
(HUVEC) could not be grown reproducibly for more than 2
to 3 passages (Gimbrone et al 1974 and Gimbrone 1976).
Work by Gospodarowicz et al (1978) showed that vascular
endothelial cells could be grown and maintained in
culture long term, if the culture medium was
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supplemented with high concentrations of bovine brain
or pituitary fibroblast growth factor (FGF). Later
studies showed that HUVEC do not respond mitogenically
at low seeding densities to high concentrations of FGF
but to crude preparations of bovine pituitary, brain
and hypothalamus (Maciag et al 1979). This neural-
derived endothelial cell growth factor (ECGF) is an
acid- and heat-labile protein which is physically and
chemically distinct from FGF (Maciag et al 1981).
Addition of ECGF to low density cultures of HUVEC
results in a significant increase in cell growth and is
now routinely used in the growth mediums for long term
serial propagation of human vascular endothelial cells.
This work set the standard for the development of
methods of isolating and culturing of endothelium from
a variety of animal sources. Schwartz (1978) provided
the method of growing bovine aortic endothelium, which
is very easy to maintain for long periods in culture
and can be grown very quickly in large quantities
without special growth factor requirements.
A very simple method for cloning bovine aortic
endothelial cells developed by Gadjusek & Schwartz
(1983) , allows growth of cell lines for much longer
periods of time by eliminating contaminating and
senescent cells. The method can also be adapted to
human and porcine cells.
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More recent research has shown an increase in
techniques of isolating and growing microvessel
endothelium from a variety of sources both human and
animal ( Goetz et al, 1983 ; Kern et al, 1983 ; Wagner
& Matthews, 1975 ).
The techniques used in the following section were
based on the methods of Jaffe (1973) , Schwartz (1978)
and Gadjusek & Schwartz (1983).
2.1.2. Bovine Aortic Endothelial Cells.
Bovine vessels were obtained from the local
abattoir at the time of slaughter. Segments of thoracic
aorta approximately 30 cm in length were collected no
more than 15 minutes after the death of the animal and
processed immediately. Both ends of the vessel segments
were tied off with sterile " Kwill" filling tubes
inserted. Enzyme and washing mediums were added to the
vessel lumen by way of these tubes. The aorta was then
filled with cold Earle's balanced salts (EBS)
containing 2 ug/ml gentamicin and placed in a cold box
for transport back to the lab.
Fat and connective tissue were dissected from the
aorta and the intercostal vessels were ligated. The
lumen was then rinsed well with sterile saline and
filled with 10 ml of 0.1% collagenase in EBS. The
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vessel was wrapped in cling-film ( to aid the transfer
of heat around the vessel and prevent evaporative
cooling ) and incubated at 37°C for 15 to 20 minutes.
Gentle massaging of the vessel aided the release of
loosened cells before the co11agenase/ce11 solution was
removed. The lumen was rinsed twice with Dulbecco's
modification of Eagles medium (DMEM) supplemented with
2 ug/ml gentamicin and 20% newborn calf serum (NBCS)
(DMEM/NBCS). The co11agenase/ce11 suspension was
centrifuged at lOOOxg for 10 minutes and the cell
pellet was rinsed once with DMEM/NBCS. The cells were
finally resuspended in 20 ml of DMEM/NBCS and placed in
2
a 75 cm glass "medical flat" culture bottle.
Collagenase treatment removed the cells from the
vessel wall in large sheets which made an accurate cell
count impossible, therefore the cells obtained from one
such length of aorta were initially cultured in 20 ml
2
of medium in a 75 cm bottle. If the cells were free
from contamination and in general good condition they
usually reached confluence after 48 hours.
2.1.3. Pig Aortic Endothelial Cells.
Pig cells were obtained by exactly the same method
as described for the bovine aortic endothelium. The
growth medium for pig cells was DMEM supplemented with
2 ug/ml of gentamicin,15% NBCS and 5% pig serum (PS).
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The cells generally reached confluence after 24 to 48
hours. However the pig cells were more susceptible to
infection than the bovine cells and many of the primary
cultures would not adhere or grow and had to be
discarded.
2.1.4. Human Umbilical Vein Endothelial Cells.
Umbilical cords were obtained from the labour wards
of the Simpson Memorial and the Elsie Inglis Maternity
Hospitals, Edinburgh, with the kind help of the nursing
staff.
The procedure used for endothelial cell isolation
was an adaptation of the method of Jaffe et al (1973).
Pieces of cord between 20 and 30 cm long were
drained of as much blood as possible and placed in
cold sterile EBS solution containing 2 ug/ml
gentamicin and kept refrigerated until processed. Cords
which had been heavily clamped were discarded. The vein
at each end of the cord was cannulated using the blunt
plastic sheath of a 1.7 mm gauge intravenous cannula
and held in place with surgical ties. Blood was
flushed from the vein with sterile saline and then
with 0.1% collagenase solution. One end was then
clamped and 2 to 5 ml of collagenase/EBS was infused
into the vessel. Over-filling of the vessel was avoided
since this tended to lead to rupturing and leakage and
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probably to contamination with non-endothe1ia 1 cell
types such as fibroblasts and smooth muscle cells.
The cord was wrapped in cling-film and incubated at
37°C for 15 to 20 minutes.
The co11agenase/ce11 suspension was flushed out
with 10 ml of DMEM supplemented with 150 ug/ml of
endothelial cell growth factor (ECGF ; from bovine
hypothalamus), 15% foetal calf serum (FCS), 5% adult
human serum (AHS) and 2ug/ml gentamicin. The cells were
pelleted by centrifuging at 1000 x g for 10 minutes and
rinsed once before being resuspended in 5ml of the
above medium. The cells from one piece of cord this
2
length were initially cultured in a 25 cm plastic
tissue culture bottle which had been previously coated
with fibronectin or with 0.2% gelatin. Cells reached
confluence after 3 to 5 days with medium changes every
other day.
Cords were usually processed within 2 to 3 hours of
delivery. However some sections of cord were kept
overnight under refrigeration without any apparent
effects on cell recovery or viability.
The ECGF and fibronectin were very kindly donated
by Dr N Hunter of the Scottish National Blood
Transfusion Headquarters, Forrest Road, Edinburgh.
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2.1.5. Adult Human Saphenous Vein Endothelial Cells.
Adult saphenous vein was obtained from coronary
artery bypass patients. Pieces of vein surplus to the
graft requirement, which ranged from 10 to 15 cm long,
were placed immediately in ice cold EBS/ 2 ug/ml
gentamicin solution and kept in the fridge until they
could be processed . Some sections of vein were kept
overnight under refrigeration without any apparent
effects on cell recovery or viability .
The vein was cannulated and tied with the same
procedure as for the umbilical cords and processed in
exactly the same way. Adult human cells were also
cultured on fibronectin or gelatin coated plastic and
medium was changed every other day. Cells from one
2
10 to 15 cm segment of vein were grown in 25 cm
flasks. Cells from shorter segments were cultured
initially in one 16mm diameter well of a 24 well
plate, and subcultured to the other wells of the plate
once confluence was reached. Confluence was generally
attained after 5 to 10 days, depending on cell
condition and initial seeding density.
2.1.6. Subculturing.
All uncloned cell lines were subcultured as soon as
they had reached confluence. The same basic procedure
was used for all types of endothelial cells.
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The old growth medium was decanted and the cell
monolayer was rinsed once with a small volume of lOmM
sucrose / ImM EDTA in 20mM HEPES buffered PBS ( Kaplan
1983). A small volume of this buffer ( 5ml/25cm^
flask and 10ml/75cm^ flask) at 37°C, was incubated
with the cells at 37°C for 5 minutes or until they
had detached from the surface of the culture vessel.
Monolayers which did not resuspend within 10 to 15
minutes in this buffer were transferred to a fresh
aliquot of the same buffer containing 0.02% trypsin and
incubated for a further 2 to 3 minutes at 37°C. Human
cells which were grown on fibronectin coated vessels
usually required trypsin treatment.
Cells were recovered from the sucrose/EDTA buffer
by centrifugation at 300 x g for 5 minutes. The cell
pellet was resuspended in the appropriate amount of
growth medium and dispensed into tissue culture
flasks. Bovine cells in good condition and growing
fast were usually split at a 1:3 or a 1:4 ratio. Human
cells were always split at a 1:2 ratio.
2.1.7. Cloning.
Primary isolates of endothelium are quite often
contaminated with non-endothe1ia1 cell types such as
smooth muscle cells and fibroblasts. Mixed cultures
are quickly overgrown by fibroblasts. Several
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techniques for isolating pure endothelial cell cultures
have been reported. Semi-selective mediums, such as
those containing d-valine which slows the growth of
smooth muscle cells and fibroblasts (Picciano et al
1984) and some with agents cytocidal to the non-
endothelial cell types (Schwartz 1978) have been used.
More specific methods have utilised endothelial cell
capacity for low density lipoprotein (LDL) uptake. By
fluorescent labelling of acetylated LDL the endothelial
cells can be separated by fluorescent activated cell
sorting (FACS) (Voyta et al 1984).
The method of obtaining pure endothelial cell
lines by cloning is time consuming but it was chosen
because of its simplicity and because it does not
require any special materials or equipment. The
procedure used was based on that of Gajdusek and
Schwartz (1983) and was used for all endothelial cell
types.
Confluent cultures in their first or second passage
were resuspended using lOmM sucrose / ImM EDTA / 0.02%
trypsin in 20mM HEPES buffered PBS. The cell suspension
was aspirated through a 25 gauge needle 2 to 3 times
to break up cell clumps, and diluted 50:50 with serum -
containing growth medium to inactivate the trypsin. The
cells were recovered by centrifugation at 1000 x g for
5 minutes and washed once in growth medium before being
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finally resuspended in a small amount of medium. Cells
were counted with an improved Neubauer haemocytometer
and the appropriate dilutions were made in complete
growth medium.
Bovine and porcine cells were diluted so that on
average there was one cell per well in 100 ul aliquots
in a 96 well plate. Human cells seemed to be a bit
more reluctant to grow at low densities and were
therefore cloned by limiting dilution. Cells were
diluted to 230 cells in 4.6 ml of complete growth
medium and plated into 36 wells of a 96 well pre-coated
plate, in 100 ul aliquots. To the remaining 1 ml of
cell suspension a further 4 ml of growth medium was
added and another 36 wells were plated with 100 ul. To
the remaining cell suspension, 1.4 ml of medium was
added and the remaining 24 wells were plated with 100
ul. The first 36 wells should on average have 5
cells/well, the second 36 wells, 1 cell/well and the
remaining 24 wells, 0.5 cells/well. Therefore if the
cells did not grow at single cell density, colonies
from the higher densities were grown up and recloned.
Immediately after plating a further 100 ul of
conditioned medium (see section 2.1.8.) was added to
each well. The wells were checked after 24 hours for
cell growth. Those wells containing single cells or
small single colonies were noted and considered to be a
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clone. After 5 days the wells were examined again and
only those with single colonies of 8 to 10 cells were
marked and received further attention. The medium was
changed every 4 to 5 days using a 50 : 50, fresh :
conditioned medium mixture, until the cells had reached
confluence. The cells were then transferred, on a well
to well basis, to a 24 x 16mm well plate in normal
growth medium, using standard subculturing techniques.
If the cells of each well retained the cobblestone
morphology of endothelium on reaching confluence and
were not obviously contaminated with smooth muscle
2
cells or fibroblasts, they were expanded to 25 cm
flasks and grown on in the usual way.
2.1.8. Preparation of Conditioned Medium.
Confluent cultures of endothelial cells were
maintained in the appropriate complete growth medium
for 5 days. The medium was removed from the cells,
centrifuged for 15 minutes at 1000 x g to remove dead
cells and debris and passed through a 0.22 urn
Millipore filter to ensure sterility. It was stored at
2.1.8. Fibroblast and Smooth Muscle Cell Culture.
Primary endothelial cell cultures contaminated with
smooth muscle cells were preferentially kept and cloned
accordingly. Growth medium was exactly the same as that
used for endothelium.
2.1.10. Liquid Nitrogen Storage.
When good primary cell and cloned cell lines were
obtained, a quantity was stored in liquid nitrogen for
future use.
Cells in their first or second passage at
confluence were resuspended as in section 2.1.6 . Cells
were counted before being centrifuged and rinsed once
in EBS. Final resuspension was in 90% FCS and 10% DMSO
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at 5x10 cells/ml for human cells and 2.5x10 cells/ml
for bovine and pig endothelium. Aliquots of 0.5 ml in
sterile cryotubes were cooled slowly to -70°C and kept
at this temperature for 12 to 24 hours before being
transferred to vapour phase liquid nitrogen ( Oi &
Herzenberg 1980 ).
2.1.11. Recovery of Cells from Liquid Nitrogen Storage.
Vials were removed from the liquid nitrogen
immediately before use and thawed quickly,but not
completely in a 37°C waterbath. 5 ml of cold growth
medium was added dropwise. Slow addition of cold medium
at this stage prevents rupture of the cells through
heat or osmotic shock.
Cells were recovered by gentle centrifugation ( 200
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x g for 10 minutes ) and resuspended slowly as before.
Final resuspension was in 5 ml of growth medium at
37°C. Cells were then plated in 25 cm^ flasks.
Confluence was reached between 5 and 10 days depending
on the number remaining viable after storage and
recovery.
2.2. ENDOTHELIAL CELL IDENTIFICATION.
2.2.1. Morphological Criteria.
In the majority of the bovine and porcine cultures,
identification was based on morphological criteria.
Endothelial cells tend to be polygonal in shape and
form a tight cobblestone appearance when confluent.
Pure endothelia grow in a single uniform monolayer with
cells showing contact inhibition. At confluence cell
growth becomes static and cultures of pure endothelium
can be maintained for long periods of time without
subculturing. With frequent medium changes cell
turnover is relatively slow.
By contrast fibroblasts and smooth muscle cells,
the two common contaminants of endothelial cultures
from large vessels, are elongated and less well defined
in shape. Fibroblasts grow in multiple layers and very
quickly overgrow any endothelial cells present in a
culture. The striking difference in morphology between
these cells helps to eliminate contaminated cultures
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early on.
Human umbilical vein and adult saphenous vein
endothelium are less easily discriminated from
contaminating cells in early primary cultures. Human
cells in non - confluent cultures have a tendency to
grow in an elongated manner until the cells are
confluent and then they assume a more typical polygonal
- cobblestone appearance. They do exhibit contact
inhibition and monolayer growth.
2.2.2 Immunological Criteria.
The most widely used immunological marker for
endothelial cells is von Willebrand factor. Cells
incubated with a fluorescently labelled anti-vWF
antibody are identified by fluorescent microscopy.
More recent work with monoclonal antibodies and
lectins have produced two more reliable markers, PAL-E
which is a pan endothelial cell antibody ( Schlingeman
1985 ) and the lectin Ulex europaeus which is highly
specific for endothelial cells (Holthofer et al 1982).
Biochemical markers such as angiotensin converting
enzyme ( ACE ) have been used but would appear to
unreliable (Del Vecchio & Smith 1982). In one cloned
cell line of bovine aortic origin isolated and grown in
this laboratory, ACE production was not detectable at
passages 15. In terms of morphology and growth
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characteristics, these cells appeared normal. It was
not known whether these cells had lost this function
through an ageing process, or a non-ACE producing cell
line had been unwittingly selected at cloning.
Endothelial cells were identified by morphology and
by the presence of vWF antigen.
2.3 MONOCLONAL ANTIBODY PRODUCTION
2.3.1. Introduction.
The technique of hybridising mouse antibody
producing spleen cells with "immortal" mouse myeloma
cells to produce a cell line secreting monospecific
tailor - made antibodies was developed by Kohler &
Milstein in 1975. The technique was first used for the
derivation of anti - sheep red cell antibodies but
since then has been used widely.
There are a few variations on the original
hybridisation method and the following procedure is
based on that of Oi & Herzenberg (1980). The few
alterations to the method were on the kind advice of Dr
L. Micklem of the Department of Surgery, University of
Edinburgh.
2.3.2. Immunisation of Mice.
Three to five week old BALB/c mice were used to
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provide the immune spleen cells needed for fusion. Two
types of immunogen were used in separate groups of
mice. Mouse immunisation protocol was the same for both
types of immunogen.
Immunogen 1.
Endothelial cells were isolated and grown as
described in section 2.1. When the monolayers were
confluent the cells were resuspended by scraping them
off the vessel surface with a glass rod in the
sucrose/EDTA buffer ( without trypsin ) described in
section 2.1.6. The suspension was then aspirated
through a 25 gauge needle to break up cell clumps.
Cells were recovered by centrifugation and the
pellet was rinsed 3 times in serum - free EBS with a 15
second mix (vortex mixer) at each rinse. This step was
to free the cell surface of any serum albumin from the
growth medium which may have adhered. Cells were
finally suspended in a volume of EBS such that each
5 7
mouse received between 10 and 10 cells in a 0.2 - 0.3
ml volume.
Each mouse in the group received 2 intraperitoneal
(i.p.) injections of the cell suspension at 21 day
intervals. No Freund's adjuvant was used. After the
second injection, tail bleed plasma was tested for
antibody production, as described in section 2.3.2.
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Pre-immunisat ion tail bleeds (pooled sample) were used
as an immunological base line for this particular group
of mice. Those mice which were immuno-positive for
endothelial cell proteins were given a booster
injection 3 days before being killed. Mice which were
immuno-negative were dropped from the programme. These
mice were used in the production of mixed thymocyte
medium, (section 2.2.8.)
Immunogen 2.
In the mouse the spleen is a good source of
immunologically competant cells. Studies on endothelial
- lymphocyte interactions show that viable lymphocytes
actively bind to the endothelial cell surface. After 4
to 6 hours incubation the lymphocytes detach ( de Bono
1977 ) . It was thought that during this detachment the
lymphocytes may "remove" a significant part of the
endothelial cell surface and in turn present it to the
immune systems of the injected mice.
Monolayers of BAEC at their second or third
subculture were used 2 days after becoming confluent. A
suspension of cells in complete growth medium was
prepared from the spleens of non - immunised BALB/c
mice. The old medium on the endothelial monolayers was
removed and replaced with the spleen cell preparation
and incubated overnight at 37°C. After gentle agitation
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the spleen cells were removed leaving an apparently
intact endothelial monolayer. The spleen cells were
recovered by spinning at 1500 x g for 10 minutes and
were very gently rinsed twice in EBS before being
finally resuspended in a volume of EBS such that each
mouse received 0.3 ml.
2
To the cells in one 75 cm flask was added the
cells of one 4 to 5 week old BALB/c spleen, which was
then used to immunise 5 mice. Again immunisation was by
2 i.p. injections 21 days apart. Immunity was checked
before the mice were given a final booster of whole
endothelial cells, prepared in the same way as
Immunogen 1.
2.3.3. Myeloma Parent Cell Line.
P3-NSI-1 abbreviated to NS-1 is a cell line derived
from the BALB/c myeloma cell line MOPC-21. NS-1 cells
synthesise the MOPC-21 k light chain but are incapable
of producing the MOPC-21 y^ heavy chain. Hybrid cells
lines from this fusion partner will therefore produce
mixed molecules with only the MOPC-21 k light chain (
McMichael & Fabre 1982. ).
NS-1 cells were very kindly provided by Dr Micklem.
These cells were grown in RPMI 1640 medium supplemented
with 0.85 g/1 sodium bicarbonate, 20 mM HEPES, 10 mM
sodium pyruvate, 2 ug/ml gentamicin and 5% FCS. Cells
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which were taken from liquid nitrogen storage were
initially grown in the above medium supplemented with
10% FCS and in a 5% CO2, 95% air atmosphere. Once
growth was well established the FCS content of the
medium was reduced to 5%. Cell density was maintained
4 6
at 5 x 10 - 1 x 10 per ml. With the cells in
logarythmic growth phase, cultures were split every 2
to 3 days.
For fusion, NS-1 cells in log phase growth ( a
5
density of 10 cells per ml ) were collected by
centrifugation at 500 x g and rinsed once in serum free
RPMI 1640 medium.
NS-1 cells are 8-azaguanine resistant and are
therefore HAT sensitive. The mechanism of HAT selection
is explained in section 2.3.6. Due to spontaneous
genetic drift, NS-1 cells which had been kept in
culture for long periods tended to lose HAT
sensitivity. Those cell lines which had done so were
grown in growth medium to which 8-azaguanine was added
-4
to a final concentration of 10 M. The cells were then
re-cloned and those cultures strongly HAT sensitive
were kept as stock.
2.3.4. Mouse Spleen Parent Cell Preparation.
The mice primed three days prior to fusion were
killed by cervical dislocation. The spleens were
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removed under sterile conditions and a suspension of
cells was made in serum free RPMI 1640 medium by
forcing the whole spleen through aa 19 gauge needle
with a 1ml syringe. After allowing the large clumps of
fatty connective tissue to settle, the suspension was
transferred to a fresh sterile tube and centrifuged at
1000 x g for 10 minutes. The cells were then rinsed
three times in serum free RPMI medium.
2.3.5. Fusion.
The following procedure is a variation on the
method of Oi & Herzenberg (1980).
The parent cell lines were prepared as described
and counted . They were then mixed together in a
sterile centrifuge tube at a ratio of 1:4 (NS-
1:spleen). The cells were then centrifuged at 400 x g
for 10 minutes at room temperature to form a tight
pellet. The supernatant was removed completely and all
consequent procedures were carried out at 37°C.
A 50% solution of polyethylene glycol 1500 ( PEG )
was prepared by autoclaving 20 - 50g of the material
for 20 minutes at 121 - 132°C and adding an equivalent
volume of sterile RPMI medium to it before it
solidified. The PEG solution was stored at room
temperature. During storage the solution turns alkaline
which did not seem to affect it as a fusion agent,
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therefore the pH was not altered.
The PEG solution , serum free and 5% FCS RPMI
mediums were all pre-warmed to 37°C . Using a sterile
pasteur pipette, 1ml of 50% PEG was slowly and gently
stirred into the cell pellet over 1 minute. Stirring
was continued for a further 1 minute. Using the same
pipette, 1ml of serum free medium was added in the same
way over 1 minute. This was repeated once. A further
7ml of serum free medium was added by gentle stirring
over a A minute period. Pipetting of the cell
suspension was avoided during this procedure to prevent
breaking up cell clumps and therefore reducing the
chances of cell fusion.
The suspension was centrifuged at 200 x g for 10
minutes at room temperature. The supernatant was
carefully decanted and a volume of 5% FCS RPMI medium
was added to the cell pellet to give 10^ cells per
0.1ml. At this stage the cells may be pipetted once
before aliquoting into 96 well flat-bottomed plates at
0.1ml per well and incubated in a 5% CO2 in air
mix at 37°C.
2.3.6. HAT Selection.
The fusion procedure is a random process and
results in a mixture of cell pairs e.g NS-1:NS-1 , NS-
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1:spleen , spleen:spleen as well as unfused parent
cells. Only the NS-l:spleen cell hybrid is of
importance in antibody production. The addition of
hypoxanthine, aminopterin and thymidine ( HAT ) to the
growth medium positively selects the growth of NS-
1:spleen hybrids by the following mechanism.
Aminopterin is an analogue of folic acid and blocks
the biosynthesis of purines and pyrimidines. Therefore
to survive the cells must utilise the hypoxanthine and
thymidine provided in the HAT medium to synthesise the
nucleotides via a salvage pathway. NS-1 cells are
however lacking the enzyme hypoxanthine-guanine
phosphoribosyltransferase ( HGPRTase ) which is
required in the salvage pathway of nucleotide
biosynthesis. Therefore in HAT medium NS-1 and NS-1:NS-
1 hybrids cannot survive. Normal spleen cells do
however have this enzyme and so a NS-1:spleen hybrid
will be able to utilise the hypoxanthine and thymidine
in the HAT. There is no need for positive selection
against the growth of the spleen cells since they have
limited growth in culture and most will have died
within 2-3 days.
The 50X HAT solution was diluted 1:50 in 5% FCS
RPMI medium. The day the perfusion was done was denoted
day 0. On day 1, 0.1ml of HAT medium was added to each
well. On days 2, 3, 5,8 and 11, half the medium was
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aspirated from the wells and replaced with 0.1ml of
fresh HAT medium, taking care not to disturb the cells.
After day 11 half the medium was replaced every 3 -4
days .
After 2 - 3 days the HAT treatment drastically
reduced the number of cells and the cultures appeared
dead. However, after 14 - 20 days small but distinct
colonies of hybrid cells were seen at low magnification
( their appearance being very similar to the parent NS-
1 cells ). When 50 - 90% of the well surface was
covered by cell colonies, the first antibody screening
assay (section 2.3.2) was done and positive colonies
were selected for expansion and cloning.
Colony expansion was done in conjunction with the
change to HT medium, part of the process of weaning the
cells off HAT medium. The contents of each small well
was transferred to 0.5ml of IX HT 5% FCS RPMI medium in
a 16mm diameter well of a 24 well plate. A further
0.5ml of this medium was added to each well after 24
hours if the cells looked settled. If cell numbers were
low or if the cells did not start to increase in number
after 48 hours then mouse thymocytes were added as
feeder cells.
Cells were kept in these plates until growth was
well established. At this stage a small aliquot of
cells was taken for storage in liquid nitrogen, some
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for cloning and the rest were expanded to 25 cm flasks
in 5% FCS RPMI medium ( 5 - 10ml volume per flask ).
2.3.7. Cloning.
At this stage the cultures contain a mixture of a
variety of antibody producing hybrids and non-producing
hybrids. To produce cultures of a single cell type
secreting the desired antibody, the cultures were
cloned by limiting dilution ( Oi & Herzenberg 1980 ).
The number of viable cells in the sample to be
cloned was determined by counting acridine orange /
ethidium bromide ( AO/EB ) stained cells. This stain
shows viable cells as bright green and dead cells as
brown under fluorescent light.
The sample was diluted so that 230 live hybrids
were suspended in 4.6ml of thymocyte containing growth
medium or mixed thymocyte medium (2.2.8.). The first
36 wells of a 96 well plate were then aliquoted with
0.1ml each well with this suspension. To the remaining
1.0ml , 4.0ml of the thymocyte medium was added and
another 36 wells were plated. Finally 1.4ml of
thymocyte medium was added to the remaining cell
suspension and the last 24 wells were plated.
The clones were then fed at days 5 and 12 by adding
0.1ml of fresh RPMI 1640 with 15% FCS to each well with
as little disturbance as possible to the cells. By day
14 the colonies of cloned cells were large enough to
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test for antibody production. The cells producing the
desired antibody were then expanded to larger numbers
as described in section 2.2.5.
By this method of cloning, the first 36 wells
should, on average, contain 5 cells per well, the
second 36 wells, 1 cell per well and the 24 wells, 0.5
cells per well. At least one of these plating
concentrations should give monoclonal growth. However,
depending on which concentration the antibody producing
cells were found in, the cells were frequently re-
cloned until monoclonal growth was achieved.
2.3.8. Cloning Medium.
Thymocyte Cloning Medium
The purpose of the thymocytes in the cloning medium
was to act as feeder cells in culture and also as
carrier cells in diluting the hybrid cell sample.
The thymuses from 4-5 week old BALB/c mice were
removed aseptically and a cell suspension prepared in
RPMI 1640 medium containing 15% FCS. The cells were
suspended by aspirating the whole thymus through a 19
gauge needle. The suspension was used at a
1 8
concentration of 10 - 10 thymocytes per ml.
If cloning was done directly from the master plate,
the above medium contained IX HT.
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Mixed Thymocyte Medium
This medium was used as a substitute for thymocyte
containing medium on some occasions. It did not appear
to make any difference to the rate of growth of the
clones and it was advantageous in some respects. It
could be made in large quantities some time in advance
and stored at -20°C for short periods or at -80°C for
long term storage. It also left the clones free of cell
debris making them easier to see under low power light
microscopy and therefore easier to keep track of their
growth progress.
The thymuses from equal numbers of 4 - 6 week old
BALB/c mice and CBA mice were removed aseptically. A
cell suspension was made in serum free RPMI 1640 medium
as previously described. Large clumps of connective
tissue were allowed to settle and the fine cell
suspension was removed and centrifuged at 450 x g for 8
minutes. The cells were washed 3 times with serum free
RPMI 1640. The thymocytes were resuspended in RPMI 1640
with 15% FCS at a concentration of 5 x 10^ cells/ml and
cultured at 37°C for 48 hours only. After 48 hours the
medium becomes suppressive to hybridomas.
The cells and debris were then removed from the
medium by centrifugation at 1000 x g for 10 minutes and
the supernatant was filtered ( 0.22u ) to ensure
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sterility. Aliquots were stored at either -20°C or
-80°C. This medium was diluted 1:2 with fresh sterile
RPMI 1640/15% FCS before being used.
2.3.9. Bulk Growth of Monoclonal Hybridomas.
Large amounts of monoclonal antibody can be
produced simply by increasing the quantity of hybridoma
cells in culture. The cultures of interest were
expanded gradually to large tissue culture vessels
which had a capacity of 200 - 300ml. Depending on the
rate of growth of the cells, fresh medium was added
every day or every other day until the volume capacity
had been reached and the cell concentration at its
maximum. The antibody containing growth medium was
harvested by spinning down the cells and the
supernatant was stored at 4°C , sterile or with 0.02%
sodium azide as a preservative. A quantity of cells
were replaced in the vessel for further expansion.
2.3.10. Ascites.
Large amounts of monoclonal antibody with high
titre can be obtained by growing the hybribomas as
ascites tumours in mice.
The mineral oil, pristane when injected
i.p. induces ascites in BALB/c mice, which provide a
favourable environment for the growth of hybridomas.
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Mice 4-5 weeks old were given 2 intraperitoneal
injections of 0.3ml of pristane, 1 week apart. The
cloned hybridoma cells were then injected 7 to 10 days
later. Injections of 1 - 5 x 10^ cells were given to
each mouse i.p. in a 0.3ml volume.
The mice were checked daily for abdominal swelling
and when this appeared the fluid was drained using a 19
gauge needle. The fluid was pooled and centrifuged and
stored with 0.02% sodium azide at 4°C. Ascitic fluids
containing IgM monoclonal antibody stored at 4°C
since the molecule is unstable at temperatures below 0,
but those fluids containing IgG antibody were stored at
—20°C.
2.3.11. Liquid Nitrogen Storage of Hybridomas.
At each stage in the expansion and cloning
procedures, a sample of cells were taken for storage as
a back up to the cells in culture. It is particularly
important to have stocks of the uncloned cell lines
since cloned cells which have been in culture for long
periods can lose their antibody producing capacity.
Cells in log phase growth were harvested by
centrifugation at 400 x g for 5 minutes and rinsed once
in 5% FCS RPMI 1640 medium and counted on an improved






PEROXIDASE CONJUGATED ANT I-MOUSE ANTIBODY
A
MOUSE MONOCLONAL PRIMARY ANTIBODY
ENDOTHELIAL CELLS
DlAG.2.1. Horseradish peroxidase (HRP) labelled second antibody
detects monoclonal primary antibody bound to endothelial cells.
The HRP catalyses the precipitation of diaminobenzidine (DAB) to
form a brown insoluble complex.
and finally resuspended at 1 - 5 x 10^ cells per ml in
cold freezing medium. The freezing medium was prepared
by adding DMSO dropwise to ice cold FCS to a final
concentration of 10% and gently shaking.
The cell suspension was distributed in 1ml aliquots
in sterile cryotubes and cooled slowly to - 70°C
After 12 to 24 hours at this temperature the samples
were transferred to the gas phase of a liquid nitrogen
refrigerator.
Cells were recovered from storage by thawing
quickly but incompletely at 37°C. The contents of the
cryotube was transferred to a sterile 30ml centrifuge
tube and 5 ml of 10% FCS RPMI 1640 medium was added
dropwise to the cells while gently stirring. The cells
were washed once in this medium by centrifuging as
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above and finally suspended at 2 x 10 cells per ml for
cu1ture.
2.4. MONOCLONAL ANTIBODY SCREENING
2.4.1. Introduction.
The screening procedure is an indirect ELISA method
using a horseradish peroxidase ( HRP ) conjugated
antibody. The principle of the reaction is summarised
in Diag.2.1.
In step 1 the primary antibody binds to the antigen
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(endothelial component). The HRP conjugate is added and
binds to the Fc region of the primary antibody, in step
2. The addition of o - phenylenediamine ( oPD ) or
3,3-diaminobenzidine tetra-hydrochloride (DAB) which
are substrates for peroxidase, results in oxidation of
the substrate to a brown insoluble complex. (Ritchie et
al 1983).
2.A.2. Primary Screening - Fixed Cell Elisa.
The hybridomas from the initial fusion plate were
tested for antibody production as soon as cell growth
covered 70 - 90% of the well surface.
Endothelial cells from the appropriate source were
plated into 96 well plates and cultured until
confluent. The growth medium was removed and replaced
with 0.01% glutaraldehyde in PBS and the fixation
process was allowed to proceed for 15 minutes at room
temperature. The fixed cells were rinsed 3 times with
PBS and once with distilled water, drained and stored
at -20°C until used.
The plates were thawed by adding PBS to each well
and letting the plate stand at room temperature for 15
minutes. The PBS was tipped out and 0.1ml of growth
medium was carefully removed from each well of the
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FIG.2.1. Primary screening of fusion growth medium
supernatants. Orange precipitate indicates the presence
of anti-endothelial cell antibodies.
well of the endothelial test plate. The plates were
incubated at room temperature for 60 minutes.
The antibody supernate was removed and the cells
rinsed 5 times with PBS. The peroxidase conjugated
rabbit anti - mouse second antibody was diluted 1:100
in PBS and 0.1ml was added to each well and incubated
at room temperature for 30 minutes. After the second
antibody was removed the cells were rinsed 10 times
with PBS.
Addition of 0.1ml of 0.04% o-phenly1enediamine (o-
PD) / 0.012% H2O2 solution to each well initiated
precipitation of the o-PD in the presence of the
peroxidase labelled antibody, indicating the presence
of endothelial cell bound antibody (Fig.2.1). On each
plate a set of second antibody plus substrate, and
substrate only controls were included.
The second antibody + substrate controls also
developed a pale yellow / orange precipitate but at a
much slower rate than the antibody positive cells.
These controls were used as the basis against which the
positive results were judged. Since a photometric plate
reader was not available the plates were scored in the
following way; the wells which developed orange/brown
colour within 1 minute of the substrate being added
were scored +++ those within 3 minutes ++ and those
within 5 minutes +. After 5 minutes the control wells
71
DIAG. 2.2 Scratch damaged cell monolayer. Arrows indicate
areas denuded of endothelium.
started to turn yellow , only those wells showing a
darker colour than the controls were scored, wells at
the same colour as the controls were denoted 0.
On a successful fusion only the +++ scoring hybrids
were selected for expansion and cloning. With less
successful fusions the ++ and + hybrids were used.
This method was also used for the initial screening
of the cloning plates.
2.4.3. Secondary Screening - Damaged / Regrowing Cell
Model (DAB ELISA).
The primary screening programme picks out a
selection of general anti - endothelial cell antibodies
by looking at the cell monolayer as a whole. The
secondary screening process is designed to look at
individual cells and allows selection of specific
monoclonal antibodies.
The basic principles of the technique are the same
as the primary screening process.
Endothelial cells were grown to confluence in 24 x
16mm plates. Using a glass pasteur pipette with a 1mm
diameter end, two scratches were made parallel to each
other through the centre of the well (Diag.2.2).
Scratches were approximately 5mm apart. This left an
area denuded of endothelium with damaged cells along
the scratch edge. The plates were either used
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immediately for ELISA or were re-incubated to allow the
scratch edges to regrow.
After scratching the cell layer was rinsed gently
with PBS to remove free cells and fixed in 0.01%
glutaraldehyde for 15 minutes at room temperature. The
cells were rinsed well with PBS and primary antibody
was added in the form of neat supernate for 1 hour at
room temperature. After 5 rinses with PBS incubation
with peroxidase conjugated second antibody 1:100 in PBS
was carried out for 30 minutes at room temperature.
After 10 PBS washes, 0.5ml of diaminobenzidine at
O.Amg/ml in Tris buffered saline (TBS) / 0.01% H2O2
was added to each well. The cells were checked for
colour development under low power light microscopy.
Positive cells colour orange to dark brown. Counter
staining of negative cells was with Mayer's
Haematoxy1in.
2.5. MONOCLONAL ANTIBODY PURIFICATION.
The antibodies showing particular staining
patterns, which are discussed in detail in chapter 3,
were grown up as previously described. The method of
isolation depends to some extent on the antibody
subtype ,therefore all supernatants of interest were
typed by Ouchterlony double diffusion analysis ( using
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a kit from The Binding Site, University of Birmingham).
2.5.1. Protein Precipitation.
The antibodies grown as bulk cultures were
concentrated from the culture supernate by saturated
ammonium sulphate (SAS) protein precipitation. This
procedure was not necessary for antibody isolation, but
by reducing the volume of the antibody it made the
affinity chromatography procedure less time consuming.
SAS was prepared by dissolving 900g of
(NH^) 2SO4. (BDH) in llitre of hot distilled water. The
solution was filtered through a Buchner funnel while
still hot and allowed to cool overnight at room
temperature before the pH was adjusted to 7.4 with
NH4OH. The antibody medium was clarified by
centrifugation at 10 000 x g for 5 minutes and the pH
was adjusted to 7.4. The SAS and antibody solutions
were both chilled to 4°C . The SAS was added slowly to
the supernate with gentle stirring until 40% saturation
was reached. Precipitation continued at 4°C overnight.
The protein precipitate formed was stored with an
excess of SAS in a sealed container at 4°C.
2.5.2. Protein Reconstitution.
The protein precipitate was resuspended in SAS and
centrifuged at 10 OOOxg for 10 minutes. The supernate
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was removed completely and the pellet resuspended in a
minimal amount of DDW. This was dialysed for at least
36 hours against 200 volumes of 0.05M TRIS / 0.15M NaCl
pH8.6 with three changes of buffer.
2.5.3. Protein A - Sepharose Affinity Chromatography.
Work by Goding (1978) has shown that protein A has
an affinity for IgG subgroups from various sources. The
antibody will bind to the protein A at certain pH's and
can be separated from it by altering these conditions.
The following procedure is that of Oi and
Herzenberg (1980).
Protein A - sepharose , 1.5g was swollen in an
excess of 0.05M Tris / 0.15M NaCl / 0.02% NaN3 pH8.6
for 15 minutes at room temperature. A column of bed
volume of 6ml ( 1.6 x 5cm ) was prepared and washed
with 200ml of pH8.6 buffer.
The antibody in the form of reconstituted protein
was run through the column at a slow flow rate
(approximately 1ml per minute). The column was then
washed with pH8. 6 buffer until the A28O hac* returned to
baseline and all unbound protein was washed out.
Stepwise elution of the bound antibody was carried
out under altered pH conditions. The following buffers
were used in order :
pH 7.0 ; 0.05M phosphate / 0.15M NaCl
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pH 5.5 ; 0.05M citrate / 0.15M NaCl
pH 4.3 ; 0.05M acetate / 0.15M NaCl
pH 2.3 ; 0.05M glycine / 0.15M NaCl
In each case the A28O was monitored and the buffer flow
continued until the baseline had returned to zero. The
fractions which showed absorbance were pooled and
neutralised using the pH 8.6 buffer and stored at 4°C
with 0.02% NaN3. All antibodies eluted in the pH 5.5 or
4.3 fraction.
Column regeneration was carried out by washing with
the pH 2.3 buffer after each run and equilibrated with
pH 8.6 buffer.
2.5.4. Hydroxylapatite Affinity Chromatography.
A number of the antibodies produced were of IgM
subtype. IgM antibodies from murine origin have been
reported not to bind to protein A (Ey et al 1978). IgM
does however have some affinity for hydroxylapatite.
The following method was based on that of Stanker
(1985) .
COLUMN BUFFER : 0.01M sodium phosphate/ 0.02% NaN3
pH 6.8
ELUTION BUFFERS : 0.1M, 0.2M, 0.35M, 0.4M sodium
phosphate pH 6.8
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COLUMN REGENERATING BUFFER : 0.5M sodium phosphate
pH 8.6
Hydroxylapatite was hydrated in column buffer
overnight at room temperature. A column with a bed
volume of 75 ml ( 2.5cm x 15 cm ) was prepared. The
antibody was prepared as in section 2.4. If the
antibody was in ascites form. then it was clarified by
filtration ( 0.22u Millipore filter ) and added
directly to the column. The unbound protein was washed
through with column buffer before stepwise elution with
the elution buffers ( starting with the lowest salt
concentration buffer ).
All fractions were monitored at A28O anc* those
containing protein were tested for antibody activity by
ELISA (2.3.2). Positive fractions were pooled,
concentrated by ultrafiltration and stored at 4°C with
0.02% NaN3.
2.6. MICROSCOPY AND PHOTOGRAPHY.
A Leitz Diavert inverted microscope with a Cosina
camera and attachments were used for all
photomicrography. All photographs were taken at 100 x
magnification unless otherwise stated, with phase
contrast optics and a blue filter. Photomicrographs
were taken on Kodacolour Gold 400 or 200 ASA film.
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CHAPTER 3
IMMUNOHISTOLOGICAL STAINING PATTERNS OF MONOCLONAL
ANTIBODIES ON ENDOTHELIAL CELLS IN VITRO.
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3.1 INTRODUCTION
The role of endothelial injury in vascular
thrombosis and atherosclerosis is well recognised and
has been discussed (1.6). Most of the evidence for this
comes from experiments in which the endothelium is
deliberately damaged and the consequences examined
(Hirsch and Robertson 1977, Ramsay et al 1982, Groves
et al 1979, Moore 1973, Clowes and Karnovsky 1977).
Evidence for non-deliberate damage to endothelium
in vivo is difficult to obtain and comes from
morphological studies on excised vessels (Davies et al
1988), known disease models such as homocysteinemia
(Starkebaum and Harlan 1986) and as the result of
therapeutic interventions such as heparin-associated
thrombocytopenia (Cines et al 1987), and balloon
angioplasty (Block et al 1981).
Monoclonal antibodies to damaged endothelium may make
it easier to detect such damage in vivo. In the
following experiments the techniques used to produce in
vitro endothelial damage were based on techniques which
have been used to produce endothelial damage in vivo,
such as mechanical abrasion, air drying and heat. As a
comparison a range of mechanisms which have been
suggested to lead to naturally occuring endothelial
damage were also tested. These include bacterial
endotoxin, hydrogen peroxide, thrombin and hyperoxia.
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3.2.ANTIBODY SCREENING AND SELECTION ,
A total of 25 fusions were done from which 137
colonies of hybridoma cells producing anti-endothe1ia1
antibody were chosen for expansion and cloning, on the
results of the two screening methods in section 2.3,
Of this 137, 27 were cloned giving rise to a total of
90 cloned cell lines. The reproducibility of the method
for each screening was maintained by using cloned
endothelial cell lines in their second or third
subculture 24 hours after reaching confluence. If
secondary screening was negative, the ELISA was
repeated using a primary cell culture. Only a few
hybridoma clones could be investigated in any detail,
the rest are kept in liquid nitrogen storage. After
expansion and before cloning the antibodies were tested
on both non-damaged and scratch damaged cells with
diaminobenzidine (DAB ELISA) procedure (2.3.3), give a
more detailed staining pattern.
Hybridomas producing antibodies with interesting
staining patterns were cloned and screened using the
DAB ELISA method. Many of these cell lines proved to be
unstable and stopped producing antibody after a short
time in culture. However a panel of clones were chosen
for further investigation according to their in vitro
stability and the staining pattern they produced on
endothelial monolayers. Four major staining patterns
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FIG.3.3. Diffuse "speckly" staining pattern of B9B8 on
human umbilical vein endothelium.
FIG.3.1. Diffuse staining pattern of D6F1 on bovine
aortic endothelium. Mayer's haematoxylin counterstain.
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FIG.3.2. Diffuse staining pattern of B9G6 on human
umbilical vein endothelium.
were observed and are described in the following
sections.
3.3. DIFFUSE STAINING.
The antibodies in this group bound to non -
deliberately damaged endothelial cells giving a general
non-specific staining pattern. Fig. 3.1 shows antibody
D6F1 on bovine aortic endothelial cells. Fig.3.2 shows
antibody B9G6 on human umbilical vein endothelium. This
antibody stained the cytoplasm of all the cells in the
monolayer but with varying intensity. Fig.3.3 shows
antibody B9B8 on human umbilical vein endothelium. This
antibody gave a "speckly" diffuse staining pattern and
may in fact be due to cell alteration or damage
There appears to be no increase in staining at the
scratch edge with this antibody.
Of the antibodies producing a diffuse staining
pattern only D6F1 was produced in quantity for further
investigation. The others were either unstable in
culture or are still in liquid nitrogen storage
awaiting further investigation.
3.4. NEGATIVE STAINING.
Two antibodies, B10A10 and B10C10, clones from the
same cell line appeared to stain the plastic around the
cells in a culture of HUVEC where some cell detachment
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FIG.3.5. Bovine aortic endothelial cell monolayer
showing numerous giant cells.
FIG.3.6. Perinuclear staining of giant cells by C9F8,
Adult human saphenous vein endothelium.
FIG.3.4. Negative staining pattern of B10A10 on human
umbilical vein endothelium.
had occured. Very little cell staining was apparent
(Fig.3.4). Control experiments show that the antibodies
did not bind to untreated plastic or the fibronectin or
gelatin surface on which HUVEC were grown.
3.5. GIANT CELL / PERINUCLEAR STAINING.
In vitro cell senescence is typified by the
presence of giant multinucleate cells (HaudenschiId
1975, Rosen et al 1981). Fig.3.5 shows a control
bovine aortic cell monolayer with numerous giant cells.
Fig.3.6 shows perinuclear staining of these giant
cells on adult human saphenous vein endothelium
(SAVEC) with antibody C9F8. Similar staining patterns
were also seen with antibodies C14H11 and C11D7. This
type of perinuclear staining was only seen with
antibodies directed to SAVEC.
3.6. DAMAGED CELL STAINING.
Narrow scratch damage has been used as a method of
looking at endothelial repair after injury in vivo
(Reidy and Schwartz 1980). Here a similar in vitro
scratch damaged / regrowing model was used for
screening monoclonal antibodies. Scratches were made
with a glass pasteur pipette the end of which was
approximately 1mm in diameter. This produced denuded
areas of approximately 10 to 15 cells wide. Two
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FIG.3.8. Scratch damaged monolayer of bovine aortic
endothelial cells-
scratches were made approximately 0.5cm apart across
the centre of each well. Figs. 3.7 and 3.8 show
a confluent monolayer of bovine aortic endothelial
cells before and after scratch damage.
Antibodies which reacted with scratch damaged cells
were tested on cells damaged by other methods. Cell
damage was also assessed by the non - immunological
cytochemical stains trypan blue and acridine orange /
ethidium bromide ( AO/EB ). Damaged plasma membrane
allows entry of 0.1% trypan blue into the cytoplasm
where it binds to intracellular proteins. With AO/EB (
one-part-per-mi11 ion solution of acridine orange and
ethidium bromide in PBS. One part cell suspension was
mixed with one part AO/EB solution) live cells
metabolise the dye and fluoresce bright green whereas
dead cells fluoresce brown/orange.
Table 3.1 shows the antibodies staining damaged
cells. Antibody subtype was determined by Ouchterlony
double diffusion analysis (Mouse Monoclonal Typing Kit,
The Binding Site Ltd., University of Birmingham).
3.6.1 Non-specific staining of damaged cells by IgG.
Investigations by Hansson et al (1979 and 1980)
show the accumulation of IgG in injured endothelial
cells . It has been suggested that IgG binds by the Fc
region of the molecule to the vimentin component of
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ANTIBODY SPECIES Ig IMMUNISATION
OF E.C. SUBTYPE PROTOCOL
A3E10 BAEC IgM 1
*B7H5 HUVEC 1
*B8D2 HUVEC 1
B10F1 HUVEC IgM 1
*B17B11 HUVEC 1
B17E4 HUVEC IgM 1
*D5G2 BAEC 2
D6G11 BAEC IgM 2
D8G8 BAEC IgM 2
P13C1 PAEC Not known 1
P14G11 PAEC I gG2a 1
TABLE 3.1. Monoclonal antibodies to scratch damaged
endothelium. Cell lines * were unstable in
culture and stopped producing antibody
after 2 to 3 subcultures.
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FIG.3.9. Non-specific staining of fixed bovine aortic
endothelial cells by mouse IgG.
FIG.3.10. Pre-incubation of bovine aortic endothelial
cells with autologous IgG blocks non-specific
binding of mouse IgG.
cytoplasmic intermediate filaments (Hansson and
Schwartz 1984).
Changes in the plasma membrane permeability of
damaged cells permits access of IgG molecules to
cytoplasmic proteins. Fig.3.9 shows the presence of
mouse IgG in bovine endothelial cells at the monolayer
edge. These cells had not been deliberately damaged in
any way prior to fixation and it was assumed that
damaged had occured during the fixation process (0.025%
glutaraldehyde). (see section 3.7). The cells at
scratch edges also showed IgG accumulation.
Incubation of fixed and non-fixed cells with an
excess of autologous serum or IgG, in this case neat
newborn calf serum (NBCS), prior to mouse IgG
incubation and staining, blocks the non-specific
binding sites (Fig.3.10). The peroxidase conjugated
second antibody used in the staining procedure is
directed to mouse immunoglobulins and therefore does
not recognise the bovine IgG on the non-specific
binding sites. Therefore, in all following in vitro
investigations with monoclonal antibodies the cells
were preincubated with serum or non-mouse IgG prior to
monoclonal antibody staining.
In conjunction with the cytochemical stains damage
to the cells was assessed by the presence of IgG.
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FIG.3.13. P14G11 stained scratch damaged bovine aortic
endothelial cells, showing damaged cells away
from the edge of the scratch.





FIG.3.12. D8G8/B8 stained scratch damaged bovine aortic
endothelial cells.
3.6.2. Scratch Damage.
On secondary screening , a group of antibodies were
found to stain the cells along the scratched edges of
otherwise normal endothelial monolayers (Fig.3.11 and
3.12). These antibodies are listed in Table 3.1.
Hybridomas from the adult human saphenous vein
endothelium immunised mice did not produce antibodies
to scratch damaged cells.
In most instances the antibody bound to cells
immediately adjacent to the scratch edge, as seen in
Figs.3.11 and 3.12. However, in some cases, especially
those monolayers damaged by wider scratches, damaged
cells were evident up to 10 cells in from the scratch
edge (Fig.3.13). Antibody stained cells were still
physically attached to the plastic surface. Cells which
had been removed from the scratch area and were
floating free in the medium also stained intensely.
Trypan blue and AO/EB staining of these cells confirmed
that they were not viable. Not all the cells at the
scratch edge were damaged, as some excluded trypan
blue. This was also apparent on antibody staining
(Fig.3.12).
3.6.3. Regenerated scratch damaged cells.
Scratch damaged cell monolayers were allowed to





FIG.3.14. Regrown scratch (arrows) damaged bovine aortic
endothelial cells. D8G8/B11. Mayer's
haematoxylin counterstain.
FIG.3.15. Regenerating cells at a scratch edge two hours
after scratching. D8G8/B11. Magn.x400.
Mayer's haematoxylin counterstain.
of 5 to 10 cells wide regrows completely in
approximately 24 hours. Fig.3.14 shows a regrown
scratch area (indicated by arrows). Antibody D8G8/B8
bound to cells in this area of regrowth making the line
of the scratch quite visible even after monolayer
regeneration (approximately 24 hours after initial
damage). Fig.3.15 shows at high magnification, cells at
the scratch edge stained with antibody D8G8/B8 one hour
after scratching. The stained cells show signs of
regeneration, elongation in the direction of growth and
cytoplasmic lamellapodia (arrows) as the cells migrate
into the denuded area.
3.6.4. Air Dried Damage.
Air drying has been used as a model of damage in
in vivo studies (Clowes and Karnovsky 1977).
Growth medium was removed from confluent monolayers
and cells were allowed to dry out at 37°C. At intervals
of 5 minutes up to 30 minutes samples of cells were
fixed in 0.025% glutaraldehyde, treated with autologous
serum or non-mouse IgG to block non-specific binding
sites and treated with antibody in the standard
screening procedure . At times up to 20 minutes little
damage was apparent with trypan blue and antibody
screening. After 20 minutes air drying extensive
staining is seen with both antibody P14G11 and trypan
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FIG.3.18. Heat damaged bovine aortic endothelial cells
A3E10/D11.
FIG.3.16. P14G11 stained air dried damaged bovine aortic
endothelial cells.
FIG.3.17. Air dried damaged bovine aortic endothelial
cells showing trypan blue uptake.
blue. (Figs.3.16 and 3.17).
3.6.5. Heat Damage.
This effect was noticed as an aside to the scratch
damage method. The scratches are made with a glass
pasteur pipette which was heated in a bunsen flame to
bend the tip to a 90° angle, to allow easier access to
the cell surface in the 24 well plates. On screening
with antibody a small round patch of cells at the start
of the scratch stained heavily . This patch of cells
corresponded in size to the pipette tip and in position
to where the pipette was introduced to the cell
surface. The procedure was repeated without scratching
the monolayer or any physical contact with the cells
and before the pipette tip was completely cool. On
staining for antibody (A3E10/D11) a group of cells
corresponding to the hot pipette tip was apparent
(Fig.3.18). It was assumed that heat had caused the
damage to the patch of cells.
3.6.6. Hyperoxic Damage.
Prolonged exposures to high partial pressures of
oxygen can result in alterations of structure and
function of many organs (Clark et al ). Various
theories have been proposed as to the mechanisms of O2
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toxicity. The production and action of free radicals
being the favoured theory at present time.
Investigations into the effect of hyperoxic
conditions on cultured endothelial cells have shown
increases in lactate dehydrogenase (LDH) release and
decrease in 5-hydroxytryptamine (5-HT) uptake which are
both indicative of cell injury. These studies have also
shown a decrease in catalase (CAT) activity and an
increase in superoxide dismutase (SOD) activity. (Block
et al 1985) These changes in antioxidant enzyme
activity suggest an increase in generation and a
decrease in elimination of hydrogen peroxide (H2O2) in
endothelial cells exposed to high O2 levels. This would
in turn lead to an increase in in the intracellular
production of hydroxal radical which has also been
implicated in cell injury (Varami et al 1985).
Cells were grown as normal until confluent and
changed to a normal growth medium saturated with pure
oxygen (>95% O2). The cells were placed in a modular
incubator chamber (Flow Laboratories) which was flushed
with oxygen for 10 minutes and then sealed and
incubated at 37°C. Fresh O2 was added as above every 12
hours. At 48 and 96 hours the cells were fixed in
glutaraldehyde and stained with monoclonal antibody.
The results are shown in Table 3.2.
Very little staining if any, was seen after 48
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ANTIBODY CELL DAMAGE
48 hours 96 hours
A3E10/D11 _ +++
D6G11/E12 - ++
D8G8/B8 ( + ) ++
D8G8/B11 ( + ) ++
IgG CONTROL ( + ) ++
NBCS CONTROL — —
PER.AB CONTROL — _
DAB CONTROL - -
TABLE 3.2. Hyperoxic damage as detected by the
monoclonal antibodies above. (+) indicates some
staining of cells around the well edge only. ++
moderate staining, +++ strong staining. PER.AB -
peroxidase conjugated second antibody.
ANTIBODY CELL DAMAGE
48 hours 96 hours
A3E10/D11 ( + ) ++
A3E10/D11 * — —
D6G11/E12 ( + ) ++





TABLE 3.3. Inhibition of hyperoxic damage by ascorbic
acid. * indicates cultures treated with ascorbic acid
prior to incubation in oxygen. (+) indicates staining
at the well edges only.
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FIG.3.19. Oxygen damaged bovine aortic endothelial
cells stained with D8G8/B8.
FIG.3.20. Non—damaged bovine aortic endothelial cells
grown in 5% CO2 in air. D8G8/B8.
hours, however extensive staining was present after 96
hours in a high oxygen atmosphere. Fig.3.19 shows
bovine aortic endothelial cells stained with D8G8/B8
after 96 hours in hyperoxic conditions. The monolayer
configuration has been disrupted and cells look spindly
and straggly. Fig.3.20 shows a control bovine aortic
endothelial cell culture grown in a normal 5% CO2 in
air atmosphere and treated with antibody D8G8/B8. Cell
morphology looked normal and no antibody staining was
apparent.
This experiment was repeated in the presence of ImM
ascorbic acid as an antioxidant. The results are shown
in Table 3.3. Ascorbic acid appears to inhibit the
damage caused by hyperoxa to some extent.
Control cells were treated with the same panel of
antibodies after incubation in a 5% CO2 in air
atmosphere, with and without ImM ascorbic acid
Results are shown in Table 3.4, Fig.3.20. No damage had
occurred in these control cells.
3.6.7. Hydrogen Peroxide Damage.
Hydrogen peroxide (H2O2) has been implicated in
endothelial cell injury in a number of situations such
as in hyperoxia (section 3.6.6.), homocystinuria
(Starkebaum and Harlan 1986) and with the respiratory
burst associated with granulocyte activation which
89
ANTIBODY CELL DAMAGE
48 hours 96 hours
A3E10/D11 ( + ) ( + )
D6G11/E12 - -
D8G8/B8 - -
D8G8/B11 ( + ) -
IgG CONTROL ( + ) —
NBCS CONTROL - —
PER.Ab CONTROL — —
DAB CONTROL - -
TABLE 3.4. Assessment of damage to cells grown in 5%
CO2 in air atmosphere, control results to hyperoxic
damage. (+) indicate staining of cells at well edge
only. Control cells treated with ImM Ascorbic acid










DIAG. 3.1 Diagramatic representation of cell staining after
damage by hydrogen peroxide (A) and thrombin (B).
Only the cells at the well edge stained with
thrombin, the cells in the centre of the well
remained undamaged.
Cells at the well edge were lost after treatment
with hydrogen peroxide leaving stained damaged




occurs at the vessel wall during the inflammatory
response. ( Weiss et al 1981, Harlan et al 1981, Ager
et al 1984 ) .
Cells were grown to confluence and the growth
medium removed and replaced with varying concentrations
of H2O2 in serum free medium 199 (M199). During
incubation of the cells at 37°C their condition was
checked every 5 minutes to make sure that detachment
had not taken place, as this would have meant loss of
cells during the staining procedure. After 30 minutes
incubation the cell surface looked very patchy with ill
- defined cell borders, therefore the medium was
removed and the cells fixed and stained with P14G11.
The results are shown on Table 3.7. The staining was
different here from the other experiments in this
group. All cells were stained in the centre of the
well. The cells around the well edge were lost during
fixing and washing stages. This and the obvious
difference in degree of staining with increasing
peroxide concentration was easily seen when the plate
was viewed with back illumination. (Diag.3.1.)
3.6.8. Endotoxin Damage.
Endotoxin, a gram - negative bacterial
1ipopolysaccharide (LPS) is known to be pyrogenic and
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is associated in the pathogenesis of septic
disseminated intravascular coagulation (Bradley 1974).
It produces a number of direct effects on endothelial
cells such as pyknosis, release of lactate
dehydrogenase and an increase in prostacyclin
production ( Meyrick et al 1986, Sage et al 1986 ).
Cells were grown as normal until confluent. The
growth medium was removed and replaced with 0.5 to 2.0
ug/ml of endotoxin ( E.Coli serotype 055:B5 - Sigma )
diluted in serum free M199. The cells were incubated
with the endotoxin at 37°C for 2 hours. At the end of
this time the medium was removed and the cells rinsed
gently with PBS. They were then fixed and stained with
antibody P14G11. The results are shown in Table 3.5.
Very little staining was seen except at the cells
around the well edge. There was no noticeable
difference in the the amount of staining with
increasing endotoxin concentration.
3.6.9. Thrombin Damage.
Thrombin has been implicated in increased
permeability of endothelium during inflammation as
shown by uptake of Evan's Blue (Killackey et al 1986).
It has also been shown to cause contraction and cell
5 1
damage as indicated Cr release in intact, isolated
blood vessel segments (Lough and Moore 1975). In
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2 . 0 +
TABLE 3.5. Endotoxin damage to bovine aortic
endothelial cells as detected by antibody P14G11.
THROMBIN CONC. (I.U) CELL DAMAGE
0.5
1 . 0 +
2 . 0 ++
3 . 0 +++
TABLE. 3.6. Thrombin damage to bovine aortic
endothelial cells as detected by antibody P14G11.
H2 02 CONC.(mM) CELL DAMAGE
1 . 5 +
3.0 +++
4.5 ++++
TABLE 3.7. Hydrogen peroxide damage to bovine aortic
endothelial cells as detected by antibody P14G11.
studies with cultured endothelial cells, thrombin at
low concentrations has induced endothelial injury
(Barnhart and Chen 1978).
Cells were grown to confluence. The growth medium
was removed and replaced with varying concentrations of
thrombin in serum free M199 and incubated at 37° C for
2 hours. Cells were then rinsed, fixed and stained with
antibody P14G11. The results are shown in Table.3.6.
This was difficult to assess under the microscope,
however when the plate was examined with back
illumination a marked difference could be seen in
degree of staining with increasing thrombin
concentration. The staining was confined to the cells
at the edge of the well, the area of which increased
with increasing amounts of thrombin. (Diag.3.1).
3.7. CELL STAINING AS A RESULT OF NON-DELIBERATE
DAMAGE.
When DAB ELISA screening antibodies to scratch
damaged monolayers was carried out in 24 x 16mm well
plates, secondary staining was apparent which was not
associated with the scratch damage. An area of cells
around the well edge stained intensely either as single
cells or as small patches of cells. The area of
staining was very consistently confined to a ring of
cells approximately 10 cell widths from the edge of the
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FIG.3.23. P14G11 stained bovine aortic endothelial






FIG.3.24. High magnification (x400) of
Mayer's haematoxylin counterstain.
fig.3.24.
FIG.3.21. D8G8/B11 stained bovine aortic endothelial
cells at the edge of the culture well. Mayer's
haematoxylin counterstain.
FIG.3.22. High magnification (x400) of one area of
FIG.21. Mayer's haematoxylin counterstain.
A





DIAG. 3.2 Cross sectional (A) and top (B) views of
damaged cells at the well edge of a confluent
monolayer.
cells approximately 10 cell widths from the edge of the
well and 5 to 10 cells wide (Diag.3.2). These cells
stained with trypan blue and showed accumulation of
IgG, confirming their damaged status. On examination of
confluent monolayers under low power light microscopy
before staining, these cells appeared normal with no
significant difference to the cells in other parts of
the culture well. In some older cultures this area of
the monolayer contained a higher proportion of giant
cells which also stained intensely. On closer
examination after staining with antibody these cells
did however have a more rounded shape and monolayer
confluence was disrupted in some areas with loss of
cell to cell contact (Figs.3.21 to 3.24).
This staining was was also present in control
intact non - scratched monolayers. Therefore making the
the possibility of this being a distance effect of
scratch damage unlikely. Variations in degree of
staining was noticed with the length of time the cells
were maintained in these culture plates. Young cells
which were fixed and stained as soon as confluence was
reached, approximately 24 to 36 hours showed very
little edge staining . Whereas cultures which had been
maintained in these wells for longer than 48 hours
after becoming confluent showed much more staining.
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FIG.3.27. P14G11 stained, fixed scratch damaged pig
aortic endothelium.
FIG.3.28. P14G11 stained, non-fixed scratch damaged pig
aortic endothelium.
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FIG.3.26. A3E10/D11 stained, non—fixed scratch damaged
bovine aortic endothelium.
3.8. BINDING OF ANTIBODY TO FIXED AND NON-FIXED CELLS.
All primary and secondary screening procedures were
carried out on glutaraldehyde fixed cells. This
procedure itself causes some degree of membrane
disruption . Therefore antibody incubations were
repeated on non-fixed cells. The results for the non¬
specific binding of IgG remained the same and the
blocking of the binding could be achieved in the same
way. However D8G8 , D6G11 and A3E10 antibodies did not
bind to unfixed damaged cells (Figs.3.25 and 3.26).
P14G11 on the other hand was found to bind to both
fixed and non-fixed damaged cells (Figs.3.27 and 3.28).
The cells were fixed in 0.025% glutaraldehyde after
primary antibody incubations and washes and before the
peroxidase labelled second antibody incubation. Non-
fixed cells were sensitive to the second antibody
incubation stage and were lost from the plate on
subsequent washes. This screening procedure was much
more difficult with non-fixed HUVEC. Large numbers of
cells were lost from the plate during initial
incubations and washing steps, making interpretation of
the results difficult.











TABLE 3.8. Antibodies staining fixed and non-fixed
endothelial cells.
ANTIBODY BAEC PAEC HUVEC SPINDLES
A3E10 (++) _ +
B9B8 - + (++) 9
B10A10 + + + +
B17E4 + ? (++) 9
D6F1 (++) 9 9 —
D8G8 (++) ++ ++ ++
D6G11 (++) ++ ++ ++
P14G11 ++ (++) ++ -
TABLE 3.9. Cross - reactivity of monoclonal antibodies
with endothelial cells from different sources.
The results in parenthesis denote the endothelial type
against which the antibody was raised.
? : Not known
3.9. CROSS-REACTIVITY OF MONOCLONAL ANTIBODIES.
Mice were immunised with endothelial cells from
four sources, cow aorta (BAEC), pig aorta (PAEC), human
umbilical vein (HUVEC) and adult human saphenous vein
(SAVEC) with a view to raising monoclonal antibodies
specific to each type of cell. When monoclonal cell
lines were established which produced stable antibodies
with consistent staining patterns on homologous
endothelial cell lines, their reactivity with cells
from other sources was investigated.
Saphenous vein endothelium was not used in these
tests due to problems in growing and maintaining stable
cultures of this particular cell at the time.
Cells were grown to confluence in 24 x 16mm
plates, scratched, fixed and stained with antibody. The
results are shown in Table 3.9.
3.10. STAINING OF FROZEN SECTIONS WITH SELECTED
MONOCLONAL ANTIBODIES.
Antibodies which reacted well with cultured
endothelium were tested on acetone fixed frozen
sections. Sections of normal lung tissue were kindly
provided by the Department of Pathology, Edinburgh
University.
Sections stored at -70°C were thawed at RT slowly.
Endogenous peroxidase activity was inactivated by
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FIG.3.31 Lung. D8G8. Very little obvious staining of
endothelium. There may be some small vessel staining,
arrow bottom right. Some mesothelial staining (M) .
FIG.3.32. Lung. B10A10. No endothelial staining
/ ' '
f'
FIG.3.29. Lung. Mayer's Haematoxylin stained control.
FIG.3.30. Lung. D6F1 staining endothelium (E) of large
vessel and some staining of mesothelium (M).
incubation with methanol containing 0.3% H2O2 for 1
hour at RT. Non-specific binding sites were blocked by
incubation with autologous serum for 15 minutes at RT.
The sections were stained with DAB (section 2.3.3),
using lOOul of neat antibody containing growth medium
supernatant. After the final DAB staining step the
sections were rinsed in tap water and counterstained
with Mayer's Haematoxylin for 5-10 minutes. Colour was
developed by rinsing in tap water and sections were
dehydrated through 50%, 75%, 95% and absolute ethanol
for 5 minutes each step. After clearing in toluene for
5 minutes sections were mounted in DPX and examined by
low power light microscopy
Antibody D6F1 which produced a diffuse staining
pattern on cultured endothelial cells, stained large
vessel endothelium in lung sections. There was no
smooth muscle cell staining but there was some
mesothelial staining (Fig.3.30.).
D8G8 which stains only damaged cultured endothelial
cells, showed very little staining on lung sections
with no distinctive endothelial staining (Fig.31). Some
staining of the mesothelium was apparent and there may
be some small vessel staining (Fig.3.32). B10A10 which
gave a 'negative' staining pattern on cultured cells,
did not show any endothelial cell staining on lung
sections as was expected (Fig.3.32). P14G11 (Fig.3.33)
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FIG.3.33. Lung. P14G11. Heavy non-specific staining.
FIG.3.34. Lung. B17E4. Endothelial (E) and smooth
muscle cell (SMC) staining.
produced heavy non-specific staining. B17E4 (Fig.3.34)
stained both endothelium and smooth muscle cells
distinctively.
3.11. DISCUSSION.
The antibodies produced by the four immunisation
groups were placed in categories according to the
staining patterns found.
Diffuse staining was defined as general non¬
specific staining of non-damaged endothelium. Only two
antibodies were found to produce such staining, D6F1
and B9G6. D6F1 was directed against bovine aortic
endothelial cells. The mice in this group (D) were
immunised with immunogen 2, spleen cells pre-incubated
with BAEC (2.2.2). It stained all the cells of a
scratch damaged monolayer of cloned endothelium without
preference for damaged cells. It also shows the same
staining pattern on non-damaged endothelial monolayers.
In non-confluent cultures not all the cells stain as
shown in Fig.3.1. D6F1 was the only antibody effective
in non-specific staining of endothelium in tissue
sections (Fig.3.30).
B9G6 (Fig.3.2) was raised against HUVEC. The mice
in this group (B) were immunised with immunogen 1
(whole cell preparations of endothelial cells). In an
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uncloned HUVEC culture B9G6 stained all the cells, but
with varying degrees of intensity. This would suggest
that the epitope recognised by B9G6 antibody is
produced by cells to varying amounts, perhaps
indicating different stages of growth or metabolism of
individual cells. The epitopes recognised by these
antibodies are most probably membrane components since
intracellular access of IgM molecules would be highly
unlikely in undamaged cells.
B9B8 (Fig.3.3) is included in the diffuse staining
group although it gave a "speckly" staining pattern.
This may in fact be a variation in the damaged cell
staining with the antibody recognising cytoplasmic
components extruded through damaged plasma membrane.
Two antibodies B10A10 and B10C10 from the same cell
line gave a negative staining pattern. These were
directed against HUVEC but cross-reacted with BAEC and
PAEC and spindle cell cultures. Plastic, fibronectin
and gelatin controls proved to be negative. It seems
likely that these antibodies recognise a component of
the endothelial extracellular matrix which is present
only on the apical surface of the cell and is only
accessible to the antibody when the cell has been
removed non-enzymatically . These components may be
cell attachment proteins such as vitronectin or
col 1agen.
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Perinuclear staining of giant cells occurred only
with antibodies directed against SAVEC. Giant cells are
a typical feature of senescing cell cultures from all
sources. SAVEC cultures tend to have greater numbers of
giant cells in primary culture and can very rarely be
grown for more than one or two subcultures. This may
indicate that these cells have already reached the end
of their replicative life span in situ and hence the
difficulty in maintaining these cells in culture. The
source of SAVEC in this laboratory is from coronary
artery bypass patients and the difficulty in
maintaining endothelial cells from such a source may be
a reflection of the pre-existing vascular disease in
such patients. Staining was confined to what appeared
to be intracellular granules or vesicles surrounding
the nucleus of giant cells. Cells showed varying
degrees of staining. In Fig.3.6 the cells in the top
left and bottom right of the picture have nuclei
completely surrounded by stained granules. These cells
are unmistakably giant cells with characteristically
large quantities of stringy cytoplasm. The cells in the
centre of the picture have less staining and have the
morphologic appearance of normal cells. The presence of
such granules or vesicles may be an early indication of
cellular senescence. If so, such antibodies may have a
potential role in the assessment of suitable vessels
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for grafting.
The negative and perinuclear staining effects could
not be investigated in any detail due to instability of
the hybridoma cell lines producing these antibodies.
Cells either died or stopped producing antibody after
two to three days in culture or could not be revived
from liquid nitrogen storage.
A number of antibodies screened on scratched
damaged monolayers stained the cells lining the scratch
edge. These cells showed trypan blue uptake and
accumulation of IgG confirming their damaged status.
Staining was usually confined to the cells
immediately adjacent to the scratch edge, indicating
that damage was also confined to the cells at the
scratch edge (Figs3.11 and 3.12). However in some
instances staining occured in cells up to 10 cells away
from the scratch edge (Fig 3.13). This may indicate
that scratch damage has a distance effect. Schwartz et
al (1978) have shown that cells not immediately
associated with areas of damage exhibit changes in
thymidine uptake and DNA synthesis associated with
regeneration. The effect seen in Fig. 3.13 may in fact
be associated with cell regeneration, the stained cells
at the scratch edge indicating regeneration rather than
damage. Cell monolayers were therefore scratched and
allowed to regrow before antibody treatment (Section
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3.6.3). The site of the scratch was still evident as a
line of stained cells although the cells were
completely confluent (Fig.3.14). It may be that these
cells would eventually be pushed off the monolayer by
regenerating cells from behind and that in this case
healing of the wound is not in fact complete. However
when scratched damaged cells were examined after two
hours of regrowth, antibody stained cells did show
tentative signs of regeneration i.e. elongation and
alignment in the direction of movement. However,
without further work on the metabolism of these cells
it is not possible to deduce from the staining pattern
alone whether these cells are damaged or regenerating
cells. Trypan blue uptake would indicate that they are
non-viable, however trypan blue really only shows
membrane damage. There is no indication that the damage
is irreversible and it may be sublethal. However
without further investigation it is impossible to say
that these are regenerating cells.
Cells damaged by air drying, heat and hyperoxic
conditions did stain with antibodies D8G8, P14G11 and
A3E10. The cells damaged by hyperoxic conditions did
have gross monolayer morphology changes. However the
heat and air damaged cells did not look any different
to normal cells on examination under low power light
microscopy. These antibodies may have a potential
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application in detecting sublethal or early non-
denuding endothelial injury.
Endotoxin damage was not detected by these
antibodies. The concentration of LPS used was in the
range of that used by Sage et al 1986 to induce damage.
No macroscopic morphological changes were observed with
these concentrations and very little cell staining
occured even with increased concentrations of LPS. Some
staining of the cells at the well edges did occur but
was considered non-specific. Treatment of the cells
with thrombin and hydrogen peroxide produced
interesting staining patterns. Thrombin at 0.5 U caused
no antibody detectable damage. At 1.0 U staining of
cells around the edge of the monolayer was apparent.
This staining increased in intensity with increasing
concentrations of thrombin without staining cells in
the centre of the well. The concentration of hydrogen
peroxide used gave cell staining in the centre of the
well which increased in intensity with increasing
concentration. The cells around the edge of the well
which had stained intensely after thrombin treatment
were lost from the well after hydrogen peroxide
treatment. The cells at the edge of the culture well
appeared to be more susceptible to lethal damage by
thrombin and by hydrogen peroxide.
Staining of cells around the well edges was an
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Critical region of meniscus
A
Areas of damage in monolayers grown in 24 well plates.
Critical region of meniscus
B
Area of damage in monolayers grown in 96 well plates.
tititita Damaged cells
c ) Non-damaged cells
DIAG. 3.3 Areas of non-deliberate damage in monolayers
grown in 24 and 96 well plates appear to coincide
with what may be critical points of the meniscus
in terms of surface tension effects.
effect seen with all the anti-damaged cell antibodies
screened. Staining varied in intensity according to how
long the cells had been maintained in culture in 24
well plates. Investigation of cells grown in other
sizes and types of vessel, revealed that monolayers in
2 2
25cm and 75cm flasks did not show this staining
pattern. However, monolayers grown in 96 well plates
showed cell damage in the centre of the well but not
around the edges. The areas of damage in both the 24
and 96 well plates appear to coincide with critical
regions of the meniscus of the culture medium in the
individual wells (1.0ml and 0.1ml respectively).
Diagram 3.3 attempts to explain the association. Three
possible explanations of this effect exist.
1. These are areas where gas diffusion is least
efficient. In the 24 well plates this a plausible
explanation of cell damage. However, the cells
immediately adjacent to the vertical walls of the well
do not appear to be damaged (no trypan blue uptake or
non-specific staining by IgG). The damaged cells in the
96 well plates occurs in the centre of the wells where
gas diffusion would be optimal. On these plates, damage
at this region could be due "drying out" effects.
2. Surface tension forces at the gas - fluid interface
may be acting on the cell surface. The formation of a
meniscus however ensures equal surface pressures on
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both sides of the interface , ruling out pressure
forces as a cause of damage. Newly plated cells, i.e.
cell suspensions before cell to plastic adherence
during routine subculturing procedures, tend to
aggregate in the centre of the 24 plate wells and
around the edges of the 96 plate wells. This effect was
not unique to endothelial cell suspensions but was also
noted with the hybridoma cells, which were also grown
in 96 and 24 well plates with 0.1ml and 1.0ml of medium
respectively. This would suggest that some other
physical forces may be acting on both cell suspensions
and cell monolayers at these areas of fluid — plastic
interface or the fluid - air interface.
3. Accumulation of toxic waste products. In static
culture toxic waste product accumulation may become
localised at specific sites. These sites in turn may be
determined by physical forces and fluid mechanics.
Without frequent medium changes these waste products
could cause localised cell damage. It was noted that
non-deliberate cell damage became more pronounced with
length of time in culture. This type of damage was very
slight in cultures which reached confluence and were
used within 24 hours.
All of the antibodies screened except one (P14G11)
bound only to fixed cells. P14G11 appeared to bind with
equal affinity to both fixed and non-fixed cells.
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P14G11 is an IgG type antibody whereas the others are
IgM's. The size and conformation of these molecules
differs greatly and differences in binding between
fixed and non—fixed cells can be explained in terms
antibody and antigen "size" and plasma membrane damage.




SEPARATION OF ENDOTHELIAL CELL PROTEINS BY SDS -
POLYACRYLAMIDE GEL ELECTROPHORESIS AND IMMUNODETECTION
OF WESTERN BLOTS WITH MONOCLONAL ANTIBODIES.
106
4.1. INTRODUCTION.
The work described in this chapter uses the
techniques of polyacrylamide gel electrophoresis (PAGE)
and protein transfer (Western Blotting) to investigate
the reactivity of endothelial cell proteins with the
monoclonal antibodies developed in the 1aboratory,and
aims to provide a framework for discussing the
mechanisms of the diverse staining patterns produced by
the antibodies as discussed in chapter 3.
The method of separating and identifying
polypeptides by polyacrylamide gel electrophoresis in
the presence of the detergent sodium dodecyl sulphate
(SDS) has proven to be reliable and reproducible
(Maizel 1966, Shapiro et al 1966, Vinuela et al 1967,
Fairbanks et al 1971). By this technique, molecular
weights can be estimated quickly and simply ( Shapiro
et al 1967, Weber and Osborn 1969 ). Further analysis
of separated proteins is facilitated by e1ectrophoretic
transfer onto nitrocellulose or nylon based membranes
(Towbin et al 1979, Burnette 1981 ).
SDS - PAGE and immunoblotting techniques have been
widely used in investigating aspects of endothelial
cell behaviour under conditions of normal growth
(Vlodavsky et al 1979, Ketis et al 1986, Dickinson et
al 1986,) and in conditions of stress (Sage et al
1986). The recent boom in monoclonal antibody
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production has also led to immunolological
identification of specific endothelial proteins
(Darnule et al 1983, Kaplan et al 1983, Arvieux et al
1986).
There are two main limitations of SDS-PAGE which
must be considered when interpreting the results of the
following experiments. First, separation is only on the
basis of effective molecular weight and two different
proteins with the same molecular weight will not be
resolved. Second, it implies that antigen is both
stable and soluble under these conditions.
The initial experiments investigate the general
reproducibility of protein patterns during
electrophoresis and compare the differences and
similarities of these patterns in cells from different
species. Once a reproducible technique of separating
the proteins had been established their antigenicity
was investigated using the monoclonal antibodies
described in Chapter 3.
A.2. METHODS.
4.2.1. Preparation of Cells for Sodium Dodecyl Sulphate
Polyacrylamide Gel Electrophoresis (SDS-PAGE).
The cells were prepared for electrophoresis
according to the method of Vlodavsky et al (1979).
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Confluent monolayers of cells were gently rinsed 3
times with PBS and resuspended by incubation in lOmM
sucrose/ ImM EDTA in 20mM HEPES buffered PBS at 37°C
until the cells were detached (section 2.1.6). The cell
suspension was then rinsed 3 times in serum free EBS
with 15 second mixes on a vortex mixer at each rinse.
5 6
Cell pellets of 10 to 10 were resuspended in 1 to
2ml of lysis buffer : 15% glycerol





1 unit of DNAse I per ml of buff
This was incubated for 30 minutes at 37°C in an HNO3
washed glass tube with shaking. A further 2 hour
incubation at 37°C was carried out after the addition
of 2-mercaptoethano1 to a final concentration of 5%.
Immediately before use, dithiothreitol was added at a
final concentration of 0.1M and the samples were boiled
for exactly 2 minutes and immediately cooled on ice.
Samples were spun at 10 000 rpm for 5 minutes before
the addition of the glycerol and bromophenol blue
tracking dye.
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4.2.2. SDS - PAGE.
The Laernmli (1970) buffer system was used
throughout all the electrophoresis experiments.
ELECTRODE BUFFER : 0.025M Tris ; 0.192M Glycine ; 0.1%
SDS pH8.3
GEL BUFFER : 0.75M Tris ; 0.2% SDS
Resolving gel buffer pH8.8
Stacking gel buffer pH6.8
ACRYLAMIDE STOCK : 22.2% acrylamide ; 0.6% NN'-
bisacrylamide, made up in double
distilled water (DDH2O) and filtered
through Whatman No.l paper and
stored in a dark bottle at 4°C and
discarded after 2 weeks.
AMMONIUM PERSULPHATE STOCK : 1.5% ammonium persulphate
in DDH2O and made up fresh
each time.
ACRYLAMIDE CONC. IN GEL
10% 7 . 5% 5% 3.3%
ACRYLAMIDE STOCK 18 13.5 9 3
WATER — 4.5 9 6
BUFFER 20 20 20 10
AMMONIUM PERS. 2 2 2 1
TEMED 0.06 0. 06 0. 06 0 . 03
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The figures given in the table are the quantities in ml
of each component of the gel required for one 1.5mm
thick slab gel of the appropriate concentration of
acrylamide. The 3.3% gel denoted by * was used only as
a stacking gel and the volume given above was enough to
provide a 1cm layer on two slab gels. Each component of
the gel was mixed in the above order adding the TEMED
immediately before pouring the gel and mixing in each
solution very gently as it was being added. All
solutions were at room temperature before mixing to
avoid formation of gas bubbles which would prevent the
gel from setting.
Samples of 20 — 50ul of cell lysate were carefully
applied to each well using a Hamilton syringe and
molecular weight standards ( Sigma ) were included in
each run according to the manufacturers instructions.
Electrophoresis was carried out in an LKB 2001 Vertical
Electrophoresis Unit at 50mA constant current until the
samples were through the stacking gel and then at 70mA
until the sample front was 1cm from the bottom of the
gel. Gels were then prepared for protein transfer or
stained in Coomassie Blue R250 and or silver stained.
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4.2.3. Staining of Polyacrylamide Gels.
Coomassie Blue Stain.
Coomassie Blue (CB) R250 (0.25%) was dissolved in
95% ethanol, stirred for 1 hour and filtered through
Whatman No 1 paper. Gels were stained overnight in a
50/50 mixture of stain concentrate and 10% acetic acid.
Destaining was carried out in the following solutions
in the order listed :
200ml ethanol + 300ml 5% acetic acid for 1-2 hours
(150ml ethanol + 350ml 5% acetic acid for 1-2 hours) x 2
100ml ethanol + 400ml 5% acetic acid for 2 hours
150ml water + 350ml 5% acetic acid 1-2 hours
Destained gels were soaked in 48% methanol/ 5%
glycerol for at least 2 hours before drying at 80°C for
2 hours.
Silver Nitrate Staining.
The method was that of Dzandu et al (1984).
Silver nitrate stain is specific for lipids and
sialoglycoproteins, staining them yellow and providing
a contrast to Coomassie blue staining polypeptides.
Each slab gel was treated in 500ml of solution
unless otherwise stated. The gel was fixed in 40%
methanol / 10% acetic acid for 1 hour at room
temperature and washed in 10% ethanol / 5% acetic acid
for 2 consecutive 30 minute washes. This also removed
residual SDS.
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Equilibration was carried out in 200ml of oxidiser
reagent (6.4mM nitric acid / 6.8mM potassium
dichromate) for 10 minutes, which stains the gel pale
yellow. The oxidiser reagent was washed with DDH2O
until the background colour cleared. The gel was then
stained with 200ml of 20mM silver nitrate for 30
minutes and then washed 3 times for 1 minute each in
DDH2O to remove unbound silver. The presence of unbound
silver in the final wash was checked by cloudiness when
1 drop of 1M HC1 was added to 1ml of rinse. Rinsing was
continued until the gel was free of unbound silver.
The gel was then transferred to 200ml of developer
solution at 40°C (0.28M sodium carbonate / 0.008%
paraformaldehyde). This solution was changed as soon as
turned brown in colour, which continued until yellow
bands appeared on the gel. It was rinsed with DDH2O and
10% acetic acid added to enhance the yellow colour of
the bands.
Silver stained gels were preserved in the same way
as Coomassie blue gels.
4.2.4. Protein Transfer (Western Blotting).
Gels intended for blotting were immediately
equilibrated in transfer buffer : 25mM Tris/ 192mM
glycine/ 20% v/v methanol/ 0.01% SDS pH8.3 for 15-30
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minutes. The immobilising membrane, either
nitrocellulose (NC) or Immobilon P (PVDF) and filter
papers were also equilibrated in this buffer. The gel
was laid on the NC or Immobilon membrane and sandwiched
between sheets of filter paper. With 2 or 3 scouring
pads on either side to hold the gel and membrane
tightly together, they were inserted in a holder with
the membrane facing the anode. This was completely
immersed in transfer buffer and electrophoresed for 1
hour at 1 amp
4.2.5. Immunostaining of Western Blots.
The NC sheets were cut into strips corresponding to
the sample lanes before the paper had dried. The
standards and a total protein control lanes were
stained in 0.1% amido black/ 25% propanol/ 10% acetic
acid for 5 minutes and destained in 25% propanol/ 10%
acetic acid, 2 or 3 volumes with a final rinse in cold
water before being dried between strips of filter
paper. The other strips were incubated with antibody
and protein bands detected either by
aminoethylcarbazole (AEC) substrate reaction or by
immunogold silver staining.
AEC Substrate Reaction : The transfer strips were
incubated in 20% BSA solution overnight at room
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temperature. This was a quenching step to reduce non¬
specific background staining. Incubation with primary
antibody (monoclonal antibody) was carried out at room
temperature for 1 to 2 hours. If the antibody was in
growth medium supernate form it was added at a 1:2
dilution , if it was purified antibody then a 1:10 or a
1:100 dilution was used.
The strips were then washed 4 times for 15 minutes
each time with PBS/1XBSA and incubated for 1 hour with
peroxidase conjugated rabbit anti - mouse second
antibody at a 1:100 dilution in PBS/1%BSA. The washes
were then repeated 3 times, 5 minutes each.
The 3-amino-9-ethy1carbazo1e stock solution was
made up at 20mg in 2.5ml of dimethylformamide and
stored at 4°C. The substrate incubation solution was
2.5ml of stock solution + 47.5ml of 0.05M acetate
buffer pH5.0 and filtered through Whatman No 1 paper.
Immediately before incubation with the transfer strips
125ul of 6% H2O2 was added to the substrate solution. A
red insoluble precipitate characterises the antigen-
antibody complex and as soon as this became visible the
strips were removed, rinsed with water and dried
between sheets of filter paper.
Immunogold Silver Staining : The following method was
that recommended by Janssen Life Sciences Ltd for use
with their Auroprobe BLplus — Intense II products.
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The transfer strips were incubated overnight in 5%
BSA / 20mM Tris-HCl / 0.9% NaCl / 20mM NaN3 pH8.2 at
room temperature. All further incubations and washes
were done at room temperature under constant agitation.
The strips were washed 3 times for 5 minutes each time
in 0.1% BSA Tris buffer (as above) and incubated with
primary antibody diluted in 0.1% BSA Tris buffer as in
AEC substrate reaction section. Again the strips were
washed 3 times for 5 minutes as above and incubated for
2 hours with gold labelled second antibody
(AuroProbe^BLplus GAMIgM+IgG) at a 1:100 dilution in
0.1% BSA Tris buffer with 1:20 v/v gelatin. Strips were
washed 2 times for 5 minutes each in 0.1% BSA Tris
buffer and 2 times for 1 minute each in DDH2O. Equal
volumes of initiator and enhancer solutions from the
TM
Intense II kit were mixed thoroughly immediately
before use. The strips were incubated in this
enhancement solution under constant agitation until the
required resolution of colour was obtained (10 - 20
minutes ). The stained NC strips were then washed in
excess DDH2O several times and dried between sheets of
filter paper.
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4.3. COMPARISON OF PROTEIN BANDS OF ENDOTHELIAL CELL
LYSATES AS DETECTED BY COOMASSIE BLUE AND SILVER
STAINS.
The textile dye Coomassie Blue R250 (CB) was first
used by Fazekas de St.Groth et al (1963) to stain
proteins separated on cellulose acetate strips. In
slightly acid conditions the dye anion is
electrostatically attracted to the NH3' groups of the
protein molecule with Van der Waals forces holding the
reactants together. The protein - dye complex is firm
but fully reversible under the appropriate conditions
of pH. Coomassie blue is the conventional method of
staining proteins in polyacrylamide gels (Meyer and
Lamberts 1975 ). It is highly selective for proteins
and can detect 0.2 - 0.5ug of protein in a sharp band,
but is not quantitative. Different proteins bind
coomassie blue to different extents.
A method devised by Dzandu et al (1984) uses silver
to detect lipids and sialoglycoproteins in
electrophoretically separated cell components. It is
complementary to CB staining in that negatively stained
regions of silver stained gels stain with CB. It can
therefore be used as a double staining technique on the
same ge1.
In the following experiments the cells were not
treated enzymatically prior to electrophoresis so no
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FIG.4.1(a). Silver and coomassie blue stained sections of
supernate fraction of bovine, porcine and human
endothelial cell lysates.
A: molecular weight standards, B: bovine aortic C:
porcine aortic D: adult human saphenous vein, E: human
umbilical vein endothelium. 5% acrylamide gel.
distinction between lipids and sialoglycoproteins can
be made. However, lipids / sialoglycoproteins as
a group, as stained by this method can be compared to
the proteins stained by coomassie blue. Two sets of
experiments were done with the two staining methods.
4.3.1. Comparison of protein band patterns from bovine,
porcine and human endothelium.
The electrophoresis and staining methods are
described in section 2.5. Endothelial cell lysates from
bovine and porcine aorta, adult human saphenous and
human umbilical vein were separated into supernatant
and pellet fractions by spinning for 3 to 5 minutes at
7 000 x g and run on 5% acrylamide gels and stained
with CB and silver. The results are shown in Fig.4.1(a)
The cell lysates were prepared in a Tris buffer which
interferes with protein estimation. Although methods
are available which exclude such interference
(Polacheck and Cabib 1981), it was felt that precise
quantitation of protein was not required for these
experiments. Cells were counted before lysing and
samples were prepared from lysates from equal numbers
of cells and in this way the "amount" of protein was
kept fairly constant.
Lane B (BAEC) contains too much protein (sample
size of 100 ul) and individual bands in the CB stained
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FlG.4.1(b). Silver and coomassie blue stained sections of
pellet fraction of bovine, porcine and human endothelial
cell lysates.
1: molecular weight standards, 2: bovine aortic, 3:
porcine aortic, 4: adult human saphenous vein, 5: human
umbilical vein endothelium
lane are difficult to see, especially in the lower
molecular weight regions. The other lanes contain less
protein (sample size of 50 ul). With total protein
staining (CB) there were few major differences in band
pattern between bovine, porcine and human . On
comparing lanes D (SAVEC) and E (HUVEC), a very high
molecular weight protein band (a) is present on human
umbilical vein endothelial cells but not on those from
adult saphenous vein. This protein is also present on
pig aortic endothelium (C) and bovine aortic
endothelium (B).
The silver stained gels show only one major band
(b) which runs parallel to the 66kD standard. It is
very prominent on pig aortic, human saphenous and
umbilical vein endothelium but is not so clear on
bovine aortic, even although equivalent amounts of
sample were run. A heavily stained band with a very
high molecular weight (c) is present on BAEC but is not
a feature of other cell types.
The pellet fractions of these cell preparations
were trypsinised ( without this step the samples would
not migrate through the gel). This fraction contained
fewer proteins and all with low molecular weights up to
approximately 45kD (Fig.4.1(b)) Homology exists between
the bovine (lane 2), saphenous vein (lane 4) and the
umbilical vein (lane 5) cells, however the pig aortic
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FIG.4.2(a). Silver and coomassie blue stained whole cell
lysates of bovine aortic endothelial cells of inreasing
subcultures.
1: molecular weight standards, 2: first subculture cells,
3: second subculture cells, 4: fourteenth subculture
cells. 5% acrylamide gel.
cells (lane 3) differ in that two bands, one above and
one below the major band of approximately 30kD (a) are
missing . The silver staining band pattern is similar
to that of the CB stained gel.
4.3.2. Comparison of protein band pattern in cells of
increasing- age.
The bovine cell line B135 was harvested after 1,2
and 14 subcultures. Cells were resuspended using
sucrose / EDTA buffer and prepared for electrophoresis
as described (2.5). Each sample was prepared in 1ml of
lysis buffer and contained protein from 10^ cells,
lOOul of sample was applied to each well of 5% and 10%
gels. The results are shown in Fig.4.2(a). The CB total
protein stain shows very little difference between the
first (2) and second (3) subculture samples.
Overloading of the wells has caused some problem in
visualising individual bands in the lower molecular
weight regions. A cluster of high molecular weight
proteins (a) increase in intensity of staining with
increasing number of subcultures. This suggests that
these proteins increase in quantity as the cells are
subcultured. A second region of disparity (b) on the CB
stained gel is also seen on the silver stained gel. On
lanes 2 and 3 a CB stained band in this region is
followed by a negatively stained band which stains as a
120
FIG.4.2(b). Silver stained pellet fractions of bovine
aortic endothelial cells of inreasing subculture.
1: molecular weight standards, 2: first subculture cells,
3: second subculture cells, 4: fourteenth subculture
cells. 10% acrylamide gel.
lipid / sialoglycoprotein on silver staining. This band
is not present on the silver stained section of lane 4
and on the CB stained section three bands are present
with no negative stained region. Two differences are
seen on the silver stained sections only. The first
subculture sample (2) shows a band at the 66kD region
(c) which is not present on the second or fourteenth
subcultures. Two bands are present in this region on
lane 4. An area of heavily stained bands of low
molecular weight (d) are present on lanes 2 and 3 but
are faint in lane 4. These bands are more clearly seen
in the pellet fraction of the cell lysate (Fig.4.2(b)).
This shows a band (a) just below the 45kD marker which
decreases in staining with increasing subcultures. A
similar pattern is seen with a band just below the 29kD
marker (b) but to a lesser extent. In general, from
Figs. 4.2(a) and (b) it would seem that as the cells
age the relative amount of lipid / sialoglycoprotein
detected by silver staining decreases, compared with
total protein as stained by CB. The stacking gels of
these samples were retained to show how much lipid /
sialoglycoprotein remains at the origin and does not
migrate through the resolving gel. To look in more
detail at lipid / sialoglycoporotein content a much
lower percentage acrylamide resolving gel would have to
be used or the cell components broken down into smaller
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molecules. No further work was done on resolving the
lipid / sialoglycoprotein fraction, for reasons
discussed below.
4.4. MOLECULAR WEIGHT ESTIMATION.
From the CB stained gels the molecular weights were
estimated by the method of Weber and Osborn (1969).
These investigators observed that the mobilities of
proteins in polyacrylamide gels were a linear function
of the logarithm of their molecular weights. SDS, an
anionic detergent, binds to the hydrophobic regions of
proteins and separates most of them into their
component subunits. SDS binding also imparts a large
negative charge to the denatured polypepetides. This
masks the charge normally present in the absence of SDS
and allows the separation to be based on the size of
the molecule. Results are highly reproducible not only
for globular proteins but also for helical, rod-shaped
protein molecules. However, the linear relationship
between mobility and molecular weight does not hold
true in some instances. With proteins of high molecular
weight (90kD to 200kD and over) curvature of the plots
of mobility against log molecular weight have been
observed. The linearity is related to the amount of
cross linking in the gel matrix. High molecular weight
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proteins show a greater degree of linearity if
separated on gels with a low percentage of acrylamide
and cross-linker, whereas low molecular weight proteins
show greater linearity on high percentage acrylamide
gels (Hames 1981).
Endothelial cell lysates were prepared and the
proteins separated as described. Each gel was run in
duplicate, one being used for protein transfer and the
other for total protein staining by CB. Molecular
weight standard kits, MW-SDS-70 and MW-SDS-200 (Sigma)
gave a range of molecular weights from 14kD to 205kD.
The length of the gels and the distance of stained
proteins from the origin were measured in centimetres
and the relative mobility of the protein bands were
calculated from the formula :
Rf = A/C x B/D where:
A = distance of protein migration through the gel
B = length of gel before staining
C = length of gel after destaining
D = distance of dye migration i.e. buffer front
The Rf values of the standards were plotted against
logfQ °f molecular weights and least squares regression
analysis was used to find the straight line of best
fit. The molecular weights of the unknown proteins were
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GRAPH 4 1 High molecular weight standards (MW—SDS— 200)
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myosin 205 1 69 36
b-galactosidase 1 1 6 1 29 1 3
phosphorylase b 97.4 94.9 2.5
bovine albumin 66 73 7
egg albumin 45 53 8
carbonic anhydrase 29 25 4
MW-SDS-70
bovine albumin 66 59 7
egg albumin 45 48 3
glyceraldehyde¬
s-phosphate 36 37 1
carbonic anhydrase 29 29 0
trypsinogen 24 27 3
trypsin inhibitor 20.1 18.8 1 .3
a-lactalbumin 14.2 13.8 0.4
TABLE. 4.1. Comparison of estimated molecular weights to
actual molecular weights of standard kits MW-SDS-200 and
MW-SDS-7 0.
STANDARD KNOWN MW ESTIMATED MW (kD)
(kD) 1 2 3
MW-SDS-7 0
bovine albumin 66 59 62 61
egg albumin 45 48 45 46
glyceraldehyde-
3-phosphate 36 37 40 39
carbonic anhydrase 29 29 29 32
trypsinogen 24 27 27 21
trypsin inhibitor 20.1 1 88 19.4 20.0
a-lactalbumin
9
14.2 13.0 13.6 14.7
A
correlation (r ) 97.7% 98.6% 97.6%
MW-SDS-200
myosin 205 1 70 1 49 1 69
b-galactosidase 1 1 6 1 1 7 1 23 1 29
phosphorylase b 97.4 1 05.5 1 09.6 94.9
bovine albumin 66 79 80 73
egg albumin 45 48 50 53
carbonic anhydrase
9
29 25 25 25
A
correlation (r ) 96.2% 92.0% 95.4%
TABLE 4.2. Comparison of estimated molecular weights with
known molecular weights of standards from three gels.
calculated from their Rf values and the equation of the
line. The calculations were all done on computer using
a standard Minitab statistics package.
Molecular weight standards (MWS) from both kits
were run on the same 10% acrylamide gel (Fig.4.3) and
R values calculated from the above formula. The line
of best fit was found for both sets of standards
(Graphs 4.1 and 4.2). In theory, the relationship
between mobility and molecular weight should be linear.
However, as has already been discussed, high molecular
weight proteins do not behave so on highly cross-linked
gels (10% acrylamide in this case). A comparison of
"estimated" molecular weights to known molecular
weights was made by applying the Rf values of the MWS
proteins to the appropriate line of best fit from
graphs 4.1 and 4.2. The results (table 4.1) show quite
a difference between estimated molecular weights and
known molecular weights. The difference between the
known and estimated molecular weights (table 4.1) is
smaller with the low molecular weight standards (MWS-
SDS-70). From the regression analysis, the correlation,
2
r , value was higher for the low MWS, 97.7% compared to
95.4% for the high MWS. This would suggest that the low
MWS show a greater degree of linearity than the high
MWS under these experimental conditions. These






















































FIG.4.4. Coomassie blue stained 10% acrylamide gel of
human umbilical vein (HUVEC) and bovine aortic (BAEC)
endothelial cell lysates.
1: molecular weight standards, 2: HUVEC - H150.5, 3:
HUVEC - H149.4, 4: HUVEC - H148.1, 5: BAEC - B144.5, 6:
molecular weight standards.
c □ E F G H I J
FIG.4.3. Coomassie blue stained 10% acrylamide gel of
human (SAPHEC and HUVEC), bovine aortic (BAEC) and
porcine aortic (PAEC) endothelial cell lysates.
A and B: HUVEC - H149.1, C: newborn calf serum, D: BAEC -
B144.6, E: adult human serum, F and G: SAPHEC - A15.4 and
A20.3, H: pig serum, I: PAEC - P53.1, J: molecular weight
standards.
STANDARD MW EST. MW OF HUVEC PROTEIN BANDS
KNOWN EST. H150.5 H1 49.4 H1 48.1
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1 8 1 8 1 8
1 6 1 6 1 5
1 5 1 5 1 6
1 4 1 4
TABLE 4.3. Estimated molecular weights of the major
protein bands of human umbilical vein
endothelial cells.
The molecular weight values are spaced to correspond
roughly to the spacing of the bands in relation to each
other on the gel.
STANDARD MW EST. MW OF PROTEIN BANDS
KNOWN. EST. A20.3 P53.1
98 98
78 78
66 61 64 64
56 56
45 46 48 48
36 39 39 39
29 32 36 36
24 21 21 21
20 20 20 20
1 9 1 9
1 7 1 7
1 4 1 5
TABLE 4.4. Estimated molecular weights of the major
protein bands of adult human saphenous vein and pig
aortic endothelial cells.
from six 10% acrylamide gels prepared and run under the
same conditions (table 4.2).
On the basis of these results, molecular weights of
unknown protein bands were estimated from the low
molecular weight standards. Most protein bands of
interest fell within the range of these standards and
any bands of interest which were outside this range had
molecular weights estimated from the high molecular
weight standards.
Endothelial cell proteins were separated on 10%
acrylamide gels and the molecular weights of the major
bands stained were estimated as described above. The
molecular weights of the standards and the unknowns in
tables 4.3, 4.4, 4.5 are spaced in such a way as to
correspond roughly to the spacing of the bands in
relation to each other on the gel. Human umbilical vein
endothelium protein bands are shown in table 4.3, graph
4.3 and fig.4.3. Pig aortic and adult human saphenous
vein bands are shown in table 4.4, graph 4.4 and
fig.4.4. Bovine aortic protein bands are shown in table
4.5. These result were taken from gels shown in figs.
4.3 and 4.4. The mean of the estimated molecular
weights were calculated and since these protein bands
were also present on human and pig endothlial cells
these are the molecular weights referred to in the
following results.
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FIG.4.5. Coomassie blue stained 10% acrylamide gel of
molecular weight standards.
A: MW-SDS-200 standard kit, molecular weights
205k,116k,97.4k,66k,45k, 29kD. B: bovine aortic
endothelium, C: MW-SDS-70 standard kit, moleular weights
66k,45k,36k,29k,24k,20.1k,14.2kD, D: 36kD standard, E:
29kD standard, F: 24kD standard, G: 20.1kD standard, H:






























































































TABLE4.5.Estimatedmolecularweightsfth joprot inbandf bovineaorticendothelialcells.Thst mateswert k nfrhr differentgelsandthr sultsvariedsligh ly,molecularw ight standardsatheirestim tedmolecularw ightsrlsohown, thereforeemeanvaluesofhBAECmo cularw ightsrgiv nin thefarrightcolumn.
4.5. IMMUNODETECTION OF PROTEIN BANDS ON WESTERN BLOTS
Acrylamide gels are fragile and difficult to work
with. In order to detect reactions between proteins
separated by SDS-PAGE and antibodies, it is more
convenient to transfer the protein to a more stable
material such as nitrocellulose.
Protein blotting is a simple, non-quantitative
technique, convenient and fast and provides a stable
base for the analysis, concentration or purification of
antibodies and other protein ligands (Burnette 1981,
Legocki and Verma 1981, Olmsted 1981). A variety of
transfer membranes are available. The most commonly
used being nitrocellulose (NC) and more recently, nylon
based membranes which are more robust than NC.
The binding of monoclonal antibodies to separated,
transferred endothelial cell proteins was tested with a
selection of monoclonal antibodies discussed in chapter
3. The antibodies chosen were from the most stable cell
lines and which gave the most consistent results in
fixed cell ELISA. The results are discussed in detail
for each individual antibody.
4.5.1. A3E10.
This antibody recognises damaged bovine aortic
endothelial cells (BAEC) in fixed cell ELISA tests. It
is an IgM subtype and was developed from mice which had
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FIG.4.6. Immunoblot of antibody A3E10 on endothelial cell
lysates.
The following abbreviations apply to figs. 4.6 to 4.12.
BAEC (bovine aortic endothelium) PAEC (porcine aortic
endothelium) HUVEC (human umbilical vein endothelium)
SAVEC (adult human saphenous vein endothelium) BSP
(bovine spindle cells) AHS (adult human serum) NBCS
(newborn calf serum) PS (porcine serum)
Molecular weights are shown in kD.
been immunised by protocol 1 (2.2.2). Three clones from
this cell line produced stable antibody, C9, D10 and
Dll. D10 and Dll have the same characteristics,
therefore only C9 and Dll are shown in Fig.4.6. The
amino-ethy1carbazole (AEC) staining method has produced
high backgrounds in strips 1,5 and 9 with some
patchiness in strip 9. Strips 3,7 and 8 were stained by
the silver enhanced gold method (2.6.5.)
These clones show different cross-reactivity
patterns. Clone C9 reacts with bovine aortic
endothelial cells (BAEC) and pig aortic endothelial
cells (PAEC) but not with bovine spindle cells (BSP)
and human umbilical vein endothelial cells (HUVEC). Dll
reacts with BAEC, BSP, HUVEC and only very faintly with
PAEC. On BAEC it binds to two protein bands with an
approximate molecular weight of 47kD. On PAEC it reacts
with 3 major bands with molecular weights of 55kD,
47kD and 33kD. Some faintly stained bands can also be
seen between the 33kD and the 47kD bands. Clone Dll
shows a slightly different pattern. It reacts with two
major bands of molecular weight 47kD and 18kD on BAEC.
On BSP the same 47kD protein is stained but to a lesser
degree and a 17kD protein to greater degree. On HUVEC
only the 47kD protein band is stained. On PAEC no
definite bands are highly stained but faint bands are
present around the 75, 47, 36 and 33kD regions. This
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FIG.4.7. Immunoblot of antibody D6G11 on endothelial cell
lysates.
Lane 1 is an amido black stain of total protein transfered.
may be non-specific staining by the silver enhancement
reagents since the strip was developed a bit longer
than usual because of the negative result after the
standard incubation time (20 minutes). There is no
reaction with either antibody to serum proteins.
4.5.2. D6G11
This antibody recognises damaged endothelium in
fixed cell ELISA. It is an IgM subtype and was raised
against BAEC from mice immunised by protocol 2. Two
stable clones were obtained from this cell line
producing antibodies A10 and D12. They both produced
identical staining patterns as shown in Fig.4.7. These
antibodies cross-react with endothelial cells from all
the sources tested. The major protein band stained had
a molecular weight of 47kD. Only this band was stained
on BAEC. The BAEC lane 6 does not show this band very
clearly but it is probably due to bad contact during
transfer. On BSP and HUVEC the 47kD protein stains
along with an 18kD band and on the BSP lane 9 three
bands at 15, 17 and 18kD stain. Lane 9 had been
gold/silver stained whereas lane 5 was AEC stained.
This would suggest that the gold / silver staining
technique is more sensitive. On PAEC these clones, like
the A3E10 antibodies, show a slightly a different
staining pattern. The major protein detected is the
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FIG. 4.8. Immunoblot of antibody D8G8/B8 on endothelial
cell lysates.
Lanes 2 and 7 are total protein stained.
47kD band, with a more faintly stained band at 18kD. A
band around 55kD is heavily stained and faint bands are
present around the 33 - 36kD region.
No staining of serum proteins occurs with either of
these clones.
4.5.3. D8G8
This antibody like D6G11 is an IgM subtype which
was raised against BAEC from mice immunised by the
second protocol. It recognises damaged endothelium in
fixed cell ELISA. The protein band staining pattern
differs from the A3E10 and D6G11 antibodies in that no
protein band at the 47kD region is detected on BAEC,
BSP and HUVEC (Fig.4.8). Protein bands of 15, 17 and
18kD are stained on HUVEC. Only the 18kD band is
stained on BAEC. Two total protein stained control
lanes are shown, BAEC (2) shows incomplete transfer of
these lower molecular weight proteins , whereas HUVEC
(7) shows good transfer. This may explain the presence
of only one band in the antibody treated BAEC and BSP.
On PAEC D8G8 shows a much greater degree of staining.
The three bands at 15, 17 and 18kD are heavily stained
along with bands at 33 and 36kD. Faintly stained bands
are present at 47 and 55kD. This PAEC lane was
gold/silver stained and the others AEC stained. It was




4.9. Immunoblot of antibody P14G11 on endothelial
lysates. Lane 1 is total protein stained.
running time, hence the band pattern is slightly out of
step with the control lanes. D8G8 does not react with
serum proteins (1).
4.5.4. P14G11
Only one stable clone was raised from this cell
line and the antibody is the only IgG2a subtype in all
the the monoclonals screened so far. It was raised
against PAEC by immunisation protocol 1 and reacts with
fixed and non-fixed damaged cells.
Fig. 4.9 shows the results of the immunoreactivity
on transferred proteins. All the transfers were
gold/silver stained, lanes 1,2 and 4 are Immobilon P
membrane the others are nitrocellulose. On Immobilon P,
amido black stains protein black, whereas it stains
blue on NC.
P14G11 gives conflicting results on PAEC. On lane 2
protein bands at 64kD and three around 55kD stain
heavily. There are also faint bands just below the 47
and 33kD areas. On lane 3 the only heavily stained band
is at 75kD with very faintly stained bands just above
and below. These blots were of cell lysate from a first
subculture cell line. The lysate was prepared for
electrophoresis and dispensed into lOOul aliquots and
stored at -20°C. When a gel was bein run a sample was
thawed slowly to room temperature and applied directly
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FIG.4.10. Immunoblot of antibody B10A10 on endothelial
cell lysates.
Lane 1 is stained for total protein.
to the stacking gel. Lane 3 was from a newly prepared
sample, i.e. it had not been frozen. The sample on lane
2 had been stored frozen for one or two weeks. It seems
likely that changes had taken place in the lysate
during the freezing, storage or thawing processes which
would result in the different immunoreactivity with
this antibody. Unfortunately this could not be repeated
with fresh lysate due to the lack of pig aortic cells.
With HUVEC this antibody detects only two protein
bands at 64 and 55kD. On BAEC the strongest staining
occurs at 15, 17 and 18kD with fainter bands at 33, 36
and 55kD. On the BAEC (lane 5) there is an area of
shadow just above the 75kD region which looks as if it
might be an artifact of staining. It is diffuse and not
sharply defined and is unlikely to be a protein band.
P14G11 does not react with serum proteins.
4.5.5. B10A10
This antibody was raised against HUVEC from mice
immunised by protocol 1. On fixed cell ELISA it
produces a diffuse negative stain and is thought to be
directed against a component of extracellular matrix.
Fig.4.10. lanes 2,3 and 6 were stained with AEC and
lanes 4,5 and 7 with silver enhanced gold.
On HUVEC the antibody stains bands with
corresponding molecular weight of 47 and 64-66kD and a
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FIG. 4.11. Immunoblot of antibody D6F1 on endothelial
cell lysates.
faint band at 55kD. On SAVEC (lanes 4 and 5) 47 and
55kD bands are clearly seen with three bands at the
75kD region faintly stained. On BAEC the 75,66 and 47kD
bands are very faintly stained. With PAEC bands at
55,47 and 45kD (very faint) are stained.
On adult human serum (AHS) a diffuse band
corresponding to the 66kD marker is faintly stained
(marked -). There are faint but sharper bands just
above and below this area. On the corresponding gel
(Fig.4.5 lane E) these bands are present just above and
below the broad 66kD albumin band.
4.5.6. D6F1
This antibody was also raised against BAEC by the
second immunisation protocol. Only one clone was kept.
In fixed cell ELISA this antibody gives a diffuse
staining pattern.
Fig.4.11 lanes 1 and 2 were AEC stained and lanes 3
and 4 silver stained. Lane 1, a first subculture cloned
bovine cell line, shows very faint bands at 47 and
55kD. Lane 2, the sixth subculture of the same cell
line, shows heavy staining of a band at 47kD with
fainter bands at 15,17 and 18kD, 55,64 and 75kD. If the
background staining were less perhaps more bands would
be seen. On silver stained HUVEC many bands are visible
with the major ones at 15,17,18 and 47kD. On silver
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FIG.4.12. Non - specific binding of IgG to endothelial
cell lysates.
stained PAEC the background is so heavily stained that
no clear bands can be seen at all. It is posible that a
preliminary washing step has been missed in the
staining procedure of this sample has been missed. This
antibody was not tested against serum proteins.
4.5.7. Non - specific IgG binding to transferred
endothelial cell proteins.
IgG accumulation is a feature of damaged cells as
discussed in section 3.2.1. IgG binds non -
specifically to intermediate filaments of the cell
cytoplasm (Hansson and Schwartz 1983). The staining
pattern on fixed cell ELISA of monoclonal antibodies
D8G8, D6G11 and A3E10 is the same as that with IgG.
This non - specific effect can be blocked by pre -
incubation of the cells with an IgG which cannot be
recognised by the second antibody detection system. A
protein transfer of BAEC lysate was incubated with a
1:100 dilution of mouse IgGl and stained by the AEC
method. The results (Fig.4.12) shows a strongly stained
band at 18kD. Faint bands were present at 15 and 17kD
but the colour faded before the blot could be
photographed and they are now difficult to see. Faint
bands can also be seen at the 31-33kD region.
These are protein bands which are also detected by
some monoclonal antibodies described in the previous
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sections in particular antibody D8G8/B8.
4.6. DISCUSSION
There are few major differences in band patterns
between endothelium from bovine, porcine and human
sources in relative protein content. The results of
section 4.3.2 show some interesting changes in
1ipid/sialoglycoprotein band pattern. Highly
subcultured cells show extensive decrease in overall
content of these components with major loss of
particular bands with inreasing number of population
doublings. Loss of major functional cell surface
proteins such as ACE is known to occur with culture age
(Levine et al 1983), making the use of highly
subcultured cells for the study of normal cell
behaviour questionable. This was taken into
consideration in subsequent experiments and hence only
cells of up to five subcultures were used. The use
of the silver staining technique for detection of
sialoglycoproteins/1ipids was limited in the
experimental protocol of cell lysate preparations and
SDS-PAGE used here. The stained gels show that the
majority of these components did not migrate through
the gel but remained at the origin of the stacking and
resolving gels. For this technique to be of more use a
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greater degree of molecular breakdown is needed perhaps
by enzymatic digestion followed by separation on gels
with less cross-linkage. Since none of the antibodies
tested by immunoblotting reacted with protein bands
corresponding to those of interest on the silver
stained gels, this technique was not pursued further.
Further separation and characterisation of
endothelial cell proteins could be carried out by
separation of the proteins in the first dimension on
the basis of isoelectric point and in the second
dimension on the basis of molecular weight (Sixma and
Schiphorst 1980). This would separate different
proteins of the same molecular weight to greater
degree. This would be a useful technique in future work
on characterisation of endothelial antigens.
The results of the immunoblotting experiments are
summarised in table 4.6.
Protein bands of nine different estimated molecular
weights were found to react with antibodies tested. The
reactivity of these proteins varied between antibodies
and endothelial source.
Four protein bands of estimated molecular weights
of 47k,18k,17k and 15kD predominate. The 18,17 and 15kD
bands ran as a triplet on CB stained gels and in some
cases reacted with the antibody as a triplet. Both the
47kD and the 18,17 and 15kD bands were present on all
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A3E10/D11 47 (75) 47 47
18 (47) 17
( 36,33)
D6G11 47 55 47 47
47 18 18
18 17 17
( 36,33) 15 15











B10A10 (75) (55) (64) (75)












TABLE A.6. Summary of the proteins bands, by molecular
weight, detected by monoclonal antibodies.
endothelium as major protein bands of whole cell
lysates.
The 47kD band was not present in any of the silver
stained preparations, but instead could be seen as a
negative region which corresponded to the CB stained
band.
The three lower molecular weight bands did have an
equivalent region of silver staining. The most heavily
stained being the one with highest molecular weight
(Fig.4.2(b)). Although it seems likely that these
proteins are glycosylated it cannot be stated with
certainty since no equivalent molecular weight
standards were run on the gel.
The other protein bands detected by monoclonal
antibodies were of estimated molecular weights
75k,64k,55k,36k and 33kD and were also common to all
endothelium with the exception of the 64kD band , which
was not present on BAEC.
The 47kD protein was the predominant band with
which antibodies A3E10, D6G11, B10A10 and D6F1 reacted.
D8G8 and P14G11 did not bind to this band in BAEC,
HUVEC or BSP and only very weakly with PAEC.
D8G8 reacted strongly with the 18k,17k and 15kD
proteins. P14G11 also reacted with these proteins on
BAEC but not on PAEC, where 75k,64k and 55kD bands were
stained.
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Antibody B10A10 which on fixed cell ELISA on sparse
cultures showed negative staining, did not react with
the low molecular weight proteins at all but weakly
with bands at 75k,64k,55k and 47k. On the basis of the
fixed cell ELISA results with this antibody it was
thought to be directed to extracellular matrix
proteins, which are manufactured and excreted by the
endothelium. However, the known components of
extracellular matrix consist of very high molecular
weight proteins such as fibronectin and the collagens.
On fixed cell DAB ELISA it was discovered that
false positive results were due to non-specific binding
of IgG (from the serum in the growth medium) to damaged
cells. This could be blocked by pre-incubation of the
cells with an autologous IgG that would not be
recognised by the second antibody in the detection
assay. Non-specific binding of IgG on immunoblots was
examined. Three protein bands of molecular weight
36k,33k and 18kD reacted. The 18k appeared to have a
stronger reaction by the more intense staining seen,
but it was also present in the control blot in greater
quantity than the 36k,33k bands. Non-specific binding
of IgG has been shown to occur via the Fc component of
the antibody to the vimentin component of intermediate
filaments (Hansson et al 1984). This was confirmed on
the basis of immunocytochemica1 studies but not with
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immunoblotting with the isolated protein. Vimentin has
a reported molecular weight of 56 - 58kD under reducing
conditions (Wu et al 1982 , Ketis et al 1986). The
protein bands which reacted with IgG in this study have
a much lower molecular weight, from 18kD to 36kD. Until
recently it was believed that the intermediate
filaments of endothelial cells consisted exclusively of
vimentin. It has been demonstrated that endothelial
cells of different vasculatures have other intermediate
filament components, such as desmin (Fujimoto and
Singer 1986). It is possible that intermediate filament
associated proteins are present and also take part in
non-specific IgG binding, which could explain the
results of section 4.5.7.
These low molecular weight protein bands are
present in a number of the immunoblots and were
generally taken to be due to non-specific binding,
except with antibody D8G8. The 18kD (17k,15k) bands
were the only proteins to which this antibody reacted.
Pre-incubation of cells with IgG to block non-specific
binding sites did not block binding of D8G8 (IgM) in
fixed cell ELISA. From this information it was
concluded that antibody D8G8 was specific for these
proteins.
The results of P14G11 are harder to explain. From
the results of fixed and non-fixed cell ELISA it is
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known that P14G11 cross reacts strongly with BAEC,
however the immunoblot results show reactivity with
different proteins of BAEC and PAEC. On PAEC the
antibody binds to three proteins of high molecular
weight and BAEC with the low molecular weight triplet
of proteins. The 55kD molecular weight protein is
common to both however, although it is very faintly
stained in the BAEC lane. This is more likely to be
due to differences in quantitative transfer of this
protein in BAEC than the behaviour of the antibody. It
is proposed that the epitope recognised by the antibody
is shared by proteins 75k,64k and 55kD in PAEC. This
epitope is also common to proteins 55k and 64kD of
HUVEC and 55kD of BAEC (64k protein is not present in
BAEC) and the 18k,17k,15k,36k and 33kD bands on BAEC
are due to non-specific binding. An alternative
explanation for this result could be that P14G11 is not
truly monoclonal and two IgG2a antibodies are present,
one which reacts with a group of high molecular weight
proteins on PAEC and one which reacts with a group of
low molecular weight proteins on BAEC.
The findings of these immunoblot experiments may
help to explain the reactivity of these antibodies on
fixed and non-fixed cells. With the exception of P14G11
none of the antibodies react with non-fixed cells. All
the antibodies tested so far are IgM subtype except
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Damaged non-fixed cell membrane does not allow
intracellular access of large IgM molecules.
Fixation of damaged cells allows access of IgM
molecules to intracellular proteins, through large
"holes" in the membrane.
D1AG. 4.2 Possible explanation of differences in
IgM antibody staining of fixed and non-fixed
cells. Intracellular proteins of varying
molecular size are denoted as open and
filled circles.
Small intracellular proteins leak from damaged non-fixed
cells where Ag-Ab complexes are formed outside the cell
and are ldst during washing stages of the staining procedure.
Therefore a negative result is shown.
When damaged cells are fixed immediately, these small proteins
that leak from the cell are most likely trapped at the cell surface
on the outside of the membrane. The IgM molecules therefore bind
to the immobilised antigen, giving a positive result on staining.
DIAG. 4.1 Possible explanation of the difference in antibody
staining of non-fixed and fixed cells with IgM type
antibodies. Intracellular proteins of varying
molecular size are denoted as open and filled
circles.
P14G11 which is IgG2a subtype. The mechanisms proposed
are as foilows.
Cell damage invariably results in plasma membrane
perturbation allowing entry of extracellular material
into the cell and leakage of small intracellular
molecules out of the cell. Antibody D8G8 binds to small
molecular weight proteins and only stains fixed cell
preparations. It is possible that in non-fixed cells
the antigen-antibody complex forms outside the cell and
is lost in subsequent washing stages of the staining
procedure, therefore giving a negative result. When
damaged cells are fixed immediately the leaking
proteins are probably trapped on the outside of the
cell surface. The large IgM antibody molecules
therefore have access to these immobilised proteins.
(Diag.4.1). This may also be the case for antibodies
A3E10 and D6F1 which bind to slightly larger molecular
weight proteins. Alternately, fixation may cause
formation of large "holes" in the already damaged cell
membrane. These holes are large enough for the entry of
IgM molecules into the cell where they bind to
intracellular proteins, whereas non-fixed damaged cells
do not (Diag.4.2).
In the case of P14G11 which was the only antibody
to stain non-fixed damaged cells and is the only IgG2a
subtype, the cell membrane of these cells probably
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DIA6. 4.3 Non-fixed damaged cell membrane
allows entry of relatively small
lgG2a molecules into the cell.
Intracellular proteins of varying
molecular size are denoted as
open and filled circles.
allows intracellular access of this much smaller and
steriochemically different molecule. (Diag.4.3).
The information gained from the immunoblot
experiments and the limitations of the immunisation and
screening protocols, indicate that the proteins that
are antigenic to the monoclonal antibodies described
here are normal cell endothelial cell proteins that
have been "exposed" by injury. These proteins are
present in normal, healthy cultured endothelium and are
not due to phenotypic expression or metabolic responses
to injury. The mice were immunised with healthy
cultured cells which had not been previously exposed to
injurious stimmuli. The cells on which the antibodies
were screened were damaged by physical means and
screened immediately therefore giving a very limited
time for phenotypic expression of protein to occur. The
antigen - antibody response is therefore indicative of
plasma membrane damage.
Many components of the normal endothelial cell have
been characterised and identified. Many are highly
glycosylated with high molecular weights, vWF subunits
of 225kD (Jaffe and Nachman 1975) fibronectin with
subunits of 210kD (Stein and Stein 1976),
thrombospondin subunits 190kD (McPherson et al 1981),
thrombomodulin 115kD (Esmon et al 1982), ACE 130kD
(Friedland et al 1981), E92 (Kaplan et al 1983), HEC-1
141
90kD subunits (Parks et al 1985). These and many more
surface proteins can be ruled out as possibilities in
identification of the antigens described here on the
basis of molecular weight. Antithrombin III has a
molecular weight of around 62kD, and a protein of
similar molecular weight was detected by antibodies
P14G11 and B10A10. However these antibodies did not
react with undamaged cells which should express
antithrombin III on the cell surface.
A number of culture shock and heat shock proteins
have been identified and are proposed as indicators of
cell injury (Sage et al 1986, Schorer et al 1985). One
of these, a 43kD protein is synthesised and released in
response to injury by endotoxin and also by rapidly
growing cells in sparse cultures, which suggest it has
a general role in cellular function as well. This
protein has a molecular weight close to that of the 47k
protein recognised by antibodies A3E10 and D6G11 etc.
Darnule et al (1983) characterised two cell surface
proteins of molecular weight 18.5k and 66k of which he
claims the 18.5k was a surface associated plasma
protein. Antibody D8G8 reacts with a group of proteins
in this molecular weight region predominantly with a
18k protein. This was not a serum protein associated
with the cell surface ( the antibody did not react with
serum proteins) but may well be a surface antigen or a
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cytoplasmic component associated with the plasma
membrane. This antibody (and D6G11) was produced by
immunisation protocol 2, where the mice were injected
with compatible spleen cells which had been incubated
with a monolayer of confluent endothelium. Spleen cell
lymphocytes adhere to the endothelial surface for up to
5 or 6 hours and then spontaneously detach (de Bono
1977). When they detach from the cell surface it may be
that they take with them a fraction of the cell surface
and thereby presenting to the mouse immune system a
component of the underside of the endothelial plasma
membrane or cytoplasmic components associated with the
membrane, such as components of the intermediate
filaments (Ketis et al 1986). The passage of
intracellular molecules between lymphocytes and
endothelium during adherence has been demonstrated
(Guinan et al 1988). It is therefore possible that the
proteins, against which the antibodies from the
immunisation protocol 2 react, are also present in
lymphocytes. Since the proteins detected by these
antibodies are also detected by antibodies from
immunisation protocol 1 (47kD, 55kD etc), this
explanation seems unlikely. However, further
investigation of the cross-reactivity of these
antibodies with other blood and lymphatic cells would
be useful.
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The experiments presented in this chapter were not
done with the intention of identifying or
characterising the endothelial antigens recognised by
the monoclonal antibodies and the work is not within
the scope of this thesis. However by identifying the
molecular weights of the antigens, possibilties of
identity can be excluded on the basis of molecular
weight and explanations of the antibody - antigen
behaviour can be made.
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CHAPTER 5.
RADIOLABELLING OF MONOCLONAL ANTIBODIES
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5.1. INTRODUCTION
Radiolabelled monoclonal antibodies make effective
probes and have been used widely in therapeutic and
diagnostic fields (McMichael and Fabre 1982).
Monoclonal antibodies can be radio 1abe11ed in a
number of ways. The criteria for the method of
labelling and the choice of isotope is based on the
lability and stability of the antibody and for what
purpose it is being labelled. For imaging and
12 5 131
autoradiography, gamma emitors such as I, I and
^^"In are required for fast and intense development of
X-ray film.
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Beta emitting isotopes such as H and C can be
introduced into the antibody molecule by a pre-labelled
sugar or amino acid during in vitro biosynthesis.
Internal labelling method involves no harsh oxidising
procedures and can produce antibodies of high specific
activity. The major advantage of beta emitors, in terms
of handling and safety, is that it is short range
emission and requires less lead shielding. However,
because of this their use in imaging and
autoradiography is limited.





DIAG.5.1 Position of iodine isotope in the tyrosine molecule
DIAG.5.2 Structure of lodogen molecule
5.2. IODINATION OF MONOCLONAL ANTIBODIES D8G8 AND
P14G11
Techniques of iodinating proteins all employ
oxidising agents to produce an electrophi1ic iodine
species (I+) from sodium iodide. The radioactive iodine
reacts with aromatic ring structures of various amino
acids such as tyrosine which is considered to be the
predominantly labelled amino acid (Diag.5.1).
Iodogen (1,3,4,6-tetrachloro-3a,6a-dipheny1glycouri1)
(Diag.5.2)(Pierce Chemical Company) is a mild oxidising
agent which is very stable and is also insoluble in
water. This insolubility allows a solid phase
iodination process, whereby the Iodogen acts at the
walls of the reaction vessel. This has two major
advantages over aqueous phase oxidising reagents
1actoperoxidase and chloramine-T; 1. the process can be
carried out in an aqueous solution without much direct
contact with (and therefore possible damage to the
protein by) the oxidising agent, 2. no reducing agents
need to be added to stop the reaction, decanting the
reactants from the vessel does so (Fraker and Speck
1978, Goding 1986).
Iodogen was used here because of its "gentler"
nature and therefore was considered less likely to
damage or inactive the monoclonal antibodies to be
1abelied.
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5.2.1. Preparation of Iodogen Tubes
lmg of Iodogen was dissolved in 0.5rnl of methylene
chloride and diluted to 5ml in methylene chloride. This
solution was dispensed into plastic Beckman microfuge
tubes in lOOul aliquots. The methylene chloride was
evaporated by a stream of dry nitrogen at room
temperature, leaving a layer of Iodogen on the inside
surface of the tubes. These were stored at -40°C.
5.2.2. Iodination Procedure
The antibody solutions contained a minimum of
500ug/ml of protein in phosphate buffer pH 7.4. To
90ul of antibody solution was added 50ul of 0.05M
phosphate pH7.4 / 0.01% v/v Tween 80 and lOul ( 37000
125 125
kBq ) of Na I in an Iodogen tube. The Na I was
added last and the contents of the tube very gently
mixed and incubated for 5 minutes at room temperature.
The contents of the tube were then transferred to a
5ml plastic tube. The reaction tube was rinsed twice
with 500ul of T-buffer ( 0. 5M phosphate / 0.5M NaCl /
2.5g/L gelatin / 1% w/v Tween 20 pH7.4 )(Dr N Hunter,
Scottish National Blood Transfusion Headquarters). The
rinses were added to the reactants and incubated for a




Unreacted molecules and free iodine were removed
from the reaction mixture by gel filtration on Sephadex
G-50 or on Excellulose GF-5 disposable desalting
columns ( Pierce Chemical Company ). Both types of
column were equilibrated with T-buffer and protein
eluted with T-buffer. 1ml fractions were collected and
counted. The labelled protein should elute in the void
volume (first count peak) and the free unreacted iodine
in the second peak. The labelled antibody was stored in
T-buffer at 4°C.
5.2.4. Counting.
All radioactivity was counted in an LKB Compugamma
125
counter with an efficiency of 75% for I.
Counts per minute (CPM) were converted to
disintigrations per minute (DPM) as follows;
CPM = DPM x EFFICIENCY
From this radioactivity was calculated in Becquerels
(Bq) where 2.2 x 109 DPM = 37MBq.
The iodinated protein fraction was counted and
percentage of radioactivity incorporated in the protein
fraction calculated.
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5.2.5. Iodination of D8G8/B11
Antibody D8G8/B11, an IgM which was purified from
hybridoma growth medium by protein A - Sepharose
affinity chromatography (2.5.3.) was iodinated by the
above process. The protein concentration was estimated
at 2mg/ml by Bradfords (1979) method. A total of 18.5
125
kBq of Na I was used in the procedure.
Total Radioactivity Used = 18.5 kBq
The first peak of radioactivity occurred in two
fractions (4 and 5). This was assumed to contain
labelled antibody.
Radioactivity in Labelled Fraction = 949 cpm
= 1265 dpm
= 0.022 kBq
Percent Radioactivity Incorporated = 0.12%
The amount of labelled protein was much lower than
expected. From the results of other laboratories
(personal communications) an average of approximately
50% of the radioactivity is incorporated into the
protein by this method. There are a number of possible
reasons as to why the amount of labelling was so low :
1. The protein estimation of the antibody solution was
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FIG.5.1. 125I D8G8/B11 ON SCRATCH DAMAGED BOVINE AORTIC
ENDOTHELIAL CELLS, DAB STAINED. Mayer's haematoxylin
counterstained. Unlabel led D8G8/B11 showed exactly the
same staining pattern.
wrong and there was much less antibody present than
originally thought. 2. Denaturation of the antibody had
occured during storage. 3. The Iodogen tube had been in
storage for some time and may have become inactive.
The following tests were carried out to determine
the nature of the labelled protein fraction.
DAB ELISA.
The screening procedure (2.4.3) was carried out on
cultured bovine aortic endothelial cells. A 1 in 10
dilution of the radioactive fraction was used with a 1
in 10 dilution of "cold" D8G8/B11 as a control. The
results (Fig 5.1) show that the radioactive fraction
contained antibody and that binding activity had not
been altered by the iodination process.
Autoradiography of Immunoblots
Bovine cell lysates, SDS-PAGE and protein transfers
were prepared as described in section 4.2.
The protein transfer was cut into strips and a
control was stained for total protein with amido black.
The others were incubated with 20% bovine serum albumin
(BSA) solution overnight to block non-specific protein
binding sites and then with a 1 in 5 dilution of
125
I D8G8/B11 in PBS for 2 hours at room temperature
with constant shaking. They were rinsed with PBS / 0.1%
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FIG.5.2. AUTORADIOGRAPH OF 18kD PROTEIN BAND, BINDING
1 25
I D8G8/B11. The photograph has been cut above the 17
and 15kD bands which were present on the amido black
stained blots but which did not show on the
autoradiograph.
BSA until no radioactivity was detected in the wash.
The strips were then dried between sheets of filter
paper and placed on X-ray film (Agfa - Gevaert, Curix
RP1) in a Kodak enhancer cassette and exposed at -70°C
for 24 hours. The film was developed on a Fuji
automatic developer.
The autoradiograph (Fig.5.2) shows a band
equivalent to the 18kD region of the amido black
stained section (photograph not shown) which is known
to react with D8G8/B11 (section 4.5.3). This would
suggest that the antibody D8G8/B11 has been labelled
125
with I without loss of antibody activity.
Autoradiography of Scratch Damaged Cells
Bovine aortic endothelial cells were grown to
confluence in 5cm diameter petri dishes with tissue
culture plastic detachable linings. Scratches were made
in the monolayer with a glass pipette, 2 scratches 1cm
apart and the cells were fixed in 0.1% glutera1dehyde
and incubated for 2 hours with a 1 in 5 dilution of
125
I D8G8/G11. Rinsing was carried out with PBS until
no radioactivity was detected in the washes. The cell
covered plastic lining was removed and wrapped in cling
film before being placed in contact with X-ray film and
exposed for 24 hours at -70°C in an enhancer
cassette. The film was developed as before.
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A DAB stained control showed antibody binding to
cells at the scratch edge. The results of the
autoradiograph were however completely negative.
There are a number of possible reasons as to the
negativity of the autoradiograph : 1. The amount of
radioactivity on the antibody present at scratch edges
was not enough to show up on this type of X-ray film
after just 24 hours of exposure. A change of film to a
more sensitive type or longer exposure times would
perhaps solve this problem if greater incorporation of
radioactivity into the antibody cannot be achieved. 2.
The radioactive label had "dropped off" the antibody
molecule. The stability of the labelled antibody was
not known under the conditions in which it was stored
(in T buffer pH7.4 at 4°C). The autoradiograph of the
protein blot was done 2 or 3 days after the iodination
procedure and the complex appeared to be stable then
however the autoradiograph of the scratched monolayers
was done approximately 2 weeks later. It is possible
that the complex is not stable for this length of time
in solution or in this particular buffer and should
perhaps be freeze dried as soon after iodination as
possible.
At this point all the D8G8/B11 ascites had been
used and problems were encountered in raising more from
the mice available at that time, so iodination
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experiments were switched to another antibody.
5.2.6. Iodination of P14G11 (Ascites Fluid).
Antibody P14G11 recognises damaged cells in both
fixed and non-fixed preparations. It also cross reacts
with human and bovine endothelial cells (chapter 3).
Radiolabeled P14G11 would make possible in vivo
investigations of damaged vascular endothelium.
Monoclonal P14G11 is an IgG2a subtype and was
raised in quantity in ascites tumours of mice (2.2.10)
and purified by protein A - sepharose affinity
chromatography (2.5.3).
The first attempt at iodination of this antibody
was on an unpurified sample of ascites fluid. Although
ascites consists of a mixture of proteins including
various immunoglobulins the major component should be
the monoclonal antibody. It was decided not to go
through the time consuming process of purifying the
antibody but to iodinate the whole ascites component
and assume that the other iodinated proteins would not
interfere with P14G11 binding to damaged cells.
The ascites had an estimated protein content of 29
mg/ml. Iodination of 90ul (2.61mg total protein) of
125
antibody with 37 000 kBq of I was carried out as
described for antibody D8G8F (5.2.5).
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Radioactivity in Labelled Fraction = 556153700 CPM
= 0.74 x 109 DPM
= 12.33 MBq
Total Radioactivity Used = 37 MBq
Percent Radioactivity Incorporated = 33.3%
The percentage of incorporation of label onto antibody
P14G11 was much higher than that of the D8G8/B11
iodination, however not all of the labelled protein in
this case were antibody.
DAB ELISA
This was carried out as described in section 2.4.3.
Bovine endothelial cells were used since no pig
endothelial cells were available at the time. A 1:10
dilution of the labelled fraction was used. The cells
along the scratch edge stained with DAB indicating the
presence of antibody.
Autoradiography of Immunoblots.
Protein transfer was performed as described
previously (section 4.2). Transfers were incubated with
1:100 and 1:1 000 dilutions of labelled fraction and
prepared for autoradiography by the same method as
described for D8G8. The developed film showed very high
155
A
FIG 5.3. AUTORADIOGRAPH OF SCRATCHED CELL MONOLAYERS
INCUBATED WITH 125I P14G11.
A - 1:100 dilution in PBS
B - 1:1000 dilution in PBS
non-specific binding with no individual bands visible
(i.e. the developed film was completely black at the
areas of the nitrocellulose strip.).
Autoradiography of Scratch Damaged Cells.
These experiments were done in exactly the same way
as described for antibody D8G8/B11 (5.2.5). A 1:10 and
1:100 dilution of the labelled fraction was tested and
controls DAB ELISA stained. The film was exposed this
time for 7 days at —70°C. The results (Fig.5.3) show
very intense background staining in both dilutions. The
scratched areas being visible as unexposed strips. The
DAB stained controls showed staining of the cells along
the scratch edge only with no high non-specific
background staining. The pre-incubation with autologous
serum step to block non-specific binding sites had been
mistakenly omitted and was thought to be the cause of
the high background result.
The experiment was repeated with lower dilutions of
antibody (1:1 000 and 1:10 000) and pre-incubation step
with neat NBCS for 15 minutes to block non-specific
binding sites. The results were completely negative.
Either the pre-incubation stage very effectively
blocked binding or the antibody dilutions were too low
to deliver enough radioactivity to the sites of damage




FIG.5.4. AUTORADIOGRAPH OF SCRATCH CELL MONOLAYERS
INCUBATED WITH 125I P14G11.
A - 1:2 dilution in PBS
B - 1:10 dilution in PBS
C - 1:100 dilution in PBS
controls were done with these antibody dilutions.
A third trial was done using a new cell line
(BAEC). The method was the same as above, this time
using 1:2, 1:10 and 1:100 dilutions of the antibody.
DAB stained controls of each dilution were also carried
out. Exposure was carried out at -70°C in an enhancer
cassette for 36 hours. The results (Fig.5.4) show that
high background activity is still present with no
concentration of exposure along the scratch edge. The
DAB ELISA controls show staining of cells at the
scratch edge at each dilution.
These high background activity results could be due
to interference by other iodinated proteins in the
the ascites fluid. For this reason it was decided that
purification of the antibody from the ascites was
necessary before iodination.
5.2.7. Iodination of Purified P14G11.
P14G11 was purified from ascites by protein A -
sepharose affinity chromatography (2.4.3). The ascites
(4ml) was clarified by Millipore filtration (0.22um)
and diluted with 0.05M Tris / 0.15M NaCl / 0.02% NaN3
pH8.6 until the pH of the final solution was
approximately 8.6 before applying to the column.
Elution of ascites and subsequent fractions were all
done at room temperature at a constant flow rate of 1ml
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/ minute and 5ml fractions were collected. The presence
of protein in the fractions was determined by
absorbance at 280nm on a Pye Unicam SP8-100 Ultraviolet
Spectrophotometer. Protein was detected in the pH5.5
and pH4.3 elution fractions. The fractions were
neutralised and tested for antibody content by DAB
ELISA on scratch damaged bovine endothelial monolayers.





The negativity of the pH8.6 wash indicates that all the
antibody in the sample applied to the column had bound
and had been released in the pH5.5 and pH4.3 fractions.
The antibody staining pattern of both fractions was
identical indicating that both fractions contained the
same antibody. Protein A has been reported to have two
binding sites of different affinity for IgG's (Lancet
et al 1978) and therefore will have different elution
properties, in this case pH5.5 and pH4.3. The positive
fractions were pooled and concentrated by
ultrafiltration and protein content was estimated
(Bradford 1979) at 0.3mg/ml (pH4.3) and 2.6mg/ml
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(pH5.5) .
The pH4. 3 fraction was chosen for iodination since
it produced the strongly positive DAB ELISA result.
150ul of antibody containing total protein of 45ug was
1 2 5
iodinated with 18 500 kBq of Na I as described. The
reaction mixture was gel filtered on Excellulose GF-5
disposable columns. Fractions of 0.5ml were collected.
The second fraction from each column was retained as
1^1 labelled antibody.
Radioactivity in Labelled Fraction = 323082200 CPM
= 0.43 x 109 DPM
= 7.17 MBq
Total Radioactivity Used = 18.5 MBq
Percent Radioactivity Incorporated = 39%
DAB ELISA
Bovine cells were grown to confluence on glass
covers lips and damaged either by scratching or by air
drying for 5 minutes at 37°C. After fixing in
glutaraldehyde and blocking non-specific binding sites
with NBCS, the cells were incubated with 50ul of neat
and 1:100 dilution of sample. After thorough rinsing
they were incubated with peroxidase labelled second
antibody and DAB substrate. The results are shown below
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TEST STAINING OF DAMAGED
CELLS
NEAT SAMPLE







Autoradiography of Damaged Cells.
The tests in section I were run in duplicate, the
second set of coverslips were rinsed and placed on x-
ray film and exposed for 48 hours. The 1:100 dilution
was negative, whereas the neat sample gave very high
backgrounds even with non-damaged cells.
The results of the DAB ELISA show that there was no
binding of antibody to non-damaged cells and even in
the scratch damaged tests antibody binding was confined
to the cells at the scratch edge. Therefore the
background activity shown by autoradiography was
probably not due to non-specific binding of antibody
but suggested that there was still large quantities of
125
free I in the preparation.
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Protein A-sepharose Affinity Chromatography of
Iodinated Fraction.
The labelled antibody fraction was run through a
protein A-sepharose column in an attempt to remove the
125 125
antibody bound I from the free I. The majority of
the radioactivity was eluted in the pH8.6 wash with
smaller peaks at pH5.5 and pH4.3 which from previous
separations indicates labelled antibody. Fractions
corresponding to these peaks were retained and tested
for antibody activity by DAB staining on bovine
endothelium. The results are shown below.





Positive results from the pH8.6 wash indicate that not
all the antibody had bound to the column. This fraction
was reapplied to a "clean" column and elution repeated.
The strong positive results for the pH5.5 fraction
indicates and the corresponding peak of radioactivity
indicate labelled antibodv. Prior to iodination,
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antibody P14G11 eluted in two different pH fractions ,
5.5 and 4.3. Purification by the same method after
iodination indicates binding of the antibody at the pH
5.5 binding site only. The iodination procedure seems
to have changed the antibody affinity for the pH4. 3
binding site so that the antibody had either run
straight through the column or had bound at the pH5.5
site .
5.3. INTERNAL LABELLING OF MONOCLONAL ANTIBODIES
D8G8/B11 AND P14G11 WITH TRITIATED LYSINE.
During biosynthesis of monoclonal antibodies,
lysine has been shown to be the most efficiently
incorporated amino acid. It is therefore the most
commonly used means of introducing a radiolabel into
the antibody molecule (Cuello et al 1982).
5.3.1. Growth of Hybridoma Cells with Lysine.
Both D8G8/B11 and P14G11 were treated in the same
way. Antibody secreting hybridomas were grown to log
phase growth in normal RPMI 1640 growth medium
supplemented with 5% FCS. They were centrifuged out of
this medium and split at a 1:2 ratio into lysine free
RPMI 1640 + 5% FCS for 24 to 48 hours or until optimal
cell density was reached. The cells were removed from
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this medium and resuspended in fresh lysine free RPMI
1640 + 5% FCS containing 0.37MBq/ml of L-[4,5-H3]
lysine monohydrochloride. Incubation with the labelled
amino acid was carried out for 24 hours, after which
the medium was decanted and retained (batch 1). The
3
cells were resuspended in fresh medium (no H lysine)
and incubated for a further 24 hours. At the end of
this second incubation the cells were no longer viable
therefore the medium and cells were separated and the
medium supernatant stored (batch 2). Both were stored
at 4°C.
5.3.2. Liquid Scintillation Counting
Counting was carried out on an LKB 1217 Rackbeta
Liquid Scintillation Counter. Samples were counted over
a 20 minute period and counts per minute (CPM) were
automatically calculated. Efficiency for tritium was
estimated at 20% by an internal standards method.
The medium supernate samples were counted directly
in scintillant in a sample size of lOul. It was found
that very little quenching occured with this sample
size and still gave a sufficient number of counts. The
cell pellet after centrifugation was dissolved in
formic acid. The cells from 1ml of suspension in log
5
phase growth ( ~10 cells ) were completely dissolved
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by lOOul of acid. Formic acid, when used in the right
cell number to volume ratio, dissolves cellular
material completely leaving a clear solution with very
little quenching effect. Unlike some other scintillant
compatable tissue solvents it can be used in plastic
tubes and plates. The control counts with formic acid
only show very little difference from the scintillant
only controls indicating very little count quenching.
The average counts from 10 control samples of lOul of
formic acid in 10ml of scintillant was 12.9 CPM whereas
for scintillant alone it was 10.5 CPM. Samples of 5ul
of cell preparation were counted.
All samples were counted in 10ml of a commercially
prepared toluene based scintillant, Cocktail T
'Scintran' ( BDH Ltd ). This scintillant was
particularly good for complete dispersal of aqueous
samp 1es.
5.3.3. Purification of Labelled Antibody by Protein A-
Sepharose Affinity Chromatography.
The pH of the supernate was adjusted to between 8
and 8.5 using 0.15M Tris / 0.05M NaCl pH8.6 buffer. It
was applied to the column at a rate of lml/min. and 5ml
fractions were eluted as described in section 2.4.3.
The presence of protein in each fraction was determined
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FIG.5.5. o-PD ELISA OF PURIFIED FRACTIONS OF 3H
P1AG11 ON FIXED PIG AORTIC ENDOTHELIAL CELLS
1 - pH 5.5 fraction (Batch 1)
2 - pH A.3 fraction (Batch 1)
3 - pH A.3 fraction (Batch 2)
A - pH 8.6 wash after sample application (Batch 1+2)
5 - P1AG11 unlabelled control
6 - Peroxidase second antibody control
measured. The absorbance profiles (Graphs 5.1 and 5.2)
show a peak at the pH 4.3 fraction which is consistent
with an increase in CPM, with the peak absorbance and
peak radioactivity occuring in the same fraction,
suggesting that the radioactivity and the protein are
associated. There is a small peak at the pH5.5 fraction
of batch 1 (graph 5.1) which in terms of absorbance
would be insignificant. Since it is associated with an
increase in CPM and therefore probably indicates the
presence of a small amount of radiolabelled protein.
With batch 2 (graph 5.2), the elution shows very little
change in absorbance and no corresponding peak in
radioactivity, so it was assumed that radio1abe11ed
protein was present in this fraction.
5.3.4. OPD - Fixed Cell Elisa Screening for Antibody.
The peak protein and radioactivity fractions from
the purification procedure were screened for antibody
activity by primary fixed cell ELISA (o-PD) (section
2.4.2). The results are shown below and in Fig.5.5.
TEST FRACTION SCORE
pH 5.5 (batch 1) ++
pH 4.3 (batch 1) +++
pH 4.3 (batch 2) ++
pH 8.6 wash/sample eluant -
P14G11 control (SN) ++
Peroxidase only control -
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The negativity of the pH 8.6 sample eluant and wash
fraction shows that all the antibody has bound to the
column. The samples positive for protein and
radioactivity contain active antibody.
5.3.5. Detection of 3[H] Antibody on SDS-PAGE and
Transferred Proteins by Scintillation Autography.
A method devised by Bonner and Laskey (1974) shows
3
that efficiency of detection of H autoradiographically
can be increased by treatment of the gel or blot with
scintillant before exposing to film. The light
generated by the interaction of the beta particles with
the scintillant exposes the film rather than the beta
3
particles directly. A sample containing 3000 DPM of H
activity can be detected after 24 hours exposure and
500 DPM after one week.
Purified antibody fractions were diluted 1:2 with
pH 6.8 gel buffer and after adding glycerol and
bromophenol blue tracking dye, 40ul samples were
applied to a 7.5% acrylamide resolving gel with a 3.3%
stacking gel and electrophoresis carried out as
described in section 2.5.2.
The gel was prepared for scintillation
autoradiography by the method described by Bonner and
Laskey (1974). Fixation and staining of the gel was
carried out as described in section 2.5.3. The
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EIG.5.8. COOMASSIE BLUE STAINED CONTROL GEL OF
H P14G11
Lane 1 - molecular weight standards
Lane 2 - pH4.3 fraction (Batch 1)
Lane 3 - pH4.3 fraction (Batch 2)
Lane 4 — unpurified "cold" P14G11 supernatant control
Jibs*
FIG.5.7. AUTORADIOGRAPH OF PURIFIED 3H P14G11 ON
7.5% ACRYLAMIDE GEL PRE-TREATED WITH SCINTILLANT
20ul samples of batch 1 and batch 2 in the same lane
FIG.5.6. AUTORADIOGRAPH OF PURIFIED 3H P14G11 ON A
7.5% ACRYLAMIDE GEL PRE-TREATED WITH SCINTILLANT
Lane 1 - pH 4.3 fraction (Batch 1), 20ul
Lane 2 - pH 4.3 fraction (Batch 2), 40ul
destained gel was then soaked in 20 times its volume of
dimethyl sulphoxide (DMSO) for 30 minutes. This was
repeated in fresh DMSO once. The gel was then
transferred to 4 volumes of 22.2% w/v 2,5 -
diphenyloxazole (PPO) in DMSO for 3 hours. After
washing in 20 volumes of water for 1 hour the gel was
dried and placed in contact with Agfa-Gevaert, Curix
RP1 x-ray film in a Kodak enhancer cassette at -70°C
for 5 days. The results are shown in Figs.5.6 and 5.7.
A coomassie blue stained control gel (Fig. 5.8) shows a
band corresponding to that of lane 1 Fig.5.6. The
coomassie blue was not sensitive enough to pick up the
corresponding band of batch 2 (lane 2). When the
autoradiograph was superimposed on the control gel the
bands corresponded to two bands with estimated
molecular weights of 169kD (bands a) and 155kD (bands
b). The experiment was repeated with samples from batch
1 and batch 2 run in the same lane (Fig.5.7) and shows
two distinct bands with estimated molecular weights of
approximately 169kD and 155kD, confirming that the
antibody purified from the two different incubation
mediums had slightly different molecular weights.
The reason for this variation in molecular weight
in what appears to be identical antibody fractions is
not immediately obvious. The differences in molecular
weight are not enough to explain it in terms of
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secretion of two different antibodies which in turn
would question the monoclonality of the cell line. A
more plausible explanation would be in the amount of
glycosylation in the heavy chains of the antibody
molecule with the length of time in culture. After the
first 24 hour incubation with the radiolabelled lysine
the cell numbers dropped and those that were viable
looked enlarged and swollen which is an indication of
impending cell death. Such cells may alter biosynthesis
of antibody for example by reducing the amount of
glycosylation of the heavy chains resulting in a
"lighter" antibody molecule without altered binding
activity. Production and secretion of IgG is not
affected by the degree of glycosylation. (Blatt and
Haimovich 1981)
5.4. DISCUSSION.
Iodination of two monoclonal antibodies by the
Iodogen method described here was not particularly
successful. With antibody D8G8/B11 (IgM) a very low
percentage incorporation of radiolabel to antibody was
attained. Despite this low specific activity (11.1
kBq/mg protein), autoradiography of immunoblots showed
that radio 1abe11ed antibody with unchanged
activity/specificity had been synthesised. However, for
the purposes of imaging individual cells, the specific
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activity of the preparation was not great enough. It is
possible that the excess of unlabel led antibody in the
preparation caused competitive inhibition of binding of
labelled antibody to sites of damage and therefore
prevented detection by autoradiography. Further work on
labelling this antibody to a higher specific activity
perhaps by using a different iodination method, may
prove useful.
Iodination of antibody P14G11 (IgG2a) by the same
method produced a preparation with a much higher
percentage incorporation of radioactive isotope.
However, subsequent autoradiographic tests showed a
high degree of non-specific activity with this labelled
antibody. Non-specific antibody binding was ruled out
as a possible cause since pretreatment of cells with an
autologous serum effectively blocked this in DAB ELISA
controls. This pretreatment did not stop high
background activity with the same concentrations of
antibody on autoradiographs. These results suggested
125
that high quantities of free I were present in the
antibody preparation. A "clean up" of the preparation
on protein A-Sepharose proved this to be right. It did
not however improve the results of the autoradiographs
and high background activity was still present. This
125
would suggest that the antibody - I bond is not
stable either as a result of the storage conditions, or
169
because of the iodination process itself. The high
background activity in the autoradiographs is probably
125
due to trapped intracellular free I which has
entered the cell through small holes in the membrane,
caused by fixation.
A different method of iodination should be tried to
see if a more stable complex is achieved. The stability
125
of ( I) iodotyrosine compounds is reported to be
between two and six weeks at 20°C in 50% aqueous
propylene glycol (Evans 1968). The iodinated antibody
was stored at 4°C which was perhaps detrimental to the
iodotyrosine bond and further work on storage
conditions needs to be done.
Internal labelling produces stable radio 1abe11ed
molecules where the label is an integral part of the
molecule and therefore inherently more stable. However
this method is restricted to low energy beta emmitors
which are limited in their use for imaging purposes.
Detection of tritiated antibody in in vitro
preparations is possible by scintillation autography.
However, if tritiated antibodies are to be of any use
in looking at in vivo or in situ distribution of




TARGETTING UROKINASE (u-PA) TO DAMAGED ENDOTHELIAL
CELLS, IN VITRO, WITH MONOCLONAL ANTIBODY P14G11.
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6.1. INTRODUCTION
The plasminogen activators t-PA and u-PA are used
therapeutically for the dissolution of clots in acute
pathological thrombosis. At present the most widely
used thrombolytic agent is Streptokinase, a nonenzymic
protein produced by strains of beta-haemolytic
streptococci. It forms a 1:1 complex with plasminogen
resulting in a combination containing an active site
which cleaves non-comp1exed plasminogen molecules to
plasmin (Kosow 1975). It does not distinguish between
fibrin bound plasminogen and circulating plasminogen,
and therefore causes systemic fibrinogen depletion
resulting in bleeding complications.
Acylated plasminogen-streptokinase complex (APSAC)
has an increased affinity for lysine binding sites on
fibrin and an active site inhibited by the acyl group
until it reaches its target. On binding to fibrin the
acyl group is removed by hydrolysis allowing activation
of plasminogen to plasmin . This mechanism reduces
systemic fibrinogen depletion and hence iatrogenic
bleeding to some extent. Both streptokinase and
APSAC cause hypotension and immune reactions as well as
bleeding complications, these side effects are well
documented (Mander and Sherry 1988, de Bono 1987).
Recombinant human t-PA and scu-PA have a number of
advantages over streptokinase and APSAC in terms of
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side effects, virtually no hypotension and immune
reactions occur with these reagents. t-PA is relatively
inactive in the absence of fibrin therefore systemic
fibrinogen depletion is avoided to some extent (de Bono
1987). However to obtain rapid coronary reperfusion
plasma t-PA levels are raised to approximately 1000
times normal physiological levels, which can result in
systemic activation of the fibrinolytic system (Collen
et al 1986) .
Single chain u-PA / pro-urokinase has similar
advantages over streptokinase and APSAC, and research
into its clinical use continues.
Effective thrombolytic agents that do not cause
systemic bleeding must distinguish between obstructive
thrombi and those preventing haemorrhage. At present no
such agents exist. Thrombus formation can occur at
areas of the vessel where the endothelial cells have
been lost, damaged or altered in response to various
events. Such areas do not involve subintimal damage
that would result in extravascu1ar bleeding. Monoclonal
antibodies that recognise damaged or altered
endothelial cells, or exposed basement membrane may
prove useful in targetting fibrinolytic agents to such
areas. The following experiments demonstrate the
conjugation of u-PA with a monoclonal antibody and the
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DIAG. 6.1 SPDP linkage of monoclonal antibody to urokinase
damage.
The monoclonal antibody P14G11 was chosen for the
conjugation because it binds to non-fixed damaged
endothelium it cross-reacts with human endothelium
(section 3.8 and 3.9). It is also an IgG2a subtype
which is relatively easily purified by protein A -
sepharose chromatography.
The heterobifunctional linking agent n-succinimidy1
3-(2-pyridyldithio)proprionate (SPDP), developed by
Carlsson et al 1978 reacts with amino groups on the
antibody, thereby introducing a reactive disulphide
group to the antibody. Reduction of the disulphide
bridge of urokinase leaves a free sulphydril group
which interacts with the derivatised antibody resulting
in the formation of an intramolecular disulphide link
(Bode et al 1985). The reaction is shown in diagram
6.1.
6.2. SPDP LINKAGE OF UROKINASE TO ANTIBODY
Antibody P14G11 was purified from ascites fluid by
protein A - sepharose affinity chromatography (section
2.5.3.). Two protein peaks were obtained in pH5.5 and
pH4. 3 fractions, both contained antibody with identical
activity. Protein fractions were pooled, neutralised
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and concentrated by ultrafiltration. Protein content
was estimated by the method of Bradford (1976).
SPDP was diluted to 2mM in absolute ethanol. P14G11
at 6.5mg in 3.0ml of phosphate buffered saline (PBS)
pH7.4 was mixed with 50ul of 20mM SPDP and allowed to
react for 30 minutes at room temperature (RT). This was
dialysed three times against 1 litre of PBS. Urokinase,
from human kidney cells, was dissolved in 0.1M sodium
acetate / 0.1M NaCl pH4.5 at 4mg/ml in a 2ml volume.
This was reduced by the addition of 0.23ml of 1.0M
dithiothreitol (DTT) / 0.1M sodium acetate / 0.1M NaCl
pH4 . 5 for 30 minutes at RT. DTT was removed by
desalting on Sephadex G25 (1.5 x 12 cm column)
equilibrated with PBS pH4.5. Peak fractions were pooled
and concentrated by ultrafiltration to an approximate
volume of 5ml. The dialysed PDP - Ab complex and the
reduced urokinase solutions were mixed, neutralised and
allowed to react overnight at RT. Unreacted molecules
were removed by gel filtration on Sepharose - 6B (1.5
x 70 cm column) equilibrated with 0.3M NaCl. Elution
was carried out with 0.3M NaCl. The protein fraction
was collected in the void volume (20ml) and
concentrated by ultrafiltration to 10ml and stored at
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FIG.6.1. Ab-u-PA FRACTION ON SCRATCH DAMAGED CELLS.
Cells at scratch edge show antibody binding.
6.3. PREPARATION OF FIBRIN PLATES
Fibrinogen Grade L (Kabi Vitrum) was dissolved in
tris buffered saline (TBS) pH7.4 at lg in 65ml and
stored at -20°C in 1ml aliquots. Stock solutions were
diluted 1:10 in TBS pH7.4. This grade of fibrinogen
contained approximately 3 to 4 micrograms/ml of
plasminogen and no additional plasminogen was required
for clotting. Thrombin was added to the fibrinogen at 1
unit / ml immediately before the gel was poured. Gels 1
to 2mm thick were made on plastic wells or plates and
allowed to set on a level surface for at least 20
minutes.
6.4. ANTIBODY BINDING ACTIVITY OF CONJUGATE
The antibody activity of the urokinase - antibody
conjugate (Ab-u-PA) was assessed by antibody / DAB
staining of scratch damaged monolayers . Bovine aortic
endothelial cells were used because of their abundance
and reliable growth. All experiments were carried out
on the same cell line at the fourth or fifth
subculture.
The Ab-u-PA fraction bound to damaged cells at the
scratch edge (Fig. 6.1). If conjugation of the two
proteins had indeed occured this result shows that the
antibody binding sites had not been destroyed by the
conjugation process or masked by the urokinase
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molecule, nor had this affected recognition of the
antibody by the peroxidase labelled second antibody in
the screening process.
6.5. UROKINASE ACTIVITY OF CONJUGATE
Urokinase activity of the Ab-UK fraction was
assessed by fibrin gel lysis. Fibrin gels were made in
24mm diameter wells of a 12 well tissue culture plate.
Dilutions of the Ab-UK were added as lul drops to the
centre of each gel. The plate was sealed and incubated
overnight at 37°C. The gels were rinsed and fixed in
methanol for 15 minutes and stained with 0.25%
Coomassie blue / ethanol for 30 minutes. Excess stain
was rinsed off with water and the gels were
photographed immediately. (Fig.6.2)
Urokinase activity was present in the Ab-u-PA
fraction as indicated by lysis of fibrin gels. The
control well shows some thining and loss of fibrin in
the centre of the well, which probably occured during
the fixation and staining process.
6.6. SDS - PAGE ANALYSIS OF CONJUGATE
SDS - polyacrylamide gel electrophoresis (SDS-PAGE)
(section 4.2.2) of the Ab-UK complex was carried out
under non - reducing conditions . Samples were diluted
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FIG.6.3. SDS - POLYACRYLAMIDE GEL OF Ab-u-PA.
Lane 1 - molecular weight standards
Lane 2 - purified P14G11
Lane 3 - urokinase
Lane 4 - Ab-u-PA
in 0.25M Tris / 0.2% SDS pH6.8 with 5 to lOug of
protein present in 50ul. A drop of glycerol and
bromophenol blue tracking dye was added to each 50ul
sample, which was then layered onto the appropriate
well of a 7.5% resolving gel with a 3.3% stacking gel.
Electrophoresis was carried out at 50mA constant
current until the buffer front was through the stacking
gel and then at 70mA until the front was 2cm from the
gel end. The gel was stained in 0.25% Coomassie Blue in
ethanol overnight and destained in repeated changes of
1:4 ethanol: 5% acetic acid.
The stained gel (Fig.6.3) showed the purified
antibody (lane 2) to run as two bands, a major band (a)
which was presumed to be the IgG2a molecule at the 150
- 160kD region and a faint band of higher molecular
weight (b). This higher molecular weight band was at
first thought to be a contaminating protein from the
antibody purification procedure. A control of IgG2a
should have been included to confirm this. Lane 3 shows
urokinase (molecular weight 33kD). The Ab-u-PA fraction
gave the same pattern as the free antibody. In theory
IgG and urokinase should have a combined molecular
weight of around 180 - 190kD. The high molecular weight
band which is much more definite in lane 4 (c) may well
be Ab-u-PA and with the majority of the protein in the
fraction being unreacted antibody. To test this idea
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the two bands were cut out of the SDS gel and placed on
a fibrin gel to see which band had fibrinolytic
activity. Unfortunately the SDS gel controls also
caused fibrinolysis. This was attributed to the
incomplete removal of SDS from the gel, which could not
be removed by rinsing alone. Attempts to run the
samples on native polyacrylamide gels, to overcome the
SDS problem, were not successful. Western blotting
techniques were applied to the SDS-PAGE samples
excluding SDS from the transfer buffers. Transferred
conjugate samples (on Immobilon P membrane) were
applied to fibrin gels for up to 48 hours. No lysis was
noted after this time and it was assumed that
conditions of transfer had inactivated the enzymatic
properties of the u-PA molecule.
The only statement that can be made from the
results of the SDS-PAGE analysis was that the Ab-u-PA
fraction did not contain free urokinase. Since this
fraction did have fibrinolytic activity (6.4) it was
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GRAPH 6.1 Standard curve of urokinase activity
(Ukidan 5000, Serono Laboratories UK.)
6.7. QUANTITATIVE ASSAY OF UROKINASE WITH CHROMOGENIC
SUBSTRATE S-2444.
Chromogenic substrate S-2444 (Kabi Diagnostics)
works on the principle of the rate at which p-




pNA release is measured photometrically at 405nm with
the correlation between absorbance and u-PA activity
linear in the range 5-40 Ploug (1.5 I.U) or CTA units
(1.0 I.U).
The standard curve (Graph 6.1) was prepared using a
urokinase preparation from Serono Laboratories UK
(Ukidan 5000) which had an activity of 5000 I.U / ml.
The urokinase used in the antibody conjugation
procedure was obtained from Sigma. Enzyme activity of
this preparation was given in Sigma Units, each Sigma
unit being equivalent to 5000 - 10000 Ploug units,
making the preparation of a standard curve from this
urokinase extremely difficult. Absorbance and











5 0.022 0. 022 0 . 022
10 0. 048 0. 048 0. 048
20 0. 099 0. 092 0 . 096
30 0.151 0. 124 0 . 138
AO 0.172 0. 230 0 . 201
Samp 1e
0. 104 0 . 103 0. 104
From the standard curve the activity of urokinase in
the Ab-u-PA sample is approximately 20 I.U. in 100
microlitres = 200 I.U / ml. Protein concentration of
the conjugate fraction was estimated at 9 micrograms /
ml (Bradford 1976).
6.8. UROKINASE ACTIVITY OF CONJUGATE WHILE BOUND TO
DAMAGED ENDOTHELIAL CELLS
Bovine cells were grown to confluency on 16mm
diameter glass coverslips. The endogenous fibrinolytic
activity of the cells (6.1) was inactivated by
incubation with a 1:100 dilution of guanidine activated
plasminogen activator inhibitor - 1 (PAI-1) from human
umbilical vein endothelium (HUVEC) conditioned growth




FIG.6.4. FIBRINOLYTIC ACTIVITY OF Ab-u-PA WHILE BOUND
TO CELLS DAMAGED BY AIR DRYING.
A - undamaged cells control (endogenous fibrinolysis)
B - undamaged cells + PAI-1
C - damaged cells only (no endogenous fibrinolysis)
D - damaged cells + Ab-u-PA
E - undamaged cells + Ab-u-PA
F - glass coverslip control
National Blood Transfusion Service ). The cells were
rinsed well with PBS to remove all traces of inhibitor
and then damaged either by scratching or air drying for
20 minutes at 37°C. After fixing for 10 minutes in 0.1%
gluteraldehyde, the cells were incubated with Ab-UK at
1:10 in PBS for 1 hour at 37°C. Each coverslip was
rinsed 5 times in PBS and carefully lowered cell side
down onto a fibrin plate, prepared as above, with
appropriate controls. Plates were sealed in a
humidified container and incubated at 37°C for 24
hours. The plates were then flooded with methanol and
the coverslips gently removed. After fixing gels were
stained with Coomassie blue. Each test was done in
duplicate with one set of coverslips being stained for
antibody.
Endogenous fibrinolytic activity of undamaged
endothelial cells (Fig.6.4A) was inhibited by PAI-1
(Fig.6.4B). Damage to the cells by air drying switches
off endogenous fibrinolytic activity (Fig.6.4C). Air
dried damaged cells incubated with the Ab-u-PA fraction
showed complete lysis of the fibrin which had been in
contact with the cells (Fig.6.4D). Undamaged cells
treated with Ab-u-PA did not show fibrinolytic activity
(Fig.6.4E). Ab-u-PA DAB stained controls of D showed
heavy staining of damaged cells with antibody and with
E, no staining of undamaged cells. Fig.6.4F is a plain
182
FIG.6.5. FIBRINOLYTIC ACTIVITY OF Ab-u-PA ON SCRATCH
DAMAGED CELLS.
A - scratch damaged cells + PAI-1 only
B - scratch damaged cells + PAI-1 + Ab-u-PA
glass coverslip control.
Scratched damaged cells have perhaps more
physiological significance. The results of the air
dried damage model showed this type of damage to
inactivate u-PA and t-P activity of the cells. With
scratch damaged cells only a very small proportion of
the cells on the coverslip are damaged and it is not
known if this type of damage inactivates endogenous PA
activity. Fig.6.5A shows a fibrin gel incubated with
scratch damaged cells (3 scratches through the centre
of the coverslip) and treated with PAI-1 only. Small
areas of fibrinolysis were present but these were not
associated with the scratches. Fig. 6.5B shows a gel
incubated with scratch damaged cells, treated with PAI-
1 and incubated with Ab-u-PA after thorough rinsing.
Lysis of the gel at the areas of scratch damage are
clearly visible. DAB stained controls showed heavy
staining of cells along the scratch edge after
incubation with Ab-u-PA. Photographs of the DAB stained
controls are not shown (see Fig.6.1 for example).
6.9. REGENERATION OF CELLS AT SITES OF DAMAGE TREATED
WITH Ab-u-PA CONJUGATE
Endothelium denuded areas are re-covered by
spreading and multiplication of the cells along the
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5. DAMAGED MONOLAYER 2 HOURS AFTER SCRATCHING.
7. DAMAGED MONOLAYER 12 HOURS AFTER SCRATCHING.
luded area has been completely recovered. Cells
site of damage are elongated and less dense than
Ln undamaged areas.
. DAMAGED CELLS 24 HOURS AFTER SCRATCHING.
atched area has completey regrown.
scratch edge. Under optimal culture conditions, a small
denuded area (3 to 4 cells wide) was usually re-covered
by cell spreading in 4 to 6 hours and complete regrowth
of the cells occurred within 12 to 24 hours, depending
on the width of the scratch. The effect on regrowth of
a scratched area of bound Ab-UK was investigated.
Bovine cells of the same cell line as used for the
other experiments were grown to confluence in 24 well
plates and scratched as before. Ab-UK was added at a
1:10 dilution in complete growth medium and the cells
were replaced in the incubator for 24 hours.
Observations were made at 2 hourly intervals and
photographs were taken (Figs.6.6, 6.7 and 6.8).
Unconjugated P14G11 (1:10) and urokinase at 0.025 units
/ ml were included in the controls. There was no
difference in speed of regrowth of the cells treated
with Ab-UK from any of the controls. These cells were
then fixed and stained for antibody by DAB substrate
reaction with negative results.
6.10. DISCUSSION.
The results of these experiments have shown that
monoclonal antibody P14G11 to damaged endothelium in
vitro can be conjugated to urokinase without loss of
antibody specificity or u-PA fibrinolytic activity. The
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u-PA activity was preserved while the conjugate was
cell bound and fibrinolytic activity appeared to be
restricted to areas of damage. Further work needs to be
done to quantify binding of urokinase to the antibody
molecule and to quantify it.
Bovine aortic endothelial cells were chosen for
these initial experiments because of their availability
and ease of growth and they produce less tissue -
plasminogen activator (t-PA) than human cells although
urokinase type - plasminogen activator (u-PA)
production does increase with length of time in culture
(Levine et al 1979). Endogenous production of
plasminogen activators was inactivated with PAI-1 to
prevent interference with the urokinase activity of the
test substance. The PAI-1 used was from a human source,
but was known to have inhibitory action on bovine t-PA
and u-PA (personal communication from Dr McGregor).
Damage to bovine endothelial cells by air drying was
found to inactivate endogenous fibrinolysis.
The conjugate also binds to unfixed damaged cells
and does not inhibit or restrict regrowth of cells over
denuded areas (6.9). The presence of active urokinase
after or even during cell regrowth is highly unlikely
due to the presence of inhibitors in the growth medium
from the endothelial cells. After cell regrowth the
monolayer was tested for the presence of antibody and
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very little staining was found. The Ab-u-PA had
probably been internalised and degraded by regenerating
cells.
The potential use of thrombolytic agents targeted
by coupling to monoclonal antibodies which recognise
damaged endothelium must remain speculative until they
can be tested further in and in vivo. It is unlikely
that they would be useful in treatment of coronary
thrombosis where established fibrin thrombus is greater
in proportion to damaged endothelium. Anti-fibrin
antibodies are already in existenceand would prove much
more effective in the dissolution of established fibrin
clots (Hui et al 1983).
Ab-u-PA preparations might have an important role
in preventing thrombus formation at the site of local
endothelial damage until the endothelium had time to
heal. This could have applications in vascular, and
particularly in microvascular, surgery, where
prevention of local thrombosis is desirable, but
systemic anticoagulation potentially hazardous. Local
application of a targetted thrombolytic drug at the
time of surgery would provide a means of ensuring such





The aims of the work described in this thesis were
to :
1. Develop monoclonal antibodies specific to damaged
or regenerating endothelial cells .
2. To partially characterise the antigens recognised
by these antibodies.
3. To use such antibodies for the detection of
damaged / regenerating endothelial cells in vascular
disease and assess their suitability for diagnostic
uses .
4. To conjugate these antibodies with thrombolytic
agents and target such activity specifically to areas
of damage.
Antibodies raised against bovine, porcine and human
endothelial cells produced a number of
immunohistochemical staining patterns on in vitro
damaged cell models. The majority of antibodies
staining damaged cells were raised against bovine and
porcine aortic endothelium. Human umbilical vein
endothelial cell immunisation group produced fewer
stable antibodies against damaged cells. No anti-
damaged endothelial cell antibodies were found with the
adult human saphenous vein immunised group. This group
did however produce antibodies directed against
intracellular granules of giant cells in senescing
cultures. Further investigation into the behaviour and
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characterisation of these antibodies may be justified.
Most of the anti-damaged cell antibodies raised
were IgM subtypes which bound to fixed damaged cells
but not to unfixed damaged cells. Antibody P14G11, an
IgG2a subtype was an exception and bound with equal
affinity to both fixed and unfixed cells. This effect
might be due to the differences in size and
stereochemistry of the IgM and IgG2a molecules in
attaining access to intracellular proteins through
damaged cell membrane.
Antibody cross-reactivity between bovine, porcine
and human endothelium existed. However, these
antibodies were not tested on cultured endothelium from
sources other than aortic, saphenous vein or umbilical
vein. Antibody reactivity with microvascular or
lymphatic endothelium is not known. Cross-reactivity
with fibroblasts and smooth muscle cells exists with
some of the anti-damaged bovine endothelial cell
antibodies. However these findings were not consistent
and more work must be done on defining specificity and
cross-reactivity of these antibodies, not only on
vascular cells but also with other cell types.
Cells damaged by other methods; air drying, heat,
hyperoxia, exposure to thrombin and to hydrogen
peroxide could also be detected by antibodies to
scratch damaged cells. Endotoxin damage could not be
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detected by these antibodies.
Cell monolayers grown on 24 well and 96 well
culture plates under normal conditions were shown to
have defined areas of non-deliberate damage. This
appeared to be sublethal injury under normal conditions
but under conditions of induced injury, such as
treatment with thrombin and hydrogen peroxide, these
cells appeared to have a predisposition for lethal
injury.
The causes of this "spontaneously" occuring injury
have not been defined but may have relevance in the
interpretation of the in vitro behaviour of "normal"
endothelial cells and may therefore warrant further
investigation.
A limited number of antibodies were tested on
frozen sections of lung, lymph node and thyroid gland
tissues. Only antibody D6F1 gave a positive staining of
endothelial cells in lung sections. The others either
gave negative results or high background non-specific
staining. Further work should be done using tissue
sections, with improvements and changes to the staining
techniques and tissue fixation procedures.
In recent years many endothelial cell antigenic
components have been identified and characterised ,
highlighting the complexity of the structure and
function of these cells. Adhesion molecules such as
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ELAM-1 (Bevilacqua et al 1989), ICAM-1 (Simmons et al
1988), VCAM-1 (Osborn et al 1989), PECAM-1 (Newman et
al 1990) and the co-expression of haemopoietic CD
antigens on vascular endothelial cells (Favaloro et al
1990) have added to the understanding of the processes
of inflammation. Other cell surface and cell membrane
proteins have been characterised and putative functions
ascribed to them (Darnule et al 1983, Dickinson et al
1986, Arvieux et al 1986, Kaplan et al 1983, Sage et al
1986).
Attempts were made to determine the molecular
weights of the antigens recognised by the monoclonal
antibodies by SDS PAGE analysis of endothelial cell
proteins. Using differential staining techniques,
subtle differences were found in total protein and
1ipoprotein/sia1oglycoprotein band patterns between
bovine and porcine aortic and human umbilical and
saphenous vein endothelium.
Changes in band pattern were also seen in cells of
increasing culture age. This finding determined the
number of subcultures at which cells were used for
immunoblot analysis.
Molecular weight estimations were determined using
standard procedures. Variations in the results occurred
from gel to gel even if experimental conditions were
repeated as accurately as possible. To overcome such
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variability the estimated molecular weight of a
particular protein band was taken as the average from
three gels. The most probable source of errors would
appear to be in the length of time the gel was run and
also in the timing of the staining and destaining
procedure. This ultimately affected the relative
mobilities of the proteins through variations in the
size of the gel and the distance travelled by
individual protein bands. It seems likely that more
stringent experimental technique would solve the
problems incurred by such inaccuracies.
Separated endothelial cell proteins were
transferred e1ectrophoretica1ly to nitrocellulose or
polyviny1idenedifluoride (Immobilon P) membranes for
antigen determination with monoclonal antibody. Three
molecular weight regions were detected by antibodies to
damaged cells; 75kD, 47-55kD and 15-18kD. Non-specific
IgG staining was characterised by staining of bands at
18kD and 30-33kD regions. These findings contradict
previous studies which have shown non-specific IgG
binding to the vimentin component of intermediate
filaments (Hansson et al 1984). Vimentin is a single
chain molecule of approximately 55kD. The results of
the experiments shown in this work would suggest that
vimentin may not be the only non-specific binding site
for IgG. Antibody D8G8 reacts with three proteins in
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this molecular weight range, 15,17 and 18kD. Pre-
blocking of non-specific binding sites with IgG does
not inhibit D8G8 binding, showing that it is not a non¬
specific effect and that binding of this antibody
occurs at a different epitope on the same protein
mo 1ecule.
The SDS-PAGE experiments have shown that at this
level of protein separation there is a great deal of
structural homogeneity between endothelial cells from
different species. It has also shown changes in
cellular protein content associated with in vitro
ageing. This may have relevance in the interpretation
of results of work involving highly passaged cells.
The conclusions to be drawn from this work are
limited by the inadequacies of the separation
technique. Many different proteins have the same
relative mobilities, molecular weights but differ in
structure and function. From the immunoblot experiments
antibodies that stained identical bands may in fact be
binding to functionally different proteins. Two
dimensional electrophoresis, with separation by
isoelectric focussing in one dimension and by
conventional reductive electrophoresis in the second
dimension would enhance this work and give a more
detailed analysis of endothelial protein content and
antigenicity. Purification of the antigens could be
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achieved by immunoprecipitation giving a more detailed
picture of structure and function. However this was
beyond the scope of this thesis and is part of the work
in progress.
Attempts to label two of the anti-damaged cell
monoclonal antibodies with radionuclides for use in an
in vivo model system were met with limited success.
Radioactive iodine labelling by the Iodogen method
was partially successful with antibody D8G8. The
labelled antibody - antigen complex could be detected
by autoradiography on Western blots. However
autoradiographs of scratch damaged cell bound antibody
did not work. This may have been due to the presence of
unlabel led antibody in the preparation which had
greater affinity for the antigenic binding sites than
the radio 1abe11ed antibody. Competition binding assays
between labelled and unlabel led antibody should have
been performed to confirm this. On the other hand there
simply may not have been enough radioactivity present
in this damaged cell model to be detected by
autoradiography.
Radioactive iodine labelling of antibody P14G11 was
not successful. Autoradiographic analysis of Western
blots, scratch damaged and air dried damaged cells gave
high background and non-specific activity after
repeated purification procedures. This was thought to
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be caused by the dissociation of iodine label from the
antibody. The instability of the complex may have been
due to the coupling conditions and perhaps P14G11 being
an IgG molecule could have withstood the slightly
harsher conditions of 1actoperoxidase or Chloramine T
coupling.
It did however prove feasible to produce tritium
labelled D8G8 and P14G11 by internal labelling with
tritiated lysine. Both tritiated antibodies were stable
for a considerable length of time. However, the
difficulties in detecting low energy beta emmision by
direct visualisation procedures makes the use of
tritiated antibody in in vivo studies impractical.
Covalent linkage of antibody P14G11 with urokinase
proved more successful in terms of conjugate stability
and specificity of antibody binding. In the in vivo
damaged cell model, fibrinolytic activity was confined
to areas of damage. This activity was attributed to
antibody bound urokinase. Binding of the antibody -
urokinase conjugate did not inhibit cell regeneration.
It is unlikely that such a conjugate would be useful in
the treatment of coronary thrombosis where thrombus is
already well established. However, local application of
such a thrombolytic agent may prove useful in vascular
surgery where local fibrinolysis is desirable but
systemic anticoagulation potentially hazardous.
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APPENDIX : LIST OF SUPPLIERS.
All general laboratory chemicals, unless otherwise
stated were obtained from :









All electrophoresis chemicals were "Electran" grade
from BDH.
Electrophoresis and protein blotting equipment was from
Pharmacia LKB Biotechnology
351 Midsummer Boulevard
Milton Keynes MK9 3HP
All tissue culture culture mediums, serums and plastics







Collagenase was obtained from :
Boehringer Mannheim UK Ltd
Bell Lane
Lewes
East Sussex BN7 1LG.
All antisera used in the antibody detection systems
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